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1. INTRODUCTION: ALLENAMIDES 
In recent years, the interest in allenes drastically increased due to their importance as building 
blocks in a large variety of synthetic transformations.[1,2] The allenes were largely employed in 
cycloaddition reactions,[3] but their challenging synthesis and their poor predisposition toward 
electrophilic activation encouraged the development of allene-equivalent compounds.  Heteroatom-
substituted allenes, in particular allenamines, have received low attention from the scientific 
community, so far. In this class of compounds, the π-donating ability of the nitrogen atom makes 
allenamines more electron-rich than allenes allowing their easy electrophilic activation. Despite 
their synthetic potential, few developments have been achieved in their manipulation due to the 
high sensibility toward hydrolysis and the tendency toward polymerization and isomerization even 
at low temperature. In order to overcome these issues, it was identified an allenamine-equivalent 
where the heteroatom is bonded to an electron-withdrawing group. This functionalization reduces 
the reactivity of the allenic framework but, at the same time, makes the allenic system more stable 
(Figure 1).[4–6]  
 
Figure 1: Disadvantages and advantages in the use of allene, allenamines and allenamides. 
Allenamides were prepared the first time by Dickinson[7] in 1967 by treating 2-pyrrolidinone with 
NaH and propargyl bromide. In contrast, when less reactive amides (for example N-tosylaniline or 
2-oxazolidinone) were used in place of the 2-pyrrolidone moiety was not possible to obtain the 
desired allenamides using the synthetic procedure reported by Dickinson. Indeed, the reaction was 
not complete and it was possible to isolate only the propoargylamide intermediate 3 (Scheme 1). A 
treatment of the latter with catalytic amount (30 mol%) of t-BuOK is required to drive the reaction 
toward the formation of desired product 4 (Scheme 1). 
 Challenging in synthesis 
 Limited reactivity 
 Challenging in manipulation 
 High sensibility toward hydrolysis 
 Easy in preparation 
 Easy electrophilic 
activation 
 Large stability 
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Scheme 1: Preparation of allenamide 4. 
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2. REACTIVITY 
The allenamides have been employed in numerous methodologies. Their electrophilic activation 
promoted by soft-metals (such as gold-based catalysts) or Brønsted acid leads to the formation of an 
iminium ion intermediate which in turn could be employed in addition reactions as well as in formal 
cycloaddition reactions. Additionally, the α-substituted allenamides can undergo an isomerization 
reaction with consequent formation of dienes (or trienes) which can be used in further cycloaddition 
reactions. Moreover, the large flexibility of allenamides allowed their employment in other 
reactions such as palladium-catalysed cross coupling reactions as well as in epoxidation reaction 
and followed by [4+3] cycloadditions (Scheme 1).  
 
Scheme 1: Allenamides as powerful building blocks in organic synthesis. 
In the following chapter some examples about the use of allenamides in organic synthesis are 
reported in order to highlight their large versatility as building blocks.  
2.1 Cycloaddition 
2.1.1 Inverse Electron-Demand Hetero[4+2] Cycloaddition 
In 1999 Hsung and co-workers[8] documented the inverse electron-demand hetero[4+2] 
cycloaddition reaction of allenamide 5 with α,β-unsatured carbonyl compounds 6 under both 
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thermal and acidic conditions obtaining the corresponding products in moderate yields. The authors 
reported that allenamides featuring an oxazolidinone or imidazolidinone scaffold resulted more 
reactive (Scheme 2). 
 
Scheme 2: Pioneering studies in inverse demand hetero[4+2] cyclization reactions with allenamides. 
Subsequently, Hsung reported the first stereoselective variant[9] of title cycloaddition reaction using 
a chiral allenamide as substrate. A range of chiral allenamides as well as heterodienes were 
submitted under optimized reaction conditions resulting in the corresponding products in good 
yields and excellent stereoselectivity (Scheme 3). 
 
 
Scheme 3: First stereoselective inverse demand hetero[4+2] cycloaddition reactions with allenamides. 
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The value of these 2-substituted pyranyl heterocycles was demonstrated with their employment  in 
the synthesis of the C1—C9 subunit (Cossy’s intermediate) of (+)-Zincophorin (Scheme 4).[10] 
 
Scheme 4: Synthesis of  (+)-Zincophorin. 
 
2.1.2 Formal [4+2] and [2+2] Cycloaddition 
The [4+2] Diels-Alder reaction is among the most powerful synthetic methods for the synthesis of 
unsatured six-membered rings due to its ample scope and simplicity of operation. López and 
Mascareñas[11], as well as Toste[12–14] and Fürstner[15], reported gold-catalysed intramolecular [4+2] 
cycloaddition of allene-tethered-dienes in order to develop a very efficient protocol for trans-fused 
bicyclic system. Subsequently, López and Mascareñas, with the aim of extending the use of this 
intramolecular cycloaddition toward more challenging intermolecular variant, developed the first 
transition metal-catalysed [4+2] cycloaddition between non-activated 1,3-dienes and 
allenamides.[16] They started their investigation trying to use electronically neutral allenes instead of 
allenamides in the process but no satisfactory results were achieved. On the contrary, the use of 
electron-rich allenamides in the condensation with isoprene in the presence of PPh3AuCl/AgSbF6 
resulted in the generation of the desired [4+2] cycloadduct product although with the concomitant 
and unexpected formation of the [2+2] cycloadduct side-product (Scheme 5). 
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Scheme 5: First transition metal-catalysed [4+2] cycloaddition of allenamides. 
In order to avoid the formation of product 20, they carried out the condensation between 8a and 
isoprene in the presence of different cationic Au-catalysts, but also the cyclobutane derivatives have 
been isolated in all of the cases. Finally, the neutral AuCl catalyst promoted the reaction with 
complete regio- and very high stereoselectivity toward the selective formation of the [4+2] 
cycloadduct 19aa in 65% yield. In order to prove the scope of the methodology, several differently 
substituted dienes and allenamides were submitted under optimized reaction conditions resulting in 
the corresponding products in good to excellent yields and in some cases with complete 
stereoselectivity (Scheme 6). 
 
 
Scheme 6: Optimized reaction conditions and scope of the regio- and stereoselective [4+2] cycloaddition. 
With the use of chiral allenamide 12a it was also possible to develop an enantioselective variant of 
this methodology. Furthermore, product 19 presents an enamide group which is a powerful building 
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block for further functionalizations. Indeed, under acidic conditions followed by reduction with 
NaBH4, it was possible to isolate the desired alcohol 23 in good yield and 9:1 diastereoisomeric 
ratio (Scheme 7). 
 
Scheme 7: Enantioselective variant of the [4+2] cycloaddition (a) and highly diastereoselective reduction (b). 
Mechanistically, the formation of undesired [2+2] cycloadduct and the presence of small amounts 
of allylether 24a, observed when the reaction has been carried out in the presence of MeOH, 
suggested the formation of an iminium ion as the intermediate. Indeed the first nucleophilic 
trapping of the iminium ion A intermediate results in the formation of allyl cation intermediate B 
which can undergo the second nucleophilic attack in the terminal carbon, resulting in a cyclohexene 
adduct 19aa or in the more substituted carbon, resulting in the cyclobutane adduct 20aa (Scheme 
8).  
 
Scheme 8: Proposed mechanism for the formation of 24aa, 20aa and 23a. 
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Subsequently, in particular in 2013, the same authors, in collaboration with Ujaque, performed 
combined experimental and computational studies in order to shed light on the reaction mechanism 
of the process.[17] Based on the obtained results, they demonstrated the formation of metal allyl 
cation from the electrophilic activation of allenamide by gold-catalyst, but the formation of desired 
[4+2] product took place through concerted [4+3] cycloaddition followed by ring contraction event 
(Scheme 9).  
 
Scheme 9: Mechanism for the formation of 19a. 
Considering the synthetic and medicinal relevance of the cyclobutane framework, the authors 
developed a gold-catalysed intermolecular [2+2] cycloaddition between allenamides and trans-
methyl styrene.[18] They found that the best catalyst to obtain the cyclobutane derivatives in 
selective manner was the π-acidic cationic phosphite gold(I) catalyst. They were able to isolate the 
desired cyclobutane 25aa in 51% yield, but by performing the reaction in the presence of 4 Å 
molecular sieves in the mixture and by adding the allenamide 8a over one hour, the yield of 25aa 
increased up to 80%. Subsequently they demonstrated the scope of the method by submitting 
differently substituted styrenes in the reaction with allenamide 8a and by isolating the desired 
cyclobutane derivatives in good to excellent yields (Scheme 10). 
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Scheme 10: Optimized reaction conditions for the Au(I)-catalysed [2+2] cycloaddition of the allenamides and its ample 
scope. 
In the same time González and co-workers in 2012, reported an intermolecular [2+2] cycloaddition 
of allenamides using electron-rich enol ethers as alkenes.[19] The phosphite-based gold-catalyst 26 
used by López and Mascareñas resulted to be the best promoting agent also for this transformation. 
It delivered the product from the condensation of allenamide 4 and 2,3-dihydrofuran 27a in 86% 
yield with complete cis-selectivity for the configuration of bicycle linking and Z configuration for 
the double bond. The scope of the reaction has been investigated by submitting differently 
substituted allenamides as well as enol ethers under optimized reaction conditions (Scheme 11). 
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Scheme 11: Optimized reaction conditions and scope for the intermolecular [2+2] cycloaddition with electron-rich enol 
ethers. 
The reaction was tolerant toward different functional groups delivering the corresponding products 
in good to excellent yields and complete stereoselectivity when cyclic enol ethers were used. Also 
acyclic enol ethers were employed in the transformation resulting in the desired products in good 
yields. 
In this line, González and co-workers in 2012 reported the first enantioselective gold(I)-catalysed 
intermolecular [2+2] cycloaddition in order to develop a synthetic procedure for enantioenriched 
cyclobutane derivatives.[20] The enantioselective step of the process is the nucleophilic attack from 
the enamide in the intermediate C to the allyl cation and they suggested that the enantioselectivity 
could be controlled by a chiral ligand on the gold catalyst (Scheme 12). 
 
Scheme 12: First enantioselective Au(I)-catalysed intermolecular [2+2] cycloaddition. 
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In this line, they started their investigation by testing different chiral phosphine ligands for gold(I) 
catalysts in the condensation of allenamide 4a and 4-methoxystyrene 29a in dichloromethane and 
very low temperature due to the high reactivity of allenamide. Subsequently, the investigation 
continued by testing the effect of the nature of the sulfonyl group bonded to the nitrogen confirming 
the sulfonyl group as the best one. The scope of the reaction was proved by submitting several 
differently substituted styrene derivatives and allenamides under optimized catalytic conditions. 
The methodology resulted to be tolerant toward different functional groups and the enantiomeric 
excesses of the products were not influenced by the nature of the substituent (Scheme 13). 
 
 
Scheme 13: Optimized reaction conditions for enantioselective [2+2] cycloaddition and scope of the reaction. 
Furthermore, the enantioselective methodology was also used to prepare cyclobutanes containing 
challenging quaternary carbon centers.[21] Using α-methylstyrene as alkene in the reaction the 
desired product has been obtained without significant variations in term of yield and enantiomeric 
excess respect the model reaction (Scheme 14). 
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Scheme 14: Synthesis of cyclobutane containing quaternary center. 
In order to develop the first asymmetric variant of intermolecular [4+2] cycloaddition of 
allenamides and dienes, López and Mascareñas designed a new chiral NHC-gold(I) complex[22] 
since chiral acyclic diaminocarbene gold-complexes were recently employed in enantioselective 
applications.[12,23]  
 
 
Scheme 15: First asymmetric variant of intermolecular [4+2] cycloaddition of allenamides and scope of the reaction. 
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They synthetized a rigid bicyclic structure to fix the orientation of the C(carbene)-Au bond and the 
closer groups R and R1  in order to promote the asymmetric induction and subsequently, the 
efficiency of the title catalyst was proved in the [4+2] cycloaddition of allenamide 8a and 
differently substituted dienes (Scheme 15). 
The methodology resulted to be tolerant toward different functional groups and all the products 
were isolated with good to excellent yields. Moreover, the enantioselectivity was not influenced by 
the nature of the substituent on the dienes and in most of the cases the enantiomeric excesses was 
more than 90%.  
 
 
2.1.3 [4+3] Cycloaddition 
[4+3] cycloaddition is a useful route to seven-membered carbocycles. Allyl or oxyallyl cations are 
commonly used as 3 atom π-system and the presence of heteroatoms in particular oxygen, nitrogen 
or sulfur, stabilizes the oxyallyl cation. The epoxidation of allenamides is an easy and facile way to 
obtain nitrogen-substituted oxyallyl cations. The first epoxidation of allenamide was reported by 
Hsung and co-workers[24] in 2001 using the chiral allenamide 33a  and dimethyldioxirane (DMDO) 
as oxidizing agent. At the time, they also demonstrated that the oxyallyl cation obtained from 
allenamide could be used in a [4+3] cycloaddition with cyclic diene. They started their investigation 
using cyclopentadiene as partner in the reaction and they were able to isolate the desired product in 
60% yield as single endo-diastereisomer (Scheme 16). 
 
Scheme 16: First epoxidation of allenamide and reaction with cyclopendadiene. 
Subsequently, they investigated the [4+3] cycloaddition using furan as diene. Also in this case only 
the endo-isomer was obtained but with moderate diastereoselectivity. They continued the 
investigation, by screening different solvents and temperatures and they also tried to use additives 
in order to improve the yield and the diastereoselectivity. Adding two equivalents of ZnCl2 in the 
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mixture and decreasing the temperature up to -78 °C it was possible to isolate the bicycle product 
35a in 80% yield and diastereoisomeric ratio more than 96:4. 
 
Scheme 17: [4+3] cycloaddition between allenamide and furan. 
The presence of the Zn(II) cation should increase the conformational rigidity of the oxyallyl cation 
and consequently promote the diastereomeric induction (Figure 1). 
 
Figure 1: Role of the Zn(II) in diastereomeric induction. 
Differently substituted allenamides were submitted under optimized reaction conditions with furan. 
The yields were satisfactory and allenamides with bulky groups in α position to the nitrogen in 
oxazolidinone ring resulted in the corresponding endo-products in high diastereoselectivity also 
without ZnCl2 as additive. Indeed the addition of diene would proceed from the less hindered face 
of the oxyallyl cation.  
Inspirited by these satisfactory results, the authors envisioned the possibility to develop an 
enantioselective [4+3] cycloaddiction of achiral allenamides and dienes using chiral Lewis acid-
catalyst.[25] They considered the activation promoted by Zn(II) in the transformation and the 
differentiation of the two faces in the oxyallyl cation intermediate effectuated by the substituent in 
the oxazolidinone ring. They rationalized that the replacement of achiral ZnCl2 with a chiral Lewis 
acid which can fix the conformation of oxyallyl cation and promote the diastereoselectivity (Figure 
2). 
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Figure 2: Use of chiral Lewis acid in enantioselective [4+3] cycloaddition. 
In this line, they started to screen different Lewis acids and chiral ligands in order to find the best 
promoting agent in term of yield and enantioselectivity. Using Cu(OTf)2 and ligand L1 they were 
able to obtain the desired cycloadduct in 46% yield and 90% enantiomeric excess. Subsequently 
they demonstrated that the yield and the enantiomeric excess can be further increase using AgSbF6 
as additive at the mixture. Allenamide 8a was submitted with differently substituted furans under 
optimized reaction conditions in order to prove the scope of the methodology (Scheme 18). 
 
 
Scheme 18: Optimized reaction conditions for the [4+3] cycloaddition with furan and scope of the reaction. 
The predominant formation of the S-enantiomer can be justified by considering the endo-1 and 
endo-2 approaches shown in Figure 3. In the endo-2 approach it is presents an interaction between 
the hydrogen on C3 carbon of the furan and the phenyl group of the ligand and this causes the 
preference toward the endo-1 approach and consequent formation of S enantiomer. The 3-
substituted furans resulted in the corresponding anti-isomer in high enantiomeric excesses. The 
preference in the formation of anti-isomers is due to interaction between R3syn on C3 of the furan 
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and the phenyl group of the ligand forcing the furan to an orientation where the substituent in C3 
position is in anti respect the oxazolidinone. On the contrary, the 2-substituted furans present a 
lower enantiomeric excess and a prevalence of syn-isomers. This evidence can be rationalized by 
considering the interaction between the substituent in C2 position of furan and the oxyallyl 
framework: this interaction can be reduced with a movement of the furan but in this way also the 
interaction with hydrogen in C3 and the phenyl group of the ligand decreases making it easier the 
endo-2 approach (Figure 3). 
 
Figure 3: endo-1 and endo-2 approaches 
In this line Hsung and co-workers in 2007[26] reported an intermolecular [4+3] cyclization of chiral 
allenamides and pyrroles which can be a useful way to obtain tropinone derivatives in high 
stereoselectivity. Furthermore the tropinone obtained can be used for the synthesis of alkaloids such 
as parvineostemonine (Scheme 19). 
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Scheme 19: Synthetic procedure for the tropinone and parvineostemonine. 
They started their investigation in order to optimize the reaction conditions and immediately they 
realized that the nitrogen of the pyrrole needs to be substituted with an electron-withdrawing group 
such as Boc or Bz to avoid its oxidation by DMDO. Despite further optimizations, it was not 
possible to obtain high diastereoselectivity for the reaction with pyrroles as that achieved in the 
process with the furans. Therefore, in order to improve the diastereomeric induction, different chiral 
allenamides were submitted under cyclization reaction with pyrrole. The products 38 and 39 were 
obtained in good yields and excellent diastereoselectivity, but on the contrary of the process with 
furans, the diastereoisomeric ratio is inexplicably in favour of the endo-II products also in the 
presence of ZnCl2 (Figure 4). 
 
Figure 4: endo-II product favourited in the reaction with pyrrole. 
Mechanistically, this result cannot be justified by the model described above, which should provide 
the diastereoisomer endo-I as main one.  
Another unexpected result was observed in the intermolecular [4+3] cycloaddition reaction between 
chiral allenamide 33a and 2-methylfuranoate.[27] Also in this case the major product was the endo-II 
diastereoisomer and furthermore a decrease of diastereoselectivity was observed when ZnCl2 was 
employed as additive. To rationalize this result, the possible conformations of the oxyallyl 
framework were considered. In particular, the endo-I approach is favourite by the double 
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coordination of the oxygens to the Zn(II) cation, but in this configuration there are two aligned 
dipoles (red arrows in Figure 5). On the contrary, in the endo-II approach the dipole interaction is 
lower and this conformer is more favourite when 2-methyl furanoate was used (Figure 5). 
 
Figure 5: New proposed model for endo-I and endo-II approaches. 
This new model can also justify the lower diastereoselectivity observed when ZnCl2 was used as 
additive. Indeed, in the absence of the additive the conformer conf-E-II reacts very fast to form the 
endo-II product, but in the presence of a cation able to coordinate the oxyallyl cation, the 
equilibrium of the two possible conformers is heavily in favour of conf-E-I causing a decrease of 
distereoselectity. To prove this new model, the authors made further experiments. In particular, they 
performed the reaction using a large excess of ZnCl2 (7 eq) to move the equilibrium toward the 
complete formation of conf-E-I. Under these conditions the reaction failed and only products of 
decomposition were obtained. This means that the conformer conf-E-I reacts more slowly through 
the endo-I approach than the decomposition reaction. Furthermore, when 2-cyanofuran was 
employed in the reaction, only the corresponding endo-II product was isolated (with and without 
the use of ZnCl2). This can be rationalized by considering the strong dipole of cyano group which 
causes the preference of the transition state with less dipole interaction. Finally, in order to excluder 
the possible steric factor, 2-methyl furan was used in the reaction resulting only in the 
corresponding endo-I product. 
These unexpected results inspired Hsung, Houk and their co-workers to shed light on the real 
mechanism of the [4+3] cycloaddition of allenamides with dienes through computational studies.[28] 
Initially, the four possible transition-state geometries in the reaction between allenamide 33a and 
furan were considered. Originally, it was supposed that the Z configuration was the favourite 
because of the increment of the diastereoselectivity for the double chelation with the ZnCl2, but 
detailed studies revealed that only the E isomer was located as an energy minimum in the reaction. 
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The less stability (14 kcal mol-1) shown by Z conformation is due to the electrostatic repulsion 
between the oxyallyl framework and carbonyl oxygen. For the E geometry, there are two concerted 
transition states which provide the endo-I and endo-II products (Figure 6). 
 
Figure 6: Transition states for E-geometry. 
In TS-II the furan is located on the less crowded face and initially this approach was considered the 
favourite, but instead, for furan is easier to add to more crowded face as shown in TS-I. Indeed, 
there is an attractive interaction between furan and phenyl group in α position on the oxazolidinone 
ring respect to the nitrogen. In particular, this interaction between the hydrogen bonded to the C3 
carbon and the negative cloud of the phenyl ring, makes the TS-I more favourite than the TS-II of 
0.2 kcal mol-1, which is a possible value for a diastereomeric ratio of 82:18. Also in the presence of 
ZnCl2 as additive, the E geometry results to be more stable than the Z configuration of 6.2 kcal mol-
1
 and it was demonstrated that the role of the ZnCl2 in the transformation is to decrease the 
activation energy. With the coordination to Zn(II) cation the difference between two possible 
approaches is 1.1 kcal mol-1, a reasonable value for a diastereomeric ratio of 96:4. When the 2-
methyl furanoate was used as diene it was obtained the opposite stereochemistry and it can be 
explained by this new model. Indeed, the repulsion interaction between the phenyl ring and the 
methyl carbonate is higher than the attractive interaction between the hydrogen bonded to C3 and 
the phenyl group. For this reason the TS-II is more favourite than the TS-I and the DFT 
calculations revealed also that the syn-adduct is more stable than the anti-adduct of 5.9 kcal mol-1.   
However, those studies demonstrated that the regioselectivity was influenced by the presence of a 
phenyl group on the oxazolidinone moiety. Until then, no examples of how the regioselectivity is 
influenced by the substituents on the dienes were reported. In this line, Houk, Hsung and their co-
workers developed an experimental and theoretical studies of the regioselectivity of the achiral 
allenamide 8a toward unsymmetrical furans.[29] The monosubstituted furans were taken in exam and 
methyl group was chosen as electron-donating group (EDG) and carboxylic esters as electron-
withdrawing groups (EWG). Several experiments were performed under thermal conditions and in 
the presence of Lewis acids and it was possible to demonstrate that the regioselectivity was not 
influenced by the use of Lewis acid. Moreover the regioselectivity was not dependent by electronic 
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character of the substituents; indeed all the furans with substituent in C2 resulted in syn-adducts 
while the C3-substituted furans gave the corresponding anti-adducts (Figure 7). 
 
Figure 7: syn and  anti approaches. 
In order to develop a model to anticipate the stereochemistry of the products, it was studied the 
cycloaddition between chiral allenamide 33a and differently substituted furans.[30] Using chiral 
allenamides it was possible to obtain four endo products: endo-I and endo-II where the 
oxazolidinone framework and the substituent of the furans are syn, and endo-I and endo-II where 
the oxazolidinone framework and the substituent of the furans are anti. 
The investigation started by studying the cycloaddition between the 2-substituted furans and the 
allenamide 33a. Considering that the Cα of the oxyallyl framework is more electrophilic and the Cγ 
is more nucleophilic, the syn-adduct is expected as product when the furan has a EWG in position 2. 
Moreover, only the endo-I adduct was observed due to the CH-π interaction between the hydrogen 
atom on C3 of furan and the phenyl ring. On the contrary, also the regioselectivity for 2-EDG-
furans is unexpectedly syn. Here the electronic effects cannot be considered and the regioselectivity 
derived only from a preference for the transition state that allows the more advanced bonding 
interaction. In this case, the endo-II adduct was isolated as only isomer when the 2-CO2Me furan 
was employed as diene. As previously reported, the repulsion interaction between the ester group 
and the phenyl group allows the addition of diene only on the less-hindered face of oxyallyl, but 
when cyano group was used instead of CO2Me, the prevailing formation of endo-I adduct was 
observed. This result can be explained because the 2-CN group is further away from the phenyl ring 
than the 2-CO2Me group and therefore the repulsion interaction is absents. All the 3-substituted 
furans employed for the reaction with allenamide 33a, resulted in the corresponding anti-I adducts 
(Figure 8). 
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Figure 8: Favoured approaches for 2- and 3-substitututed furans. 
In conclusion, the 3-substituted furans resulted in the corresponding anti-I adducts regardless the 
electronic character of the substituent, while when the 2-substituted furans were employed, it was 
possible to isolate only the syn-I adduct except for the 2-CO2Me furan which led to the formation of 
syn-II adduct due to its repulsion interaction with the phenyl ring. Subsequently, unsymmetrical 
disubstituted furans were employed for the reaction in order to explore the generality of the stereo- 
and regiochemical control.[31] Several 2-EWG-3-EDG furans as well as 2-EDG-3-EWG furans were 
used in the screening and finally it is possible to conclude that the 2-substituted furans promote the 
formation of syn-I adducts except: 1) the C2 substituent is the COOR group, or 2) there is another 
substituent in 3-position because in these cases the predominant product is the syn-II adduct. The 
regio- or the stereochemical control of the process was not influenced by the electronic character of 
the substituents.  
 
2.2 Isomerization Reaction 
Another type of cyclization where the allenamides have been involved is the 6π-ring closure. In 
particular, to develop this new type of reactivity, a previous isomerization reaction of the allene 
framework to form a diene was necessary. In this line, Hsung and co-workers in 2009 developed a 
regio- and stereoselective isomerization of allenamides.[32] In particular, they submitted the 
allenamide 40 under several thermal conditions and good to excellent yields were achieved in the 
formation of desired diene 41. The success of the reaction didn’t request strictly high temperature; 
indeed in the presence of camphorsulfonic acid (CSA) it was possible to obtain the desired product 
in 95% yield in DCM under very mild reaction conditions (Scheme 20). 
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Scheme 20: Regio- and stereoselective isomerization of allenamide 40. 
The predominant formation of the E isomer was unambiguously determinated through single-crystal 
X-ray analysis. The isomers E were also obtained when several α-derivated allenamides have been 
submitted under thermal (cond A) and acidic (cond B) reaction conditions and all the corresponding 
products were isolated in good to excellent yields (Scheme 21). 
 
 
Scheme 21: Scope of the isomerization of allenamides. 
The isomerization reaction demonstrated to be not limited in the use of α-derivated allenamides but 
also Ȗ-derivated allenamides proved to be suitable substrates for the formation of 1-amido-dienes 
exclusively as E-isomers. High yields were achieved when several Ȗ-allenamides were submitted 
under acidic conditions but to obtain satisfactory yields under thermal condition, higher 
temperatures and/or longer reaction times were necessary. This finding suggested to the authors to 
develop a regioselective thermal isomerization of α-Ȗ-disubstituted allenamides at 135 °C in 
acetonitrile. Gratefully, only the desired 2-amino-dienes were obtained in good yields (Scheme 22). 
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Scheme 22: Regioselective thermal isomerization of allenamides. 
The title transformation resulted to be an efficient way to synthesize dienes which are largely 
employed in pericyclic reactions. In particular, the authors reported a 6π-ring-closure tandem 
reaction of allenamides obtaining the cyclic-2-amido-dienes in good yields (Scheme 23). 
 
 
Scheme 23: 6π-ring-closure tandem reaction of allenamides. 
Subsequently, the authors observed that, heating the chiral allenamide 51 in DCE at 135 °C, the 
triene 54 has been formed as product instead of the expected cyclodiene 53 (Scheme 24).[33] 
 
Scheme 24: Unexpected 1,5-H shift. 
The 1,5-H shift necessary to form the final product 54 was also observed using the triene 52 
(obtained by acidic treatment of allenamide 51) resulting in the corresponding cyclodiene in 
comparative yield. In order to prevent the 1,5-H shift, the phenyl group was replaced with two 
methyl groups, but also in this case a second unexpected result was observed. Indeed, a mixture of 
two products were obtained: the desired 2-amido-diene and the unexpected product delivered from 
1,7-H shift reaction of the triene intermediate and consequent ring closure reaction (Scheme 25). 
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Scheme 25: Unexpected 1,7-H shift. 
Comparative results in term of yield and ratio of two products were achieved when the triene was 
isolated and used as starting material. The stereochemistry of the product 59, unambiguously 
determined by single-crystal X-ray analysis, proved that the ring closure reaction proceeds through 
a favourite disrotatory route due to a 1,6-induction. Several amido trienes were submitted under 
thermal conditions and in all of the cases the products delivered by tandem 1,3-H-1,7-H shift 
resulted to be the major products. Through further investigations, it was demonstrated that the 1,7-H 
shift was discouraged using allenamide bearing two methyl groups in Ȗ position of the allene 
framework. Moreover, it was also demonstrated that the 1,7-H shift depended to the olefinic 
geometry. In particular, while the 1,3-H-1,7-H shift occurred using 60-Z, the 1,7-H shift was 
completely dropped using the corresponding E isomer (Scheme 26). 
 
 
Scheme 26: Dependence of the 1,7-H shift to the olefin geometry. 
The low 1,6-induction achieved in the formation of the previous product (dr 3:1), suggested to the 
authors to develop a more efficient procedure to increase the stereoselection in the 6π-electron ring 
closure step.[34] They considered the possible transition state of the 1,3,5-hexatriene for the ring 
closure step: the presence of a large substituent in C2 position of the amidotriene could improve the 
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stereoselection of the title step due to the bigger steric hindrance than the hydrogen atom (Scheme 
27). 
 
Scheme 27: Possible transition state of the triene for the ring closure step. 
As functionalization of the C2 of the aminotriene (which corresponds of the β carbon of the allene 
framework), was chosen a bromine atom added through electrophilic halogenation with pyridinium 
tribromide salt. Several chiral allenamides were submitted under optimized bromination conditions 
resulting in the corresponding products in good to excellent yields.  Subsequently, the bromo-
amidotrienes were tested in the stereoselective electrocyclization furnishing the desired cyclodienes 
in good yields and good diastereoisomeric ratio (Scheme 28).  
 
Scheme 28: Stereoselective electrocyclization of the bromo-amidotrienes. 
A useful application for the methodology have been demonstrated by Hsung and co-workers[35] 
when, in 2012, they developed a tandem 1,3-H-shift-6π-electrocyclization followed by a 
intramolecular Diels-Alder cycloaddition reaction in order to synthesize the BCD-ring of 
Atropurpuran[36–38] which is an important compound due to its medicinal properties (Scheme 29).[39] 
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Scheme 29: Application of the tandem 1,3-H-shift-6π-electrocyclization-Diels-Alder reaction in the synthesis of the 
BCD-ring of the Atropurpuran. 
In the same line, Hsung developed a highly stereoselective variant of the Diels-Alder cycloaddition 
between the 2-amidodienes derived from allenamides and enones.[40] The first challenge for the 
authors was to avoid the competitive 1,5-H shift of the 2-amidocyclodiene. They chose the 
condensation between the cyclic diene derived from chiral allenamide 71 with methyl vinyl ketone 
as model reaction. After several experiments, the SnCl4 has been evaluated as best promoting agent 
providing only the endo-cycloadduct in good yield and good diastereoisomeric ratio (Scheme 30).  
  
 
Scheme 30: Stereoselective Diels-Alder reaction using SnCl4 as additive to suppress the 1,5-H shift. 
28 
 
The stereoselectivity of the process was improved when the chiral 2-oxazolidinone was replaced 
with other chiral amides as auxiliaries. In particular, diastereoisomeric ratio up to 95:5 was achieved 
using the allenamide 75, as shown in Scheme 31. 
 
Scheme 31: Highly stereoselective Diels-Alder reaction of allenamide 76. 
 
2.3 Palladium-Catalysed Cascade Reaction 
Another field where recently the allenamides found interesting applications is the palladium-
catalysed cascade reaction. For example, in 2007 Fuwa and Sasaki[41] reported a facile and useful 
strategy to synthesize 2,3-disubstituted indoles starting from N-(o-halophenyl) allenamides. In 
particular, using allenamide 77 in the presence of the phenylboronic acid they were able to find the 
optimal catalytic conditions to obtain the indole 78 in excellent yield (Scheme 32). 
 
Scheme 32: Palladium-catalysed cascade reaction for the synthesis of 2-substituted indoles. 
Mechanistically, the palladium(0) underwent the initial oxidative addition of the aryl iodide 
followed by the formation of π-allylpalladium intermediate via carbopalladation. The latter 
compound has been trapped by the phenyl boronic acid providing the desired 3-benzylic indole. 
Several aryl boronic acids were employed in the reaction with allenamide 77 promoted by Pd2(dba)3 
and the corresponding products were isolated in good yields. Unfortunately, not satisfactory results 
were achieved when alkylboranes were employed in the reaction instead of the aryl boronic acids. 
Therefore the authors found new reaction conditions for the use of alkylboranes (Scheme 33).  
29 
 
 
Scheme 33: Optimized reaction conditions in the use of alkylboranes. 
Finally, with the optimized catalytic conditions in their hands, also different alkylboranes were 
submitted in the reaction with allenamide 79 resulting in the desired products in good yields.  
In order to extend the methodology and to synthesize 2,3-disusbtituted indoles, the reaction was 
performed using α-substituted allenamides (Scheme 34).  
 
Scheme 34: Synthesis of 2,3-disubstituted indoles via Pd-catalysed-cascade reaction. 
In the same line, Broggini and co-workers reported an efficient procedure for the synthesis of 
enantiopure imidazolidinones from α-amino allenamides.[42] Several chiral allenamides were 
prepared from the corresponding L-α-aminoacids in excellent yields and subsequently, they were 
submitted under optimized heterocyclization reaction conditions. The desired compounds have been 
isolated in good yields and the absolute configuration was determined by X-ray single crystal 
analysis (Scheme 35). 
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Scheme 35: Synthesis of enantiopure imidazolidinones from α-amino allenamides. 
In order to extend the methodology, 2-enoyl imidazolidinones were obtained through a palladium-
catalysed carbonylative cyclization of corresponding allenamides making the reaction under CO 
atmosphere. Mechanistically, the carbometallation reaction, that the allenamide undergoes to form 
the π-allyl complex D, has been preceded by insertion of carbon monoxide on the initially generated 
PhPdI complex.  The corresponding imidazolidinones have been isolated in moderate yields and 
only in trans-configuration (except for the product 85b which has been isolated in 6:1 
diastereoisomer ratio) (Scheme 36). 
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Scheme 36: Optimized reaction conditions for the Pd-catalysed carbonylative cyclization. 
It is noteworthy that the products present the vinyl group as substituent which is a powerful 
building block for further functionalizations. 
In line with their interest in intramolecular palladium-catalysed procedure, Broggini and co-workers 
developed a Pd-catalysed carboamination and a Pd-catalysed hydroamination from indole bearing 
the allenamide moiety (Scheme 37).[43] 
 
Scheme 37: Pd-catalysed carboamination and hydroamination from indoles bearing allenamide moiety. 
They started to prepare the allenamide 86a from the indole-2-carboxylic acid and then they 
submitted the title allenamide in a reaction with different aryliodides in the presence of Pd(PPh3)4. 
The corresponding products were isolated in good yields after 2 hours. In order to develop also the 
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carbonylative amination they repeated the reactions under the same conditions but using a CO 
atmosphere. Not satisfactory results were obtained in the formation of the corresponding products, 
but the yields have been improved by performing the reactions at room temperature and for a 
prolonged time (Scheme 38). 
 
 
Scheme 38: Optimized reaction conditions for carboamination and carbonylative amination of allenamides. 
Finally, it was also developed a totally intramolecular variant of the carboamination reaction and 
the authors were able to isolate the desired pentacyclic imidazolinone in high yield (Scheme 39). 
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Scheme 39: Intramolecular carboamination of allenamide 90. 
The hydroamination reaction is a facile way to prepare nitrogen-containing heterocycles with an 
unsubstituted vinyl pendant which is a powerful building block for further transformations. The 
authors were able to find that the allenamide 86a under microwave activation provided the 
corresponding product in good yield in the presence of the Pd(PPh3)4 as catalyst. Subsequently, 
differently substituted indoles bearing allenamide moiety were submitted under optimized reaction 
conditions furnishing all the products in good yields (Scheme 40). 
 
 
Scheme 40: Optimized reaction conditions for hydroamination protocol. 
Through deuterium-labelled experiments it was proposed a reaction mechanism: initially, the Pd(0)-
catalyst reacts with the indole to generate the Pd(II)-hydride complex E, which in turn undergoes 
the insertion of the allene framework into the Pd-H bond. The π-allyl-Pd(II) complex F provides the 
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final product through the intramolecular formation of the new C-N bond and subsequent reductive 
elimination of a Pd(0) specie (Figure 9). 
 
Figure 9: Proposed reaction mechanism. 
  
2.4 Electrophilic Activation 
The allenamides can undergo an electrophilic activation promoted by soft-metals (for example gold-
based catalysts) or Brønsted acids resulting in a positively charged intermediate (G and H, Figure 
10). After the electrophilic activation, the in situ formed intermediates show two electrophilic 
positions, the α-position which will result in a liner product and the γ-position which will result in 
the branched one.  
 
Figure 10: Electrophilic activation of allenamides. 
Already in 2007 it was hypothesized the formation of an acyliminium ion by treatment of an 
allenamide with a Brønsted acid. As matter of facts, Navarro-Vázquez and co-workers[44] reported a 
new synthesis of functionalized protoberberines through cyclization of intermediate acyliminium 
ion promoted by TFA. In particular, the primary formation of intermediate acyliminium resulted 
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from electrophilic activation of allenamide by TFA, was followed by intramolecular electrophilic 
aromatic substitution on the electron-rich arene (Scheme 41). 
 
Scheme 41: Synthesis of functionalized protoberberines. 
A evidence that the allenamides can also undergo electrophilic activation by transition metal is 
reported by Kimber and co-worker in 2012[45] when they reported a procedure to prepare α-vinyl 
tetrahydroisoquinolines using allenamides as substrate and gold(I) catalyst as promoting agent 
(Scheme 42).  
 
Scheme 42: Preparation of tetrahydroisoquinolines promoted by Au(I) catalysts. 
Excellent yields were achieved when gold(I) catalysts PPh3Au(OTf) and PPh3Au(NTf2) were 
employed in the process. Further analysis demonstrated high selectivity in the transformation giving 
the diastereoisomeric excess up to 98%. 
Inspired by previously heterocyclization of α-amino allenamides under base-promoted[46] and 
palladium[42] catalysed conditions, Manzo and Broggini[47] envisioned the possibility to use gold 
salts to promote a gold-catalysed intramolecular hydroamination of allenamides (Scheme 43). They 
were able to obtain the desired differently substituted 4-imidazolidinones in good yields. Moreover, 
the vinyl group in position 2 plays an important role for further functionalizations. 
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Scheme 43: Au-catalysed intramolecular hydroaminations. 
The electrophilic activation of allenamides by gold salts until 2010 was principally used in 
intramolecular reactions with consequent formation of a cycle. Kimber and co-workers developed 
the first intermolecular gold-catalysed addition to allenamides promoted by gold(I)-catalysts. In this 
way it was developed a facile and mild synthesis of enamides.[48] Using the electron-rich aromatics 
as nucleophiles through a Friedel-Crafts-type reaction, he was able to prepare numerous enamides 
differently substituted with high regioselectivity toward the terminal carbon of the allenamides 
(Scheme 44). 
 
Scheme 44: First intermolecular gold-catalysed addition to allenamide. 
Inspired by these satisfactory results in the intermolecular hydroarylation of allenamides, 
subsequently he developed an intermolecular hydroaminations of allenamides with arylamines.[49] 
The products of this reaction were allylamino enemides which result to be important building 
blocks in organic synthesis and often present in biological systems (Scheme 45). All the allylamines 
in this protocol were obtained in good to excellent yields and in all of the cases the configuration of 
the C‒C double bond was E. 
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Scheme 45: Au-catalysed hydroamination of allenamides with arylamines. 
In this line, the interest of Bandini and co-workers in gold(I)-catalysed manipulation of  of π-
system[50–53], resulted in 2014 into the development of the gold(I)-dearomatization of 2,3-
disubstituted indoles with allenamides in order to synthetize indolenine cores that are common 
motifs in countless naturally occurring compounds.[54] Several N-tosylallenamides as well as N-
Boc- (Boc = tert-butoxycarbonyl) and N-oxazolylallenamides with aromatic and aliphatic 
substituent bonded to the N of the allenamides were submitted under optimized reaction conditions 
resulting in the corresponding products in good to excellent yields (Scheme 46). 
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Scheme 46: Au-catalysed de-aromatization of indoles with allenamides. 
The role of the counterion[55,56] of the gold(I) catalyst was investigated; in particular, weakly 
coordinating anion gave high conversion but modest regioselectivity while more coordinating 
species depressed the reaction rates but increased the regioselectivity toward the C3 site. The 
optimal compromise has been achieved using trifluoroacetic anion as the counterion.  
Finally, it was also synthesized the 5-membered spiroindolenine 107 in 86% yield through an 
intramolecular de-aromatization of indole core with allenamide with complete 5-exo-trig 
regiochemistry on the α–position of allenamide (Scheme 47). 
 
Scheme 47: Synthesis of the spiroindolenine 107. 
In conclusion, the examples reported above demonstrated the large flexibility of the allenamides in 
organic synthesis. 
The first part of this thesis has the aim the development of new enantioselective methodologies 
involving allenamides and their electrophilic activation. 
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3. ELECTROPHILIC ACTIVATION OF ALLENAMIDES BY CHIRAL 
PHOSPHORIC ACIDS 
3.1 Metal-Free Enantioselective Dearomatization of Indoles 
Dearomatization of indoles[1–3] is a useful route to obtain indolenines[4–6] and indolines[5,6] 
derivatives. Alkaloids compounds with indolenine or indoline scaffolds have been developed as 
promising biological agents due to their relevant therapeutic activity against cancer, inflammation[3] 
and hypertension. Many transformations consist of a further functionalization of indoles with C2 or 
C3 positions being already substituted. The reactivity of the indoles can be compared with the 
classical reactivity of enamine where the nucleophilic site is the carbon in 3-position (Figure 1). 
 
Figure 1: Classical reactivity of the enamine compared with the reactivity of the indole. 
When dearomatization is on C3 position, the resulting intermediate 109 has two possible pathways:  
 the C2 can undergo a nucleophilic attack resulting in the indolenine 110 (path a, Scheme 1); 
 [1,2]-shift of the substituent from C3 to C2 followed by a nucleophilic addition to C3 (path 
b, Scheme 1). 
 
Scheme 1: Dearomatization of 3-substituted indole. 
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In 2012 You and co-workers reported an enantioselective dearomatization of indoles promoted by 
chiral phosphoric acids in order to obtain pyrroloindolines.[7] The authors were able to isolate the 
desired products in good to excellent yields and with enantiomeric excess up to 83% (Scheme 2). 
 
Scheme 2:  Enantioselective dearomatization of indoles promoted by chiral phosphoric acids. 
The pyrroloindolines obtained in this transformation is part of an important class of alkaloids which 
have shown promising application in muscle relaxants, potassium channel-blockers and anti-cancer 
agents. This type of dearomatization was used by Antilla and Zhang[8] to develop the total synthesis 
of one of these alkaloyds, in particular the (‒)-Debromoflustramine B (Scheme 3). 
 
Scheme 3: Total synthesis of the (‒)-Debromoflustramine B. 
The possibility to use chiral phosphoric acids to promote an efficient enantioselective 
dearomatization of indoles and the possibility to activate the allenamides with Brønsted acids as 
reported by Navarro-Vázquez (Scheme 41, chapter 2),[9] suggested us to use this class of chiral 
Brønsted acids[10–13] in order to develop the first metal-free electrophilic activation of allenamides in 
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enantioselective transformation. In particular, BINOL-based phosphoric acids introduced as 
promoting agent for the activation of allenamides, resulted in a tight contact ion pairs between the 
chiral anion and the α,ȕ-unsatured iminium intermediate (B, Figure 2). It is important to note that 
using N(H)-free disubstituted indoles, not only the C3 position can promote the nucleophilic attack 
but also the nitrogen and moreover, the iminium intermediate has two possible electrophilic sites 
which can undergo the attack (Figure 2). 
 
Figure 2: Our hypothesis to develop the enantioselective variant of the title dearomatization using chiral Brønsted acids 
(a) and electrophilic sites of iminium ion intermediate and nucleophilic sites of 2,3-disubstituted indole (b). 
 Differently substituted BINOL-based phosphoric acids have been prepared in order to find the best 
catalyst for the reaction between allenamides and 2,3-dimethyl indole. In particular, IV, V and VI 
were prepared using the already known synthetic procedures developed by Alexakis[14] and 
MacMillan[15].  
 
Figure 3: BINOL-base phosphoric acids prepared following the synthetic procedure reported in literature. 
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The catalyst VII was prepared using a modified procedure with respect to the synthesis of VI 
(Scheme 4). 
 
Scheme 4: Synthesis of the (R)-VII. 
Although the synthetic procedure to obtain the BINOL-based phosphoric acids was already 
reported, the synthesis of the desired phosphoric acids didn’t proceed smoothly. In particular, the 
preparation of the Grignard reagent 120 was very challenging due to the large steric hindrance of 
the cyclohexyl groups that make difficult the insertion of the magnesium in the C‒Br bond. The 
formation of the desired Grignard reagent was monitored by GC-MS analysis and satisfactory 
results were achieved when the reaction was performed at high temperature and for long time. Also 
the Kumada cross-coupling was a challenging step. The Grignard reagent was transferred into the 
solution of the compound 117 and NiCl2(PPh3)2 via cannula and satisfactory yields of compound 
121 were achieved only when the THF used as solvent was previously degassed through freezing-
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pump-thaw cycles. Furthermore, it is important to highlight that the formation of the desired 
phosphoric acid VII was monitored via 31P-NMR analysis in order to check the complete hydrolysis 
of the P-Cl bond intermediate. 
With the catalysts in our hands, we submitted differently substituted allenamides in the reaction 
with 2,3-dimethylindole in the presence of 10 mol% of catalyst IV. 
As reported in Scheme 5, the allenamides featuring substituent in Ȗ position of the allene framework 
resulted in the corresponding products in low yields and very low enantiomeric excesses while α-
substituted allenamides gave the N-adduct instead of the desired C3-adduct. Only modest yields and 
not satisfactory enantioselectivities were achieved when cyclic allenamides were employed, but the 
yields increased using acyclic allenamides bearing aliphatic groups. Good yields and high 
enantiomeric excesses were obtained when allenamide 124a was used. In order to improve the yield 
and the ee the tosyl group was replaced with Boc group but unfortunately without good results both 
in term of yield and ee (Scheme 5). 
 
 
Scheme 5: Screening of the allenamides. All reactions were performed in dry benzene under nitrogen conditions 
(123a:124a-i:cat=2:1:0.1) 
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The condensation between N-phenyl-N-sulfonylallenamide 124a and 2,3-dimethylindole 123a was 
chosen as model reaction and several chiral phosphoric acids were tested as catalysts in anhydrous 
benzene at room temperature (Table 1). 
As reported in Table 1, all the catalysts screened for this transformation gave the desired product in 
good to excellent yields. C3-adduct was isolated with complete regiochemistry on the Ȗ position of 
the allenamide. Only catalysts I, II and V gave the product with not satisfactory enantiomeric 
excesses, since the other catalysts promoted the reaction with good enantioselectivity (more than 
72%). In particular, the catalyst (R)-VII (C8-TCyP) promoted the model reaction giving the 
indolenine in quantitative yield and excellent enantiomeric excess (entry 7). In order to increase the 
enantioselection the temperature of the reaction was decreased up to 10 °C (entry 8) resulting in 
higher ee (94%) for the product but lower yield (72%). Finally, the reaction promoted by (R)-VII 
was performed in the presence of activated molecular sieves (entry 10), but no significant 
contribution in terms of yield and enantioselection was recorded. The key role of the catalyst in the 
enantioselective activation of allenamide was investigated using (R)-VII at a loading of 1 mol % 
(entry 10); indeed under these conditions the indolenine was obtained in only 57% yield after 72 
hours and 87% ee. 
Table 1: Optimization of the catalytic system.[a] 
 
Entry cat T(°C) / t (h) Yield  125aa (%)[b] 
ee 
125aa(%)[c] 
1 (R)-I 25 / 16 53 28 (S) 
2 (R)-II 25 / 16 61 8 (S) 
3 (R)-III 25 / 16 92 72 (S) 
4 (R)-IV 25 / 16 75 82 (S) 
5 (R)-V 25 / 16 53 25 (S) 
6 (S)-VI 25 / 16 88 84 (R) 
7 (R)-VII 25 / 16 98 92 (S) 
8[d] (R)-VII 10 / 16 72 94 (S) 
9 (R)-VII 25 / 72 57 87 (S) 
10[e] (R)-VII 25 / 16 95 85 (S) 
[a] All reactions were performed in dry benzene under nitrogen conditions 
(123a:124a:cat=2:1:0.1, unless otherwise specified). [b] Determined after 
flash chromatography. [c] Determined with chiral HPLC. Absolute 
configuration in brackets. [d] 1 mol% of catalyst was used. [e] With 
activated 5 Å molecular sieves. 
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With the optimized reaction conditions in our hands, the scope of the reaction was investigated by 
submitting several differently substituted indoles under the dearomatization with allenamide 124 in 
the presence of (S)-VII as catalyst (Scheme 6). This methodology was tolerant toward different 
functional groups providing all the desired indolenines in good to excellent yields and excellent 
enantiomeric excesses. In particular, indoles featuring aliphatic and benzylic substituents on C3 or 
C2 positions resulted in the corresponding products in good yields and excellent enantiomeric 
excesses (up to 93%). Indoles with C(2,3)-fused cycles as substituents proved to be suitable 
substrates for the reaction. The corresponding products were isolated in good yields and 
enantiomeric excesses even more than 90%. Also different functional groups on the six-member 
aromatic ring of the indoles were tolerated. Indoles with electron-withdrawing groups as well as 
electronic-donating groups resulted in the indolenines in good yields and with high level of 
enantioselectivity. Finally, also the allenamide featuring benzenesulfonyl group instead of tosyl 
group was submitted under optimized reaction conditions with the 2,3-dimethylindole resulting in 
the desired product in 82% yield and 94% ee. 
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Scheme 6: Scope of the enantioselective dearomatization of 2,3-disubstituted indoles with allenamides. * (R)-I was 
used. [a] Catalyst loading 5 mol%, time 72 h. [b] Catalyst loading 1 mol%, time 72 h. Ts = p-toluenesulfonyl, Bs = 
benzenesulfonyl. 
The absolute configuration of the final product 125ka was determined to be R by single-crystal X-
ray analysis and on the basis of this finding we postulated the hypothetical model trajectory showed 
in Figure 4.  
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Figure 4: Hypothetical model trajectory. 
The initial electrophilic activation of allenamide by the catalyst resulted in the formation of the 
iminium specie which undergoes a Michael-type nucleophilic addition from the C3 of the indole. It 
is important to note that the N-H free of the indole takes part at the formation of the chiral ion-pair 
through hydrogen bond interaction. 
This protocol proved to be an efficient route to the synthesis of highly functionalized indolenines. 
Not only indolenines but also indolines[5,6] are important scaffold in organic chemistry for their 
biological activity. For this reason we envisioned the possibility to develop a new enantioselective 
dearomatization/hydrogen transfer cascade reaction in order to obtain enantioenriched, highly 
functionalized indolines. In this direction, we envisioned a chiral Brønsted acid-catalysed one-pot 
dearomatization/hydrogenation transfer sequence through a three-component reaction with the 
indole, the allenamide, and a Hantzsch ester (HE)[16–20] (Figure 5).  
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Figure 5: Proposed reaction mechanism for the Brønsted acid catalysed one-pot dearomatization/hydrogenation transfer 
sequence through a three-component reaction with the indole, the allenamide, and a Hantzsch ester (HE). 
The commercially available (R)-IV (TRIP) demonstrated to be an optimal catalyst for the 
enantioselective synthesis of trans-C2/C3 indolines resulting from the condensation of 2,3-
dimethylindole with N-phenyl-N-tosylallenamide (Table 2). 
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Table 2: Enantioselective dearomatization/hydrogen transfer sequence reaction.[a] 
 
Entry R1 / R2 Yield 127 (%)
[b]
  
trans + cis 
dr 127 [c]  
trans + cis 
ee (%)[d]  
trans + cis 
1 Me / H 51 19:1 98:82 
2 Et / H 49 15:1 99/33 
3 Me / Cl 72 11:1 95/70 
4 Me / Br 60 10:1 95/82 
5 Me / Me 44 12:1 94/n.d. 
[a] All reactions were performed under inert conditions using nitrogen gas 
(123:124a:127:cat=2:1:2:0.1, unless otherwise specified). [b] Determined after flash 
chromatography. [c] Determined on the reaction crude. [d] Determined with chiral HPLC. n.d. not 
determined. 
 
High levels of enantioselectivities were also obtained using indoles featuring substituents on the 
benzenoid ring. Electron-withdrawing groups as well as electron-donating groups were tolerated in 
the synthetic protocol and the corresponding indolines were isolated in moderate yields and high 
diastereoisomeric ratio. 
In conclusion, the first metal-free enantioselective electrophilic activation of allenamides promoted 
by chiral BINOL-based phosphoric acids was developed. This methodology demonstrated to be 
tolerant toward several functional groups regardless their electronic character. It was possible to 
develop an efficient and highly enantioselective synthesis of indolenines and indolines differently 
functionalized trough dearomatization of 2,3-disubstituted indoles. 
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3.1.1 Experimental Section  
1H-NMR spectra were recorded on Varian 200 (200 MHz) or Varian 400 (400 MHz) spectrometers. 
Chemical shifts are reported in ppm from TMS with the solvent resonance as the internal standard 
(deuterochloroform: 7.27 ppm). Data are reported as follows: chemical shift, multiplicity (s = 
singlet, d = doublet, t = triplet, q = quartet, sext = sextet, sept = septet, p = pseudo, b = broad, m = 
multiplet), coupling constants (Hz). 13C-NMR spectra were recorded on a Varian 200 (50 MHz), 
Varian 400 (100 MHz) spectrometers with complete proton decoupling. Chemical shifts are 
reported in ppm from TMS with the solvent as the internal standard (deuterochloroform: 77.0 ppm). 
GC-MS spectra were taken by EI ionization at 70 eV on a Hewlett-Packard 5971 with GC injection. 
They are reported as: m/z (rel. intense). LC-electrospray ionization mass spectra were obtained with 
Agilent Technologies MSD1100 single-quadrupole mass spectrometer. Chromatographic 
purification was done with 240-400 mesh silica gel. Anhydrous THF and DCM were distilled 
respectively from sodium-benzophenone and P2O5 prior to use. Other anhydrous solvents were 
supplied by Fluka or Sigma Aldrich in Sureseal® bottles and used without any further purification. 
Commercially available chemicals were purchased from Sigma Aldrich, Stream and TCI and used 
without any further purification. Analytical high performance liquid chromatography (HPLC) was 
performed on a liquid chromatograph equipped with a variable wave-length UV detector (deuterium 
lamp 190-600 nm), using a Daicel ChiracelTM
 
 AD, IA and ID (0.46 cm I.D. x 25 cm Daicel Inc). 
HPLC grade isopropanol and n-hexane were used as the eluting solvents. Melting points were 
determined with Bibby Stuart Scientific Melting Point Apparatus SMP 3 and are not corrected. All 
allenamides 124 were obtained following known procedures[1] and (124g, 124j),[2] 124i.[3] BAs I-IV 
were purchased by Sigma-Aldrich and directly used in the catalysis. BA V[4] 
and VI[5] were obtained via known procedures.  
Racemic mixtures of products 125 were obtained by using BA VIII (10 mol%) 
in DCM. Racemic mixtures of diastereomerically enriched compounds 
127/127’ were obtained by reducing the corresponding indolenines 125 to 
indolines 127/127’ with NaBH4 in MeOH at rt. Anhydrous solvents were purchased from Sigma-
Aldrich. Agilent Technologies LC/MSD Trap 1100 series (nebulizer: 15.0 PSI, dry Gas: 5.0 L/min, 
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dry Temperature: 325 °C, capillary voltage positive scan: 4000 mA, capillary voltage negative scan: 
3500 mA). Some of the indolenine products were already fully characterized in racemic form in one 
of our recent report (i.e. 125aa, 125ba, 125ca, 125da, 125ea, 125la, 125pa).[6] In these cases, only 
[]D, and 1H-NMR spectra were reported in order to verify the purity of the compounds. 
The X-ray intensity data for 125ka were measured on a Bruker Apex II CCD diffractometer. Cell 
dimensions and the orientation matrix were initially determined from a least-squares refinement on 
reflections measured in three sets of 20 exposures, collected in three different  regions, and 
eventually refined against all data. A full sphere of reciprocal space was scanned by 0.3  steps. 
The software SMART[7] was used for collecting frames of data, indexing reflections and 
determination of lattice parameters. The collected frames were then processed for integration by the 
SAINT program,[5] and an empirical absorption correction was applied using SADABS.[8] The 
structures were solved by direct methods (SIR 97)[9] and subsequent Fourier syntheses and refined 
by full-matrix least-squares on F2 (SHELXTL),[10] using anisotropic thermal parameters for all non-
hydrogen atoms. All the hydrogen atoms were located in difference Fourier maps. Those bonded to 
aromatic carbons were treated as riding atoms in geometrically idealized positions. The absolute 
configuration has been established by anomalous dispersion effects in diffraction measurements on 
the crystal (Flack parameter= 0.015(8)). The molecular graphics were generated by using 
ORTEP.[11] Color codes for the molecular graphics: blue (N), red (O), grey (C), white (H), olive 
green (Br), yellow (S).  Crystal data and other experimental details for 125ka are reported in Table 
S3 whereas bond lengths [Å] and angles (deg) are shown in Table S4. 
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Synthesis of (S)-C8TCyP (VII). 
 
A modified procedure with respect to the literature[3] was utilized for the last four steps herein 
described.  
An oven-dried two-necked flask, equipped with a condenser and connected to the inert gas line, was 
charged with 5 mL of anhydrous THF. The solvent was degassed though freezing-pump-thaw 
cycles then, Mg (86 mg, 3.6 mmol) and 1-Br-2,4,6-Cy3C6H2[3] (1.21 g, 3.0 mmol) were added in 
sequence. To the solution was added 1 bean of I2 and 10 mL of 1,2-Br2-ethane. The solution was 
vigorously kept at reflux with a heat gun as far as the color of the solution tuned to green-gray (≈ 30 
min), then to complete the formation of the Grignard reagent, the mixture was kept under reflux (oil 
bath) for about 1 h. Formation of the Grignard reagent was verified via GC-MS analysis from an 
aliquot of solution. In a second oven-dried two-necked flask was prepared a solution of 
(PPh3)2NiCl2 (33 mg, 60 mol) and compound A (430 mg, 0.52 mmol) in degassed THF (3 ml). 
The pale yellow solution was cooled at 0 °C, then the pre-cooled (rt) solution of Grignard reagent 
was transferred via cannula. The resulting dark-brown mixture was stirred overnight at 55 °C. The 
mixture was quenched with a saturated solution of NH4Cl and the THF removed under reduced 
pressure. The aqueous residue was extracted three times with AcOEt and the organic phases dried 
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over Na2SO4. After removal of the volatiles, the reaction crude was purified via flash 
chromatography (nHex 100  nHex:Et2O 95:5).  
(S)-121: viscous pale yellow oil (350 mg, 53% (not optimized)). 1H-NMR (400 MHz, CDCl3, 
diagnostic signals) δ 0.85 (t, J = 6.8 Hz, 6H), 2.22-2-39 (m, 6H), 2.47-2.56 (m, 2H), 2.70 (t, J = 8.0 
Hz, 6H), 4.21 (d, J = 5.6 Hz, 2H), 4.30 (d, J = 5.6 Hz, 2H), 6.85 (s, 2H), 7.01 (s, 4H), 7.10 (d, J = 
8.0 Hz, 2H), 7.19 (d, J = 8.0 Hz, 2H), 7.54 (s, 2H), 7.63 (s, 2H). 
210 mg of (S)-121 were suspended in 3.5 mL of reagent grade dioxane and treated with 1.0 ml of 
HCl conc. The white slurry was vigorously stirred under reflux for 3.5 h. The reaction mixture was 
cooled to 0 °C and the solution neutralized with saturated solution of NaHCO3. The aqueous phase 
was extracted with DCM, dried over Na2SO4 and the volatiles removed under reduced pressure. The 
crude was purified by flash chromatography (nHex 100  nHex:CH2Cl2 80:20). 
(S)-122: White foam (300 mg, 92%). MP = 153-156 °C. []D = +64.0° (c = 0.20, CHCl3). 1H-NMR 
(400 MHz, CDCl3, diagnostic signals) δ 0.92 (t, J = 6.8 Hz, 6H), 2.27 (t, J = 12.0 Hz, 2H), 2.49-2.61 
(m, 4H), 2.77 (t, J = 7.6 Hz, 4H), 4.80 (s, 2H), 7.09 (s, 2H), 7.14 (s, 2H), 7.18 (d, J = 8.8 Hz, 2H), 
7.24 (d, J = 8.8 Hz, 2H), 7.64 (s, 2H), 7.67 (s, 2H).  
Diol 122 (340 mg, 0.28 mmol) was suspended in 1.0 mL of pyridine and treated with 94 L of 
freshly distilled POCl3 (0.86 mmol). The viscous solution was stirred at reflux for 72 h (TLC 
monitoring revealed complete consumption of C). The reaction was acidified with HCl (1N) than 
extracted with DCM for three times. After dryness with Na2SO4 and removal of the organic solvents 
under reduced pressure, the crude was suspended in 0.5 mL of water. Then, 0.5 mL of pyridine was 
then added and the resulting mixture was refluxed for 48 h (complete hydrolysis of the P-Cl 
intermediate was controlled via 31P-NMR,  = 7.54 ppm, CDCl3). The reaction was acidified with 
HCl (1N) than extracted with DCM for three times. The organic solvents were removed under 
reduced pressure without drying over Na2SO4, and the corresponding C8-TCyP was purified via 
flash-chromatography (cHex:EtOAc 8:2). The resulting white solid was dissolved in Et2O and the 
organic phase was washed three times with HCl (6 N) to restore the phosphoric acid (VII). After 
dryness the Brønsted acid was obtained as a white crystalline solid. 
(S)-VII: white solid. Yield = 70%. MP = 158-160 °C. []D = +19.2° (c = 0.26, CHCl3). 31P-NMR 
(162 MHz, CDCl3,) δ 1.26 ppm. 1H-NMR (400 MHz, CDCl3, diagnostic signals) δ 2.42-2.46 (m, 
2H), 2.76 (t, J = 7.2 Hz, 4H), 6.91 (d, J = 8.4 Hz, 4H), 7.12 (d, J = 8.4 Hz, 2H), 7.18 (d, J = 8.4 Hz, 
2H), 7.60  (d, J = 16.4 Hz, 4H). 13C-NMR (100 MHz, CDCl3, diagnostic signals) δ 14.0, 22.6, 25.8, 
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26.2, 26.7, 26.8, 26.9, 27.0, 27.2, 29.2, 29.3, 29.5, 31.1, 31.8, 32.6, 33.2, 33.9, 34.7, 34.9, 36.0, 
37.0, 41.6, 41.9, 44.6, 121.2, 121.6, 122.4, 126.2, 126.5, 126.7, 127.6, 130.5, 130.9, 131.1, 131.7, 
132.1, 139.8, 140.7, 145.3, 145.6, 145.7, 146.1, 146.7, 146.8. 
Synthesis of indole 125h. 
A solution of 2-methylindole (544 mg, 4.15 mmol) in 12 ml of dry 
DCM is cooled to 0 °C and 5 ml (1.2 eq) of a solution of Et2AlCl (1M 
in hexane) was slowly added. The reaction crude was stirred for 10 
min then 3,4,5-trimethoxybenzoyl chloride (1.2 equiv), dissolved in 6 
ml of dry DCM, was added drop-wise. The reaction was maintained at this temperature for 10-15 
minutes and then at room temperature for 16 h. After conventional work-up (H2O, CH2Cl2, Na2SO4). 
Purification by flash chromatography (cHex:AcOEt 65:35). MP = 139-141 °C. 1H-NMR (200 MHz, 
CDCl3) 2.62 (s, 3H), 3.84 (s, 6H), 3.96 (s, 3H), 7.01 (s, 2H), 7.15-7.27 (m, 2H), 7.35 (d, J = 7.6 
Hz, 1H), 7.50 (d, J = 7.4 Hz, 1H), 8.49 (s broad, 1H). LC-MS (m/z): 326 [M+H]+, 673 [2M+Na]+. 
A flamed three-necked flask was charged with 4 ml of dry THF and 4.3 ml of a LiAlH4 (1 M, 4.3 
mmol) are added at 0 °C. Subsequently, the crude ketone dissolved in THF (4 mL), was added 
dropwise. The reaction mixture was then stirred at 50 °C for 4 h and judged complete by TLC 
(cHex:AcOEt 1:1). The reaction was quenched with a NaOH (10%) at 0 °C, the aqueous phase 
extracted with AcOEt (3 x 5 mL) and the collected organic phases dried over Na2SO4. Purification 
by flash chromatography (cHex:AcOEt 7:3) afforded 125h as a light pink solid in 30% yield (two 
steps, not optimized). MP = 138-139 °C. 1H-NMR (400 MHz, CDCl3) 2.39 (s, 3H), 2.95 (s, 3H), 
3.78 (s, 6H), 4.04 (s, 2H), 7.07 (t, J = 8.0 Hz, 1H), 7.13 (t, J = 8.0 Hz, 1H), 7.26 (d, J = 8.0 Hz, 
1H), 7.45 (d, J = 8.0 Hz, 1H), 7.93 (s broad, 1H). 13C-NMR (100 MHz, CDCl3) 11.7, 30.4, 
55.9(2C), 60.7, 105.1(2C), 110.1, 110.2, 118.2, 119.1, 120.9, 128.7, 131.7, 135.2, 135.8, 137.5, 
153.0(2C). LC-MS (m/z): 312.2 [M+H]+. 
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General procedure for the dearomatization reaction. 
A dried two-necked flask was charged with 1 mL of anhydrous benzene, 0.1 mmol of allenamide 
124a and 0.2 mmol of the desired indole (2 eq. with respect to 124a). The mixture was cooled to the 
desired temperature, then (S)-VII (5-10 mol%) was added. The reaction was allowed to reach the 
room temperature over the corresponding reaction time (16-48 h). After removal of the solvent 
under reduced pressure and the crude was purified by column chromatography to give the desired 
product 125. 
 
 (S)-125aa.[4,10] (Entry 10, Table 1). Orange oil. Yield = 98% (cHex-
AcOEt: 70:30). Ee = 92%. HPLC: Chiralcel-AD: eluent: nHex:IPA = 
80:20, flow = 0.7 mL/min, T = 40 °C, RtR (10.2 min), RtS (10.9 min). []D 
= -102 ° (c = 0.85, CHCl3). 1H-NMR (400 MHz, CDCl3) δ 1.25 (s, 3H), 
2.16 (s, 3H), 2.35 (dd, J = 7.6, 14.0 Hz, 1H), 2.45 (s, 3H), 2.49 (dd, J = 14.0 Hz, 1H), 3.69-3.76 (m, 
1H), 6.64 (d, J = 8.0 Hz, 2H), 6.79 (d, J = 2.0, 8.4 Hz, 1H), 7.09-7.11 (m, 2H), 7.19-7.26 (m, 5H), 
7.33 (d, J = 8.0 Hz, 2H), 7.41 (d, J = 7.6 Hz, 1H). 
 
 (S)-125ba.[4,12] Pale yellow solid. Yield = 75% (cHex-AcOEt: 70:30). Ee = 
92%. MP = 60-62 °C. HPLC: Chiralcel-AD: eluent: nHex:IPA = 80:20, flow 
= 0.7 mL/min, T = 40 °C, RtR (9.7 min), RtS (10.6 min). []D = -32.4° (c = 
0.85, CHCl3, ee = 85%).1H-NMR (400 MHz, CDCl3) δ 1.14 (td, J = 13.6, 
4.0 Hz, 1H), 1.28 (d, J = 12.8 Hz, 7H),  1.48-1.32 (m, 2H), 1.60-1.85 (m, 2H), 2.27 (d, J = 13.2 Hz, 
9H), 2.45 (s, 3H), 2.42-2.58 (m, 2H), 2.80 (d, J = 13.6 Hz, 1H), 3.68-3.76 (m, 1H), 6.63 (d, J = 7.6 
Hz, 13H), 6.76 (d, J = 14.0 Hz, 1H), 7.00-7.18 (m, 2H), 7.20-7.29 (m, 6H), 7.35 (d, J = 8.4 Hz, 2H). 
 
 (S)-125ca.[4,10] Sticky pale yellow wax. Yield = 51% (cHex-AcOEt: 
90:1070:30). Ee = 91%. HPLC: Chiralcel-AD: eluent: nHex:IPA = 95:5, 
flow = 0.6 mL/min, T = 40 °C, RtR (36.8 min), RtS (39.8 min). []D = -14.7° 
(c = 0.25, CHCl3). 1H-NMR (400 MHz, CDCl3) δ 0.52-0.71 (m, 1H), 0.75-
                                                 
[12]
 The reaction was carried out in the presence of (R)-VII. 
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0.91 (m, 1H), 1.55-1.62 (m, 2H), 1.65-1.80 (m, 2H), 2.00-2.11 (m, 2H), 2.45 (s, 3H), 2.35-2.57 (m, 
2H), 2.78-2.92 (m, 2H), 3.68 (dt, J = 14.0, 7.2 Hz, 1H), 6.65 (d, J = 7.6 Hz, 2H), 6.75 (d, J = 13.6 
Hz, 1H), 7.03-7.09 (m, 2H), 7.20-7.24 (m, 6H), 7.31-7.44 (m, 3H). 
 
 (S)-125da.[4,10] Pale yellow solid. Yield = 44% (cHex-AcOEt: 80:20). MP 
= 123-125 °C. Ee = 88%. HPLC: Chiralcel-AD: eluent: nHex:IPA = 
80:20, flow = 0.6 mL/min, T = 40 °C, RtR (9.2 min), RtS (9.9 min). []D = - 
8.3° (c = 0.30, CHCl3, ee = 76%). 1H-NMR (400 MHz, CDCl3) δ 0.81-0.92 
(m, 3H), 1.24-1.38 (m, 3H), 1.75-1.90 (m, 2H), 2.00-2.15 (m, 2H), 2.19-2.35 (m, 2H), 2.36-2.43 (m, 
1H), 2.46 (s, 3H), 2.48-2.55 (m, 1H), 2.55-2.71 (m, 1H), 3.64 (dt, J = 14.0, 7.6 Hz, 1H), 6.65 (d, J = 
7.6 Hz, 2H), 6.71 (d, J = 14.0 Hz, 1H), 7.04 (d, J = 7.2 Hz, 1H), 7.09 (dt, J = 1.2, 7.2 Hz, 1H), 7.27-
7.00 (m, 6H), 7.36 (d, J = 8.0 Hz, 2H), 7.41 (d, J = 7.2 Hz, 1H). 
 
 
 (S)-125ea.[4,10] Pale yellow wax. Yield = 87% (cHex-AcOEt: 80:20). Ee 
= 93%. HPLC: Chiralcel-AD: eluent: nHex:IPA = 80:20, flow = 0.7 
mL/min, T = 40 °C, RtS (10.8 min), RtR (11.9 min). []D = -29.0° (c = 
0.5, CHCl3). 1H-NMR (400 MHz, CDCl3) δ 2.18 (s, 3H), 2.41 (s, 3H), 2.49 (dd, J = 8.4, 13.6 Hz, 
1H), 2.61 (dd, J = 7.6, 13.6 Hz, 1H), 2.81 (d, J = 13.2 Hz, 1H), 3.13 (d, J = 13.2 Hz, 1H), 3.59-3.66 
(m, 1H), 6.54 (d, J = 7.6 Hz, 2H), 6.71 (d, J = 6.8 Hz, 2H), 6.74 (d, J = 14.4 Hz, 1H), 6.91 (d, J = 
7.2 Hz, 1H), 7.02-7.09 (m, 3H), 7.12-7.20 (m, 6H), 7.24-7.28 (m, 4H).  
 
 
 (R)-125fa. Pale yellow solid. Yield = 72% (cHex-AcOEt: 
85:1570:30). MP = 50-52 °C. Ee = 91%. HPLC: Chiralcel-AD: eluent: 
nHex:IPA = 80:20, flow = 0.7 mL/min, T = 40 °C, RtR (9.1 min), RtS (9.9 
min). []D = +56° (c = 0.4, CHCl3, ee = 87%). 1H-NMR (400 MHz, 
CDCl3) δ 0.35 (t, J = 7.4 Hz, 3H), 1.75-1.80 (m, 1H), 1.84-1.91 (m, 1H), 2.12 (s, 3H), 2.34 (dd, J = 
7.6, 13.6 Hz, 1H), 2.45 (s, 3H), 2.51 (dd, J = 7.6, 13.6 Hz, 1H), 3.66-3.73 (m, 1H), 6.61 (d, J = 8.0 
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Hz, 2H), 6.77 (d, J = 7.6 Hz, 1H), 7.05-7.12 (m, 2H), 7.17-7.26 (m, 6H), 7.31 (d, J = 8.4 Hz, 2H), 
7.40 (d, J = 7.2 Hz, 1H). 13C-NMR (100 MHz, CDCl3) δ 8.2, 16.1, 21.6, 28.6, 30.9, 37.0, 105.1, 
119.4, 121.9, 127.3(2C), 127.4, 128.7, 129.2(2C), 129.5(2C), 129.9(2C), 131.1, 135,4, 136.1, 141.2, 
143.7, 155.2, 185.1. LC-MS (m/z): 445 [M+H]+. Anal. calcd for (C27H28N2O2S: 444.19): C, 72.94; 
H, 6.35, N, 7.20; Found: C, 72.88, H, 6.28, N, 7.19. 
 
 
 (R)-125ga. Pale yellow oil. Yield = 98% (cHex-AcOEt: 85:1570:30). 
Ee = 92%. HPLC: Chiralcel-AD: eluent: nHex:IPA = 90:10, flow = 0.7 
mL/min, T = 40 °C, RtR (17.3 min), RtS (19.1 min). []D = +61.1 (c = 
0.7, CHCl3). 1H-NMR (400 MHz, CDCl3) δ 0.69 (t, J = 4.0 Hz, 3H), 1.62-1.69 (m, 3H), 1.75-1.81 
(m, 1H), 2.09 (s, 3H), 2.32 (dd, J = 7.6, 14.0 Hz, 1H), 2.42 (s, 3H), 2.48 (dd, J = 7.6, 13.2 Hz, 1H), 
3.62-3.70 (m, 1H), 6.59 (d, J = 6.8 Hz, 2H), 6.74 (d, J = 14.0 Hz, 1H), 7.03-7.09 (m, 3H), 7.16-7.24 
(m, 6H), 7.29 (d, J = 8.0 Hz, 2H), 7.37 (d, J = 7.6 Hz, 1H). 13C-NMR (100 MHz, CDCl3) δ 14.2, 
16.2, 17.2, 21.6, 30.9, 37.2 38.1, 105.0, 119.5, 121.6, 124.8, 127.3(2C), 127.4, 128.7, 129.2(2C), 
129.4(2C), 129.9(2C), 131.1, 135.5, 136.1, 141.6, 143.7, 185.3. LC-MS (m/z): 459 [M+H]+. Anal. 
calcd for (C28H30N2O2S: 458.20): C, 73.33; H, 6.59, N, 6.11; Found: C, 73.48, H, 6.41, N, 6.10. 
 
 
 (R)-125ha. White solid. Yield = 42% (cHex-AcOEt: 80:2070:30). 
Mp = 63-65 °C. Ee = 91%. HPLC: Chiralcel-IA: eluent: nHex:IPA = 
75:25, flow = 0.7 mL/min, T = 40 °C, RtR (13.9 min), RtS (22.0 min). 
[]D = +1.1 (c = 0.35, CHCl3). 1H-NMR (400 MHz, CDCl3) δ 2.16 (s, 
3H), 2.44 (s, 3H), 2.50 (dd, J = 7.6, 14.0, Hz, 1H), 2.66 (dd, J = 7.6, 14.0, Hz, 1H), 2.80 (d, J = 14.0 
Hz, 1H), 3.17 (d, J = 14.0 Hz, 1H), 3.56 (s, 6H), 3.64-3.72 (m, 1H), 3.73 (s, 3H), 5.86 (s, 2H), 6.58 
(d, J = 7.6 Hz, 2H), 6.80 (d, J = 14.0 Hz, 1H), 7.01-7.26 (m 8H), 7.30-7.32 (m, 3H). 13C-NMR (100 
MHz, CDCl3) δ 16.7, 21.6, 36.7, 41.9, 55.8(2C), 60.8, 63.5, 104.5, 106.0, 119.8, 122.7, 124.6, 
127.3(2C), 127.6, 128.7(2C), 129.2(2C), 129.5(2C), 129.8(2C), 131.3, 131.5, 135.3, 136.0, 136.6, 
141.1, 143.8, 152.3(2C), 155.1, 184.2. LC-MS (m/z): 597 [M+H]+. Anal. calcd for (C35H36N2O5S: 
596.23): C, 70.45; H, 6.08, N, 4.69; Found: C, 70.33, H, 6.15, N, 4.61. 
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 (R)-125ia. Pale yellow solid. Yield = 64% (cHex-AcOEt: 80:20). Ee = 
92%. Mp = 53-55 °C. HPLC: Chiralcel-AD: eluent: nHex:IPA = 80:20, 
flow = 0.7 mL/min, T = 40 °C, RtR (9.4 min), RtS (10.5 min). []D = 
+57.7 (c = 0.35, CHCl3). 1H-NMR (400 MHz, CDCl3) δ 1.21 (s, 3H), 2.10 (s, 3H), 2.31 (dd, J = 7.6, 
13.6 Hz, 1H), 2.42 (s, 3H), 2.43 (dd, J = 7.6, 13.6 Hz, 1H), 3.64-3.69 (m, 1H), 6.61 (d, J = 8.0 Hz, 
2H), 6.74-6.78 (m, 2H), 6.86 (dt, J = 2.0, 8.4 Hz, 1H), 7.17-7.24 (m, 5H), 7.27-7.33 (m, 1H), 7.33 
(d, J = 8.0 Hz, 1H). 13C-NMR (100 MHz, CDCl3) δ 15.8, 21.0, 21.6, 37.5, 58.6 (d, J = 1.5 Hz, 1C), 
104.7, 109.3 (d, J = 18.2 Hz, 1C), 113.9 (d, J = 17.6 Hz, 1C), 120.1 (d, J = 6.8 Hz, 1C), 127.2(2), 
128.8, 129.2(2C), 129.5(2C), 129.8(2C), 131.5, 135.3, 136.1, 143.9, 145.2 (d, J = 6.8 Hz, 1C), 
150.1, 161.1 (d, J = 181.1 Hz, 1C), 185.8 (d, J = 2.3 Hz, 1C). LC-MS (m/z): 471 [M+Na]+, 919 
[2M+Na]+. Anal. calcd for (C26H25FN2O2S: 448.16): C, 69.62; H, 5.62, N, 7.13; Found: C, 69.55, 
H, 5.58, N, 7.00. 
 
 
 (R)-125ja. White solid. Yield = 91% (cHex-AcOEt: 85:15). Mp = 88-
90 °C. Ee = 89%. HPLC: Chiralcel-AD: eluent: nHex:IPA = 80:20, 
flow = 0.7 mL/min, T = 40 °C, RtR (10.6 min), RtS (11.4 min). []D = 
+79.0 (c = 1.1, CHCl3, ee = 78%). 1H-NMR (400 MHz, CDCl3) δ 1.24 (s, 3H), 2.15 (s, 3H), 2.32 
(dd, J = 8.0, 14.4 Hz, 1H), 2.45 (s, 3H), 2.47 (dd, J = 8.0, 14.4 Hz, 1H), 3.38-3.74 (m, 1H), 6.69 (d, 
J = 7.6 Hz, 2H), 6.84 (d, J = 14.0 Hz, 1H), 7.05 (s, 1H), 7.18-7.34 (m, 7H), 7.37 (d, J = 8.0 Hz, 2H). 
13C-NMR (100 MHz, CDCl3) δ 15.8, 21.0, 21.6, 37.4, 58.6, 104.6, 120.4, 122.3, 127.2(2C), 127.7, 
128.9, 129.3(2C), 129.6(2C), 129.9(2C), 130.7, 131.6, 135.4, 136.1, 143.9, 145.1, 152.7, 186.7. LC-
MS (m/z): 487 [M+Na]+, 503 [M+K]+, 951 [2M+Na]+. Anal. calcd for (C26H25ClN2O2S: 464.13): 
C, 67.16; H, 5.42, N, 7.62; Found: C, 67.01, H, 5.36, N, 7.59. 
 
 
 (R)-125ka. Pale yellow solid. Yield = 60% (cHex-AcOEt: 80:20). Mp 
= 124-125 °C. Ee = 86%. HPLC: Chiralcel-AD: eluent: nHex:IPA = 
90:10, flow = 0.9 mL/min, T = 40 °C, RtR (16.8 min), RtS (17.7 min). 
[]D = +118.6 (c = 0.58, CHCl3). 1H-NMR (400 MHz, CDCl3) δ 1.21 
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(s, 3H), 2.11 (s, 3H), 2.28 (dd, J = 7.6, 13.6 Hz, 1H), 2.41 (s, 3H), 2.43 (dd, J = 7.2, 13.6 Hz, 1H), 
3.65-3.72 (m, 1H), 6.65 (d, J = 7.6 Hz, 2H), 6.82 (d, J = 13.6 Hz, 1H), 7.16 (s, 1H), 7.18-7.25 (m, 
6H), 7.30-7.36 (m, 3H). 13C-NMR (100 MHz, CDCl3) δ 15.8, 21.0, 21.6, 37.4, 58.6, 104.6, 118.6, 
120.9, 125.2, 127.7(2C), 128.9, 129.3(2C), 129.6(2C), 129.9(2C), 130.6, 135.4, 136.1, 143.9, 145.8, 
153.1, 186.8. LC-MS (m/z): 286 [M-indole]+. Anal. calcd for (C26H25BrN2O2S: 508.08): C, 61.30; 
H, 4.95, N, 5.50; Found: C, 61.19, H, 4.87, N, 5.61.  
 
 (R)-125la.[4] Pale yellow solid. Yield = 98% (cHex-AcOEt: 
90:1070:30). Ee = 72%. Mp = 129-130 °C. HPLC: Chiralcel-AD: 
eluent: nHex:IPA = 80:20, flow = 0.7 mL/min, T = 40 °C, RtS (10.4 
min), RtR (11.1 min). []D = +83.1 (c = 0.65, CHCl3). 1H-NMR (400 
MHz, CDCl3) δ 1.24 (s, 3H), 2.14 (s, 3H), 2.20-2.30 (m, 1H), 2.33 (s, 3H), 2.45 (s, 3H), 2.46-2.50 
(m, 1H), 3.76-3.82 (m, 1H), 6.70 (d, J = 7.2 Hz, 2H), 6.83 (d, J = 14.0 Hz, 1H), 6.87 (s, 1H), 7.04 
(d, J = 8.0 Hz, 1H), 7.23-7.31 (m, 6H), 7.36 (d, J = 8.0 Hz, 2H).  
 
 (R)-125ma. Pale brown solid. Yield = 60% (cHex-AcOEt: 85:15). 
Ee = 92%. Mp = 108-110 °C. HPLC: Chiralcel-IA: eluent: 
nHex:IPA = 80:20, flow = 0.7 mL/min, T = 40 °C, RtS (11.7 min), 
RtR (13.8 min). []D = +29.8° (c = 0.32, CHCl3). 1H-NMR (400 
MHz, CDCl3) δ 1.23 (s, 3H), 2.08 (s, 3H), 2.29 (dd, J = 8.0, 14.4 Hz, 1H), 2.40 (s, 3H), 2.43 (dd, J 
= 8.0, 14.4 Hz, 1H), 3.67-3.76 (m, 1H), 3.74 (s, 3H), 6.60 (d, J = 2.4 Hz, 1H), 6.64 (d, J = 7.2 Hz, 
1H), 6.71 (dd, J = 2.4, 8.0 Hz, 1H), 6.80 (d, J = 14.0 Hz, 1H), 7.15-7.21 (m, 4H), 7.26 (d, J = 8.4 
Hz, 1H) 7.32 (d, J = 8.4 Hz, 1H). 13C-NMR (100 MHz, CDCl3) δ 15.8, 21.4, 21.6, 37.6, 55.6, 58.2, 
105.2, 108.0, 112.5, 119.8, 127.2(2C), 128.7, 129.2(2C), 129.5(2C), 130.0(2C), 131.2, 135.4, 136.2, 
143.8, 144.9, 157.7, 183.4. Anal. calcd for (C27H28N2O3S: 460.18): C, 70.41; H, 6.13, N, 6.08; 
Found: C, 70.31, H, 6.09, N, 6.00. 
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 (R)-125na. Pale yellow oil. Yield = 77% (cHex-AcOEt: 90:1080:20). 
Ee = 92%. HPLC: Chiralcel-AD: eluent: nHex:IPA = 85:15, flow = 0.7 
mL/min, T = 40 °C, RtS (9.3 min), RtR (9.8 min). []D = +53.2° (c = 
0.25, CHCl3). 1H-NMR (400 MHz, CDCl3) δ 1.23 (s, 3H), 1.24 (t, J = 9.2 Hz, 3H), 2.32-2.40 (m, 
2H), 2.44 (s, 3H), 2.46-2.52 (m, 2H), 3.65-3.72 (m, 1H), 6.64 (d, J = 7.6 Hz, 2H), 6.73 (d, J = 13.6 
Hz, 1H), 7.10-7.11 (m, 2H), 7.20-7.31 (m, 7H) 7.48 (d, J = 8.0 Hz, 1H). 13C-NMR (100 MHz, 
CDCl3) δ 10.2, 21.5, 21.6, 23.3, 26.9, 37.8, 105.1, 119.7, 121.5, 124.9, 127.3(2C), 127.4, 128.9, 
129.2(2C), 129.5(2C), 129.9(2C), 131.1, 135.4, 136.1, 143.7, 144.3, 190.0. LC-MS (m/z): 287 [M-
indole]+, 467 [2M+Na]+. Anal. calcd for (C27H28N2O2S: 444.19): C, 72.94; H, 6.35, N, 6.30; Found: 
C, 72.77, H, 6.21, N, 6.19.  
 
 
 (R)-125pa. White solid. Yield = 69% (cHex-AcOEt: 90:10). Ee = 87%. 
Mp = 105-108 °C. HPLC: Chiralcel-AD: eluent: nHex:IPA = 85:15, 
flow = 0.7 mL/min, T = 40 °C, RtS (7.6 min), RtR (8.7 min). []D = 
+39.6° (c = 0.7, CHCl3). 1H-NMR (400 MHz, CDCl3) δ 0.34 (t, J = 7.6 Hz, 3H), 0.99 (t, J = 7.2 Hz, 
3H), 1.73-2.05 (m, 4H), 2.32-2.37 (m, 3H), 2.44 (s, 3H), 2.45-2.49 (m, 1H), 3.64-3.72 (m, 1H), 6.62 
(d, J = 7.2 Hz, 2H), 6.73 (d, J = 13.6 Hz, 1H), 7.06-7.11 (m, 2H), 7.21-7.30 (m, 8H) 7.46 (d, J = 7.2 
Hz, 1H).  
 
 
 (R)-3al. White wax. Yield = 82% (cHex-AcOEt: 70:3060:40). Ee = 
94%. HPLC: Chiralcel-AD: eluent: nHex:IPA = 85:15, flow = 0.7 
mL/min, T = 40 °C, RtS (11.6 min), RtR (12.4 min). []D = 75.5 (c = 0.4, 
CHCl3). 1H-NMR (400 MHz, CDCl3) δ 1.24 (s, 3H), 2.15 (s, 3H), 2.34 
(dd, J = 8.4, 13.6 Hz, 1H), 2.49 (dd, J = 8.0, 113.6 Hz, 1H), 3.69-3.76 (m, 1H), 6.61 (d, J = 8.0 Hz, 
2H), 6.78 (d, J = 13.6 Hz, 2H), 7.09-7.10 (m, 2H), 7.18-7.26 (m, 4H), 7.40-7.45 (m, 5H), 7.56-7.59 
(m, 1H). 13C-NMR (100 MHz, CDCl3) δ 15.8, 21.3, 37.4, 58.2, 105.5, 119.6, 121.7, 124.9, 127.2, 
127.5(2C), 128.8, 128.9(2C), 129.2(2C), 129.8(2C), 131.1, 132.9, 136.0, 138.3, 143.2, 154.2, 186.0. 
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LC-MS (m/z): 272 [M-indole]+. Anal. calcd for (C25H24N2O2S: 416.16): C, 72.09; H, 5.81, N, 6.73; 
Found: C, 72.22, H, 5.71, N, 6.65.  
 
 
General procedure for the enantioselective Brønsted acid cascade 
(dearomatization/hydrgenation) sequence. 
 
A dried two-necked flask was charged with 1 mL of anhydrous benzene and 25 mg of dried 5 Å 
MS. Then, 50 µmol (14 mg) of allenamide 124a, 0.1 mmol of Hantzsch ester and 0.1 mmol of the 
desired indole (2 eq. with respect to 124a) were added in sequence. After adjusting the temperature, 
the BINOL-based phosphoric acid (R)-IV (5-10 mol%) was added. The reaction was stirred at the 
same temperature for 48 h, the solvent evaporated and the crude directly purified via flash-
chromatography.[13] 
 
 
 (2R,3S)-127aa. White wax. Yield = 51% (cHex-AcOEt = 80:20). Dr = 
96:4. Ee = 99% (major), 33% (minor). []D = -65.5° (c = 0.65, CHCl3). 
HPLC:  Chiralcel-IA: eluent: nHex:IPA = 90:10, flow = 0.8 mL/min, T = 
40 °C, Rt(2R,3S) (12.3 min), Rt(minor II diast.) (15.6 min), Rt(major II diast.) (17.1 
min), Rt(2S,3R) (18.1 min). 1H-NMR (400 MHz, CDCl3) δ (major diast.) 1.08 (s, 3H), 1.15 (d, J = 6.4 
Hz, 3H), 1.86 (dd, J = 9.2, 14.0 Hz, 1H), 2.11 (dd, J = 9.2, 14.0 Hz, 1H), 2.40 (s, 3H), 3,48 (q, J = 
6.4 Hz, 1H), 4.21-4.26 (m, 1H), 6.46-6.55 (m, 3H), 6.72 (d, J = 14.4 Hz, 1H), 6.87-6.92 (m, 3H), 
7.21-7.23 (m, 3H), 7.28-7.31 (m, 2H), 7.45 (d, J = 8.4 Hz, 2H). 13C-NMR (100 MHz, CDCl3) δ 
(major diast.) 13.9, 21.6, 22.5, 34.5, 46.5, 66.0, 109.0, 123.7, 127.2, 127.4(2C), 128.8, 129.3(2C), 
129.5(2C), 130.1(2C), 130.6, 136.0, 136.9, 143.6. LC-MS (m/z): 447 [M+H]+, 469 [M+Na]+.  
                                                 
[13]
 In some cases, the product ws isolated with small amounts of the reduced form of the HE. 
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 (2R,3S)-127fa. White yellow solid. Yield = 49% (cHex-AcOEt = 90:10). 
Dr = 96:4. Ee = 99% (major), 33% (minor). HPLC:  Chiralcel-AD: eluent: 
nHex:IPA = 95:5, flow = 0.7 mL/min, T = 40 °C, Rt(2R,3S) (29.9 min), 
Rt(minor II diast.) (39.8 min), Rt(major II diast.) (44.4 min), Rt(2S,3R) (50.5 min).1H-
NMR (400 MHz, CDCl3) δ (major diast.) 0.85 (t, J = 7.4 Hz, 3H), 1.14 (d, J = 6.4 Hz, 3H), 1.45-
1.50 (m, 1H), 1.51-1.63 (m, 1H), 1.98 (dd, J = 7.6, 13.6 Hz, 1H), 2.20 (dd, J = 6.8, 13.6 Hz, 1H), 
2.43 (s, 3H), 3.66 (q, J = 7.2 Hz, 1H), 4.21-4.32 (m, 1H), 6.48-6.57 (m, 2H), 6.79 (d, J = 14.4 Hz, 
1H), 6.82-6.98 (m, 3H), 7.20-7.22 (m, 2H), 7.28-7.32 (m, 3H), 7.49 (d, J = 8.4 Hz, 2H). 13C-NMR 
(100 MHz, CDCl3) δ (major diast.) 8.8, 15.4, 21.6, 26.9, 33.0, 50.0, 61.6, 109.1, 117.9, 124.2, 
127.0, 127.4, 128.7, 129.2(2C), 129.5(2C), 129.9, 130.1(2C), 134.3, 136.0, 143.6, 149.9. LC-MS 
(m/z): 447 [M+H]+, 469 [M+Na]+.  
 
 
 (2R,3S)-127ja. White solid. Yield = 72% (cHex-AcOEt = 85:15). Dr = 
93:7. Mp = 58-60 °C. Ee = 94% (major), 80% (minor). []D = -55.1° (c 
= 0.80, CHCl3). HPLC:  Chiralcel-AD: eluent: nHex:IPA = 80:20, flow 
= 0.7 mL/min, T = 40 °C, Rt(2R,3S) (8.8 min), Rt(minor II diast.) (10.9 min), 
Rt(2S,3R) (11.1 min), Rt(major II diast.) (11.7 min). 1H-NMR (400 MHz, CDCl3) δ (major diast.) 1.10 (s, 
3H), 1.17 (d, J = 6.4 Hz, 3H), 1.87 (dd, J = 8.4, 13.2 Hz, 1H), 2.17 (dd, J = 7.2, 13.2 Hz, 1H), 2.46 
(s, 3H), 3.55 (q, J = 6.4 Hz, 1H), 4.35-4.44 (m, 1H), 6.44 (d, J = 8.4 Hz, 1H), 6.48 (d, J = 2.0 Hz, 
1H), 6.80 (d, J = 14.0 Hz, 1H), 6.86 (dd, J = 3.2, 12.0 Hz, 1H), 6.92-6.95 (m, 2H), 7.26-7.28 (m, 
2H), 7.37-7.39 (m, 2H), 7.50 (d, J = 8.0 Hz, 2H). 13C-NMR (100 MHz, CDCl3) δ (major diast.) 
13.8, 21.6, 22.3, 34.1, 46.8, 66.3, 108.1, 109.9, 122.6, 124.0, 126.8, 127.3(2C), 128.9, 129.4(2C), 
129.6(2C), 130.1(2C), 130.8, 135.8, 136.7, 138.1, 143.7, 148.2. LC-MS (m/z): 467 [M+H]+, 489 
[M+Na]+.  
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 (2R,3S)-127ka. White solid. Yield = 60% (cHex-AcOEt = 80:20). Dr = 
12:1. Ee = 96% (major), 77% (minor). HPLC:  Chiralcel-IA: eluent: 
nHex:IPA = 85:15, flow = 0.7 mL/min, T = 40 °C, Rt(2R,3S) (11.0 min), 
Rt(minor II diast.) (14.0 min), Rt(2S,3R) (14.8 min), Rt(major II diast) (15.6 min). 
1H-NMR (400 MHz, CDCl3) δ (major diast.) 1.08 (s, 3H), 1.14 (d, J = 6.4 Hz, 3H), 1.83 (dd, J = 
8.8, 13.6 Hz, 1H), 2.14 (dd, J = 6.8, 13.6 Hz, 1H), 2.43 (s, 3H), 3.50 (q, J = 6.8 Hz, 1H), 4.13-4.20 
(m, 1H), 6.37 (d, J = 8.4 Hz, 1H), 6.57 (d, J = 2.0 Hz, 1H), 6.78 (d, J = 13.6 Hz, 1H), 6.90-6.93 (m, 
1H), 6.97 (dd, J = 2.0, 8.4 Hz, 1H), 7.24-7.22 (m, 3H), 7.35-7.37 (m, 3H), 7.47 (d, J = 8.0 Hz, 2H). 
13C-NMR (100 MHz, CDCl3) δ (major diast.) 13.8, 21.6, 22.3, 34.1, 46.8, 66.2, 108.1, 109.8, 110.5, 
126.8, 127.3, 128.9, 129.5, 129.6, 129.7, 130.1, 130.8, 135.8, 136.7, 138.5, 143.7, 148.7. LC-MS 
(m/z): 513 [M+H]+, 535 [M+Na]+.  
 
 (2R,3S)-127la. White solid. Yield = 44% (cHex-AcOEt = 90:10). Dr = 
92:8. Mp = 82-84 °C. Ee = 94% (major), nd (minor). HPLC:  Chiralcel-
ID: eluent: nHex:IPA = 90:10, flow = 0.8 mL/min, T = 40 °C, Rt(2R,3S) 
(19.9 min), Rt(2S,3R) (21.2 min), Rt(minor diast.) (22.5 min). 1H-NMR (400 
MHz, CDCl3) δ (major diast.) 1.09 (s, 3H), 1.15 (d, J = 6.4 Hz, 3H), 1.51 (dd, J = 9.6, 13.6 Hz, 1H), 
2.05 (s, 3H), 2.13 (dd, J = 9.6, 13.6 Hz, 1H), 2.45 (s, 3H), 3.48 (q, J = 7.2 Hz, 1H), 4.20-4.28 (m, 
1H), 6.31 (s, 1H), 6.44 (d, J = 4.0 Hz, 1H), 6.70 (d, J = 8.0 Hz, 1H), 6.81 (d, J = 14.0 Hz, 1H, 6.92-
6.94 (m, 2H), 7.23-7.25 (m, 3H), 7.32-7.38 (m, 3H), 7.50 (d, J = 8.0 Hz, 1H). 13C-NMR (100 MHz, 
CDCl3) δ (major diast.) 14.0, 20.8, 21.6, 22.3, 34.0, 46.4, 66.1, 109.2, 109.4, 124.5, 127.3, 
127.4(2C), 128.7, 129.3(2C), 129.5(2C), 130.1(2C), 130.3, 135.8, 136.9, 138.1, 143.6, 147.3. LC-
MS (m/z): 447 [M+H]+, 469 [M+Na]+.  
 
 
Other substrates: 
125ab. Pale orange oil. Yield = 98% (cHex-AcOEt: 70:30). Ee = 47%. 
HPLC: Chiralcel-AD: eluent: nHex:IPA = 85:15, flow = 0.6 mL/min, T = 
40 °C, Rtmajor (12.1 min), Rtminor (13.0 min). 1H-NMR (400 MHz, CDCl3) 
1.29 (s, 3H), 2.22 (s, 3H), 2.41 (s, 3H), 2.43-2.39 (m, 1H), 2.55 (s, 3H), 
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2.60 (dd, J = 14.0 Hz, 7.2 Hz, 1H), 4.04-3.91 (m, 1H), 6.66 (d, J = 13.6 Hz, 1H), 7.32-7.12 (m, 5H), 
7.41 (d, J = 8.0 Hz, 2H), 7.46 (d, J = 7.6 Hz, 1H). LC-MS (m/z): 391 [M+Na]+. 
 
 
125ad. (Pale Orange solid. Yield = 63% (cHex-AcOEt: 80:2060:40). 
MP = 50-52 °C. Ee = 56%. HPLC: Chiralcel-AD: eluent: nHex:IPA = 
80:20, flow = 0.7 mL/min, T = 40 °C, Rtmajor (11.3 min), Rtminor (14.0 
min). 1H-NMR (400 MHz, CDCl3) 1.15 (s, 3H), 2.10 (s, 3H), 2.14 (d, J = 
7.6 Hz, 1H), 2.39 (d, J = 7.6 Hz, 1H), 2.47 (s, 3H), 4.12-4.16 (m, 1H), 4.18 (d, J = 15.6 Hz, 1H), 
4.32 (d, J = 15.6 Hz, 1H), 6.63 (d, J = 13.6 Hz, 1H), 6.73 (d, J = 7.2 Hz, 1H), 7.04 (t, J = 7.2 Hz, 
1H), 7.09 (d, J = 7.6 Hz, 2H), 7.23-7.25 (m, 6H), 7.41 (d, J = 7.2 Hz, 1H), 7.50 (d, J = 7.6 Hz, 2H),. 
LC-MS (m/z): 467 [M+Na]+.  
 
 
125ae. Pale yellow oil. Yield = 44% (cHex-AcOEt: 70:300:100). Ee = 
54%. HPLC: Chiralcel-AD: eluent: nHex:IPA = 88:12, flow = 0.6 mL/min, 
T = 40 °C, Rtmajor (19.0 min), Rtminor (20.4 min). 1H-NMR (400 MHz, 
CDCl3) δ 1.33 (s, 3H), 2.26 (s, 3H), 2.49 (dd, J = 14.0, 8.4 Hz, 1H), 2.66 
(dd, J = 14.0, 6.4 Hz, 1H), 3.34 (t, J = 8.0 Hz, 2H), 3.96 (m, 1H), 4.30 (t, J 
= 8.0 Hz, 2H), 6.58 (d, J = 14.0 Hz, 1H), 7.36-7.16 (m, 3H), 7.51 (d, J = 7.6 Hz, 1H). LC-MS (m/z): 
293 [M+Na]+, 271 [M+H]+.  
 
125ag. Pale yellow oil. Yield = 60% (AcOEt-MeOH: 20:1). Ee = 12%. 
HPLC: Chiralcel-AD: eluent: nHex:IPA = 85:15, flow = 0.7 mL/min, T = 
40 °C, Rtmajor (9.4 min), Rtminor (10.1 min). 1H-NMR (400 MHz, CDCl3) δ 
1.30 (s, 3H), 1.70 (brs, 4H), 2.23 (s, 3), 2.37 (brs, 2H), 2.48 (dd, J = 8.4, 
13.6 Hz, 1H), 2.65 (dd, J = 5.6, 13.6 Hz, 1H), 2.98 (brs, 2H), 4.14-4.19 (m, 
1H), 7.18-7.21 (m, 1H), 7.24-7.30 (m, 3H), 7.49 (d, J = 7.6 Hz, 2H). LC-MS (m/z): 137 [M-
2,3(Me)2indole], 305 [M+Na]+.  
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125ac. White solid. Yield = 74% (cHex-AcOEt: 90:1080:20). Mp = 
125-127 °C.  Ee = 67%. HPLC: Chiralcel-AD: eluent: nHex:IPA = 92:8, 
flow = 0.5 mL/min, T = 40 °C, Rtminor (10.4 min), Rtmajor (11.1 min). 1H-
NMR (400 MHz, CDCl3) δ 1.25 (s, 3H), 1.37 (s, 9H), 2.22 (s, 3H), 2.30 
(dd, J = 14.0, 7.6 Hz, 1H), 2.45 (dd, J = 14.0, 7.6 Hz, 1H), 6.83 (d, J = 7.6 Hz, 2H), 3.78 (m, 1H), 
7.14-7.04 (m, 2H), 6.92 (d, J = 14.0 Hz, 1H), 7.21 (d, J = 7.6 Hz, 1H), 7.31-7.22 (m, 3H), 7.48 (d, J 
= 7.6 Hz, 1H). LC-MS (m/z): 399 [M+Na]+.   
 
125ai’. Pale yellow oil. Conv. = 41% (cHex-AcOEt: 90:10). Ee = 2%. 
HPLC: Chiralcel-IC: eluent: nHex:IPA = 80:20, flow = 0.7 mL/min, T = 
40 °C, Rt (10.7 min), Rt (11.4 min). 1H-NMR (400 MHz, CDCl3) δ 1.58 
(d, J = 7.2 Hz, 3H), 2.30 (s, 3H), 2.37 (s, 3H), 2.47 (s, 3H), 4.74 (dd, J = 
4.4 Hz, 14.4 Hz, 1H), 5.06-5.10 (m, 1H), 6.93-7.24 (m, 7H), 7.30-7.36 (m, 2H), 7.46 (d, J = 8.0 Hz, 
1H). LC-MS (m/z): 300 [M–2,3(Me)2indole+H]+, 467 [M+Na]+, 483 [M+K]+. 
 
125af. Pale yellow oil. Yield = 55% (cHex-AcOEt: 60:400:100). Ee = 
3%. HPLC: Chiralcel-AD: eluent: nHex:IPA = 90:10, flow = 0.6 mL/min, T 
= 40 °C, Rtmajor (15.5 min), Rtminor (16.7 min). 1H-NMR (400 MHz, CDCl3) 
δ 0.90 (t, J = 7.2 Hz, 3H), 1.18-1.33 (m, 4H), 1.36 (s, 3H), 2.26 (s, 3H), 
2.31-2.46 (m, 2H), 2.50 (dd, J = 14.8, 7.2 Hz, 1H), 2.68 (dd, J = 14.8, 6.8 
Hz, 1H), 3.29 (td, J = 8.8, 7.2 Hz, 1H), 3.41 (td, J = 8.8, 7.2 Hz, 1H), 4.11-4.30 (m, 3H), 7.15-7.23 
(m, 1H), 7.23-7.35 (m, 2H), 7.51 (d, J = 7.6 Hz, 1H). LC-MS (m/z): 327 [M+H]+, 675 [2M+Na]+. 
 
125ah’. Pale yellow oil. Yield = 35% (cHex-AcOEt: 90:10  80:20). Ee = 
7% (major diastereomer). HPLC: Chiralcel-AD: eluent: nHex:IPA = 85:15, 
flow = 0.6 mL/min, T = 40 °C, Rtminor (13.2 min), Rtminor (14.1 min). 1H-
NMR (400 MHz, CDCl3) δ 1.71 (d, J = 6.8 Hz, 3H), 2.25 (s, 3H), 2.38 (s, 
3H), 3.60-3.73 (m, 2H), 4.36-4.50 (m, 2H), 5.14-5.27 (m, 2H), 6.93 (d, J = 13.2 Hz, 1H), 7.03-7.12 
(m, 2H), 7.33-7.40 (m, 1H), 7.46-7.52 (m, 1H). LC-MS (m/z): 307 [M+Na]+. 
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X-ray structure 125ka. 
 
 
Figure S1. ORTEP drawing of (R)-125ka with partial labelling scheme. Thermal ellipsoids are 
drawn  at 30% probability level. 
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Table S3.  Crystal data and structure refinement for 125ka. 
 
Identification code  comp3ka 
Empirical formula  C26H25BrN2O2S 
Formula weight  509.45 
Temperature  296(2) K 
Wavelength  0.71073 Å 
Crystal system  Orthorhombic 
Space group  P212121  
Unit cell dimensions a = 7.5839(6) Å = 90°. 
 b = 9.3135(7) Å = 90°. 
 c = 34.311(3) Å  = 90°. 
Volume 2423.5(3) Å3 
Z 4 
Density (calculated) 1.396 Mg/m3 
Absorption coefficient 1.807 mm-1 
F(000) 1048 
Crystal size 0.25 x 0.20 x 0.20 mm3 
Theta range for data collection 2.27 to 28.00°. 
Index ranges -9<=h<=9, -12<=k<=12, -45<=l<=45 
Reflections collected 27942 
Independent reflections 5700 [R(int) = 0.0317] 
Completeness to theta = 28.00° 99.1 %  
Absorption correction Empirical 
Max. and min. transmission 0.698 and 0.612 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 5700 / 0 / 292 
Goodness-of-fit on F2 0.941 
Final R indices [I>2sigma(I)] R1 = 0.0351, wR2 = 0.0859 
R indices (all data) R1 = 0.0621, wR2 = 0.0987 
Absolute structure parameter 0.015(8) 
Largest diff. peak and hole 0.312 and -0.258 e.Å-3 
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Table S4. Bond lengths [Å] and angles [°] for 125ka.  
 
Br-C(20)   
S-O(2)    
S-O(1)       
S-N(1)    
S-C(1)   
N(1)-C(14)     
N(1)-C(8)     
N(2)-C(24)   
N(2)-C(23)       
C(1)-C(2)       
C(1)-C(6)           
C(2)-C(3)       
C(2)-H(2)    
C(3)-C(4)   
C(3)-H(3)       
C(4)-C(5)          
C(4)-C(7)     
C(5)-C(6)       
C(5)-H(5)      
C(6)-H(6)      
C(7)-H(7A)    
C(7)-H(7B)    
C(7)-H(7C)   
C(8)-C(9)    
C(8)-C(13)   
C(9)-C(10)    
C(9)-H(9)    
C(10)-C(11)    
C(10)-H(10)   
C(11)-C(12)    
  
1.900(3) 
1.424(2) 
1.424(2) 
1.649(2) 
1.754(3) 
1.424(3) 
1.441(3) 
1.281(3) 
1.425(3) 
1.378(4) 
1.382(4) 
1.372(4) 
0.9300 
1.379(4) 
0.9300 
1.377(5) 
1.489(5) 
1.394(5) 
0.9300 
0.9300 
0.9600 
0.9600 
0.9600 
1.376(4) 
1.384(4) 
1.384(5) 
0.9300 
1.358(6) 
0.9300 
1.349(5) 
 
C(11)-H(11)    
C(12)-C(13)    
C(12)-H(12)      
C(13)-H(13)   
C(14)-C(15)  
C(14)-H(14)   
C(15)-C(16)    
C(15)-H(15)   
C(16)-C(17)  
C(16)-H(16A)  
C(16)-H(16B)  
C(17)-C(18)  
C(17)-C(24)  
C(17)-C(26)   
C(18)-C(19)   
C(18)-C(23)    
C(19)-C(20)   
C(19)-H(19)   
C(20)-C(21)    
C(21)-C(22)  
C(21)-H(21)   
C(22)-C(23)   
C(22)-H(22)  
C(24)-C(25)   
C(25)-H(25A)  
C(25)-H(25B)  
C(25)-H(25C)  
C(26)-H(26A)  
C(26)-H(26B)  
C(26)-H(26C)   
0.9300 
1.382(4) 
0.9300 
0.9300 
1.308(3) 
0.9300 
1.492(3) 
0.9300 
1.555(3) 
0.9700 
0.9700 
1.508(3) 
1.529(3) 
1.542(3) 
1.381(3) 
1.397(3) 
1.386(4) 
0.9300 
1.380(4) 
1.379(4) 
0.9300 
1.386(3) 
0.9300 
1.493(4) 
0.9600 
0.9600 
0.9600 
0.9600 
0.9600 
0.9600 
 
O(2)-S-O(1)   
O(2)-S-N(1) 
 O(1)-S-N(1)   
O(2)-S-C(1)   
120.54(15) 
106.38(13) 
106.74(12) 
108.36(13) 
C(12)-C(13)-H(13)   
C(8)-C(13)-H(13)  
C(15)-C(14)-N(1)   
C(15)-C(14)-H(14)  
120.5 
120.5 
125.4(2) 
117.3 
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O(1)-S-C(1)  
N(1)-S-C(1) 
C(14)-N(1)-C(8) 
C(14)-N(1)-S   
C(8)-N(1)-S   
C(24)-N(2)-C(23)  
C(2)-C(1)-C(6)  
C(2)-C(1)-S   
C(6)-C(1)-S  
C(3)-C(2)-C(1) 
C(3)-C(2)-H(2)   
C(1)-C(2)-H(2) 
C(4)-C(3)-C(2) 
C(4)-C(3)-H(3) 
C(2)-C(3)-H(3) 
C(3)-C(4)-C(5) 
C(3)-C(4)-C(7) 
C(5)-C(4)-C(7) 
C(4)-C(5)-C(6) 
C(4)-C(5)-H(5)  
C(6)-C(5)-H(5) 
C(1)-C(6)-C(5)  
C(1)-C(6)-H(6)  
C(5)-C(6)-H(6) 
C(4)-C(7)-H(7A) 
C(4)-C(7)-H(7B) 
H(7A)-C(7)-H(7B) 
C(4)-C(7)-H(7C) 
H(7A)-C(7)-H(7C) 
H(7B)-C(7)-H(7C) 
C(9)-C(8)-C(13 
C(9)-C(8)-N(1)  
C(13)-C(8)-N(1) 
C(8)-C(9)-C(10) 
C(8)-C(9)-H(9) 
C(10)-C(9)-H(9) 
C(11)-C(10)-C(9) 
C(11)-C(10)-H(10)   
C(9)-C(10)-H(10)  
108.04(14) 
105.88(12) 
119.95(19) 
120.02(17) 
118.94(16) 
106.8(2) 
119.4(3) 
120.0(2) 
120.4(2) 
120.3(3) 
119.8 
119.8 
121.7(3) 
119.1 
119.1 
117.4(3) 
121.8(3) 
120.8(3) 
121.9(3) 
119.1 
119.1 
119.1(3) 
120.5 
120.5 
109.5 
109.5 
109.5 
109.5 
109.5 
109.5 
119.8(3) 
118.5(3) 
121.7(2) 
119.6(3) 
120.2 
120.2 
120.1(3) 
119.9 
119.9 
N(1)-C(14)-H(14)  
C(14)-C(15)-C(16)    
C(14)-C(15)-H(15)   
C(16)-C(15)-H(15)    
C(15)-C(16)-C(17)  
C(15)-C(16)-H(16A)   
C(17)-C(16)-H(16A)    
C(15)-C(16)-H(16B)   
C(17)-C(16)-H(16B)  
H(16A)-C(16)-H(16B)  
C(18)-C(17)-C(24)  
C(18)-C(17)-C(26)  
C(24)-C(17)-C(26) 
C(18)-C(17)-C(16)  
C(24)-C(17)-C(16)  
C(26)-C(17)-C(16)  
C(19)-C(18)-C(23)    
C(19)-C(18)-C(17)    
C(23)-C(18)-C(17)  
C(18)-C(19)-C(20)  
C(18)-C(19)-H(19)  
C(20)-C(19)-H(19) 
C(21)-C(20)-C(19) 
C(21)-C(20)-Br 
C(19)-C(20)-Br 
C(22)-C(21)-C(20) 
C(22)-C(21)-H(21) 
C(20)-C(21)-H(21) 
C(21)-C(22)-C(23) 
C(21)-C(22)-H(22) 
C(23)-C(22)-H(22)  
C(22)-C(23)-C(18) 
C(22)-C(23)-N(2) 
C(18)-C(23)-N(2)  
N(2)-C(24)-C(25) 
N(2)-C(24)-C(17)  
C(25)-C(24)-C(17)  
C(24)-C(25)-H(25A) 
C(24)-C(25)-H(25B) 
117.3 
123.1(2) 
118.4 
118.4 
113.59(18) 
108.8 
108.8 
108.8 
108.8 
107.7 
99.25(18) 
112.8(2) 
113.9(2) 
111.7(2) 
110.3(2) 
108.80(19) 
120.5(2) 
132.4(2) 
107.2(2) 
117.0(2) 
121.5 
121.5 
123.0(2) 
118.36(19) 
118.7(2) 
119.9(2) 
120.0 
120.0 
118.0(2) 
121.0 
121.0 
121.6(3) 
126.7(2) 
111.7(2) 
122.2(2) 
115.0(2) 
122.8(2) 
109.5 
109.5 
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C(12)-C(11)-C(10) 
C(12)-C(11)-H(11) 
C(10)-C(11)-H(11) 
C(11)-C(12)-C(13) 
C(11)-C(12)-H(12) 
C(13)-C(12)-H(12) 
C(12)-C(13)-C(8) 
H(26A)-C(26)-H(26C)  
H(26B)-C(26)-H(26C)   
 
120.6(3) 
119.7 
119.7 
120.8(3) 
119.6 
119.6 
119.1(3) 
109.5 
109.5 
 
H(25A)-C(25)-H(25B) 
C(24)-C(25)-H(25C)    
H(25A)-C(25)-H(25C)  
H(25B)-C(25)-H(25C) 
C(17)-C(26)-H(26A) 
C(17)-C(26)-H(26B)  
H(26A)-C(26)-H(26B)  
C(17)-C(26)-H(26C)  
 
109.5 
109.5 
109.5 
109.5 
109.5 
109.5 
109.5 
109.5 
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3.2 Organocatalytic Enantioselective Synthesis of 1-Vinyl Tetrahydroisoquinoline  
Encouraged by the satisfactory results obtained in the enantioselective dearomatization of indoles, 
we continued our investigation in the metal-free activation of allenamides promoted by chiral 
phosphoric acids.  
Tetrahydroisoquinolines featuring substitution in 1 position (Figure 1) have received notable 
interest in medicinal and synthetic chemistry due to their pharmacological proprieties.[1–3]  
 
Figure 1: Alkaloids containing tetrahydroisoquinoline scaffold. 
The development of new synthetic routes for their preparation must consider the asymmetric 
formation of a chiral carbon. For this reason, enantioselective catalysis represents a useful way for 
their preparation through the introduction of a substituent on the C(1)-position. The first 
enantioselective catalytic variant was introduced by Shibasaki in 2001 (Scheme 1).[5] 
 
Scheme 1: Enantioselective construction of quaternary stereocenter developed by Shibasaki. 
Afterward, several enantioselective methodologies[6–8] have been reported but, no high enantiomeric 
excesses were recorded. Subsequently, Ma[9] reported a new route to functionalize the 
tetrahydroisoquinolines using copper catalyst with high levels of enantioselectivity (Scheme 2).  
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Scheme 2: Enantioselective functionalization of thetrahydroisoquinolines reported by Ma. 
A direct metal-free approach for the preparation of these classes of pharmaceutical compounds is 
represented by the bio-mimetic Pictet-Spengler condensation[10] of 2-phenylethylamine using 
Brønsted acids[11,12] or thiourea[13] as catalysts. However, this reaction is limited to the use of 
tryptamine and their derivatives as starting materials (Scheme 3). The reasons for the success of this 
reaction can be attributed to the presence of the indole. Indeed, the N(1)-free is able to form 
hydrogen bond interactions with the Brønsted acid or the thiourea catalysts and the indolyl core can 
also makes secondary interactions with aromatic substituent of the catalysts.  
 
Scheme 3: Pictet-Spengler reaction promoted by chiral Brønsted acid  
In order to remove the limitations in the use of tryptamine as starting material, we developed a new 
enantioselective route for the preparation of tetrahydroquinolines through a completely metal-free 
Friedel-Crafts-type cyclization promoted by chiral Brønsted acids.[14] In particular, the iminium ion 
intermediate resulted from the electrophilic activation of allenamides by Brønsted acids could 
undergo a nucleophilic attack by an electron-rich aromatic ring. We started to investigate our 
hypothesis preparing several allenamides featuring electron-rich aromatic rings and with different 
electron-withdrawing groups bonded to the nitrogen (Scheme 4).  
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Scheme 4: Preparation of allenamides. 
The synthetic procedure chosen for the preparation was not straightforward and some 
propargylamide 130 were isolated only in low yields despite the numerous efforts to optimize the 
synthetic step by changing temperature, bases and solvents. For the last step, we used a modified 
procedure with respect the common conditions reported in literature. Indeed, the isomerization of 
the propargylamide should take place using a catalytic amount of tBuOK, but under these 
conditions only traces of the allenamides desired were isolated. After considerable efforts we found 
a new procedure able to improve the yield which consists of the combined use of catalytic amount 
of tBuOK with 1 equivalent of NaH in a mixture of THF and DCM. Under these news reaction 
conditions the yields of the allenamides improved and some desired products were isolate in 
excellent yields.  
With the starting materials in our hands, we submitted the allenamides under the Friedel-Crafts-type 
cyclization in the presence of (R)-IV in DCM at room temperature. As shown in Scheme 5, the 
allenamides featuring tosyl group and benzoyl group resulted in the products in moderate yields, but 
low enantiomeric excesses. The allenamides 131d resulted in the product in good yield but as 
racemic mixture. Bulkier groups, such as Boc, used as protecting groups for the nitrogen increased 
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the ee of the product up to 32% but it was possible to isolate the corresponding 
tetrahydroisoquinoline only in 30% yield. Promising results were achieved using the formyl group 
as EWG for the nitrogen. Under the already described reaction condition, the corresponding product 
was isolated in moderate yields and 47% enantiomeric excess (Scheme 5). The presence of 
molecular sieves in the mixture of the reaction was essential. Indeed, the iminium ion intermediate 
was sensitive to water and for this reason anhydrous reaction conditions were absolutely necessary 
in order to avoid its undesired hydrolysis. 
 
 
Scheme 5: Screening of different N-protecting groups. 
The absolute configuration of the tetrahydroisoquinoline 132e was established to be R, by 
comparison of optical rotation with literature data.[15] 
The higher stereoselectivity obtained using formyl group as EWG might been achieved due to the 
hydrogen-bond interaction formed in the transition state between the catalyst and the hydrogen 
atom of the formyl group as shown in Figure 2. 
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Figure 2: Proposed transition state. 
Subsequently, in order to improve the yield and the eneantiomeric excess, the role of the solvent 
was investigated. The Friedel-Crafts-type cyclization of allenamide 131e was performed in the 
presence of catalyst (R)-IV using different solvents (Table 1). 
Table 1: Screening of the solventsa. 
 
 
 
 
 
 
 
When the cyclization was performed in trifluorotoluene the desired tetrahydroisoquinoline was 
isolated in moderate yield and 75% ee. In order to further improve the yield and the 
stereoselectivity of the transformation, the allenamide 131e was submitted to the Friedel-Crafts-type 
reaction in trifluorotoluene in the presence of different chiral BINOL-based phosphoric acids (Table 
2). 
 
 
 
Entry Solvent Yield 132e (%)b ee 132e (%)c 
1 DCM 40 47 
2 Toluene 18 72 
3 C6H5CF3 48 75 
4 C6H5F 36 70 
[a] All the reaction were carried out under nitrogen for 24 hours. [b] 
Isolated yields after flash chromatography. [c] Determined by chiral 
HPLC analysis performed after reduction with LiAlH4 of the formyl 
group to the corresponding methyl group. 
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Table 2: Screening of the BINOL-based phosphoric acidsa. 
 
 
 
 
 
No significant variations in term of the yields were observed using chiral phosphoric acids featuring 
different substituents in 3 and 3’ position of the BINOL scaffold, but using the catalyst II it was 
possible to increase the enantiomeric excess up to 81%.  
With the optimized reaction conditions in our hands, we submitted allenamides featuring different 
substituents on the phenyl moiety (Figure 3). Unfortunately, we were not able to obtain the 
corresponding products and only the amide resulted from the hydrolysis of the iminium ions 
intermediate were recovered.  
 
Figure 3: Substrates that failed the reaction. 
In conclusion, the metal-free enantioselective Friedel-Crafts-type cyclization of allenamides 
promoted by chiral BINOL-based phosphoric acids was developed. With this methodology it was 
possible to obtain a tetrahydroisoquinoline featuring a vinyl group in 1 position which is a useful 
group for further functionalizations.  
 
Entry cat Yield 132e (%)b ee 132e (%)c 
1 (R)-II 40 81 
2 (R)-IV 48 75 
3 (R)-VI 26 72 
4 (R)-IX 27 79 
5 (R)-X 33 78 
[a] All the reaction were carried out under nitrogen for 24 hours. [b] 
Isolated yields after flash chromatography. [c] Determined by chiral 
HPLC analysis performed after reduction with LiAlH4 of the formyl 
group to the corresponding methyl group. 
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3.2.1 Experimental Section 
1H NMR spectra were recorded on Varian Gemini 200 and Varian MR400 spectrometers. Chemical 
shifts are reported in ppm from TMS with the solvent resonance as the internal standard 
(deuterochloroform: δ = 7.27 ppm). Data are reported as follows: chemical shift, multiplicity (s = 
singlet, d = duplet, t = triplet, q = quartet, dd = double duplet, dt = double triplet, bs = broad signal, 
pd = pseudo duplet, pt = pseudo triplet, m = multiplet), coupling constants (Hz). 13C NMR spectra 
were recorded on Varian Gemini 200, Varian MR400 spectrometers. Chemical shifts are reported in 
ppm from TMS with the solvent as the internal standard (deuterochloroform: δ = 77.0 ppm). If 
rotamers are present, the splitted signals are labelled as A (major rotamer) and B (minor rotamer). 
GC-MS spectra were taken by EI ionization at 70 eV on a Hewlett-Packard 5971 with GC injection. 
LC-electrospray ionization mass spectra (ESI-MS) were obtained with Agilent Technologies 
MSD1100 single-quadrupole mass spectrometer. They are reported as: m/z (rel. intense). 
Chromatographic purification was done with 240-400 mesh silica gel. Purification on preparative 
thin layer chromatography was done on Merck TLC silica gel 60 F254. Determination of 
enantiomeric excess was performed on Agilent Technologies 1200 instrument equipped with a 
variable wave-length UV detector (reference 420 nm), using Daicel Chiralpak® columns (0.46 cm 
I.D. x 25 cm) and HPLC grade isopropanol and n-hexane as eluting solvents. Optical rotations were 
determined in a 1 mL cell with a path length of 1 dm (NaD line). Melting points (m.p.) were 
determined on Bibby Stuart Scientific Melting Point Apparatus SMP3 and were not corrected. 
 
Materials. If not otherwise stated, all reactions were carried out in sealed vials in open air without 
nitrogen atmosphere. Anhydrous solvents were supplied by Aldrich in Sureseal® bottles and were 
used as received avoiding further purification. 
Reagents were purchased from Aldrich and used without further purification unless otherwise 
stated. 
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General procedures for the synthesis of 2-aryl-ethylamines 128f-i.[2] 
 
 
Synthesis of nitrostyrene derivatives 133f-i. 
To a solution of aldehyde (15 mmol, 1 equiv.) in CH3NO2 (30 mL) was added NH4OAc (3.73 
mmol, 287 mg, 0.25 equiv.) in one portion. The resultant mixture was stirred at 100 °C, until 
complete conversion was obtained (4h, monitored by TLC), cooled at room temperature and water 
was added. Nitromethane was removed under reduced pressure and the residue was extracted with 
AcOEt (3 x 10 mL).The combined organic layers were dried over Na2SO4, filtered and concentrated 
under reduced pressure. The crude mixture was purified by column chromatography on silica gel 
(cyclohexane/ethyl acetate from 10:0 to 8:2) or by re-crystallization from ethanol (80-98% yield). 
 
(133f): yellow solid, 4.39 g, 81% yield; m.p. 109-111°C; 1H NMR (400 
MHz, CDCl3): δ 5.20 (2H, s), 5.24 (2H, s), 6.97 (1H, d, J = 8.3 Hz), 7.08 
(1H, d, J = 2.0 Hz), 7.12 (1H, dd, J = 8.3 Hz, J = 1.9 Hz), 7.33 (11H, m), 
7.90 (1H, d, J = 13.6 Hz); 13CNMR (101 MHz, CDCl3): δ 70.9, 71.4, 
114.1, 114.3, 123.1, 124.8, 127.1 (2C), 127.2 (2C), 128.1 (2C), 128.7 (4C), 135.6, 136.2, 136.45, 
139.1, 149.1, 152.7; Spectroscopic data are according to those reported in literature.[2] 
 
(133g): yellow solid, 2.46 g, 85% yield; m.p. 148-150°C; 1H NMR (400 MHz, 
CDCl3): δ 6.07 (2H, s), 6.88 (1H, d, J = 7.7 Hz), 7.01 (1H, d, J = 1.6 Hz), 7.09 
(1H, dd, J = 8.2 Hz, J = 1.6 Hz), 7.48 ( 1H, d, J = 13.5 Hz), 7.94 (1H, d, J = 13.5 Hz); 13C NMR 
(101 MHz, CDCl3): δ 102.1, 107.0, 109.0, 124.2, 126.6, 135.3, 139.1, 148.7, 151.4; Spectroscopic 
data are according to those reported in literature.[3] 
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(133h): yellow solid, 2.76 g, 88% yield; m.p. 80-83°C; Spectroscopic data are 
according to those reported in literature.[3] 
 
(133i): yellow sticky solid, 1.88 g, 70% yield; 1H NMR (400 MHz, CDCl3): δ 3.86 
(3H, s), 7.04-7.07 (2H, m), 7.15 (1H, d, J = 7.9 Hz), 7.36-7.40 (1H, m), 7.58 (1H, d, 
J = 13.7 Hz), 7.98 (1H, d, J = 13.8 Hz); 13C NMR (101 MHz, CDCl3): δ 55.4, 
114.0, 117.9, 121.7, 130.4, 131.3, 137.3, 139.0, 160.1; Spectroscopic data are according to those 
reported in literature.[3] 
 
Reduction of nitrostyrenes derivatives 133f-i. 
To a stirred suspension of LiAlH4 (30 mmol, 1.14 g, 3 equiv.) in THF (30 mL) at 0 °C, a solution of 
nitrostyrene derivative 133f-i (10 mmol, 1 equiv.) in THF (10 mL) was added dropwise. The 
mixture was allowed to reach room temperature and refluxed for 24 h. The mixture was cooled at 0 
°C, diluted with Et2O (5 mL) and water (1.14 mL) was slowly added. After 15 minutes, 15% (w/w) 
aqueous NaOH solution (1.14 mL) was added followed after further 15 minutes by addition of 
water (3.42 mL). The resultant mixture was stirred at room temperature for 30 minutes, then MgSO4 
was added and it was filtered through a Celite pad and it was washed with Et2O (20 mL). The 
solvent was removed under reduced pressure to afford desired amine 128f-i that was used as such in 
the next reaction steps. 
 
 
 
 
 
 
87 
 
General Procedure for the synthesis of allenamide derivatives 131a-i. 
 
Synthesis of formamide derivatives. 
 
 
 
Amine 128e-i or 3,4-dimethoxyphenethylamine (10 mmol, 1 equiv.) was dissolved in ethyl formate 
(20 mL) and the solution was refluxed for 24 h until complete conversion (monitored by 1HNMR). 
The solvent was removed under reduced pressure and the crude residue was purified by column 
chromatography on silica gel (cyclohexane/ethyl acetate from 8:2 to 1:1) to afford formamides 
129e-i. 
 
 (129e): yellow oil, 1.43 g, 86% yield; Spectroscopic data are according to 
those reported in literature.[4] 
 
 (129f): yellow oil, 1.91 g, 53% yield; 1H NMR (400 MHz, CDCl3, 25 
°C) (two rotamers A:B, ratio 5.8:1): δ 2.70 (2HB, t, J = 6.8 Hz), 2.72 
(2HA, t, J = 6.8 Hz), 3.39 (2HB, q, J = 6.8 Hz), 3.48 (2HA, q, J = 6.5 
Hz), 5.16 (4HA+2HB, s), 5.18 (2HB, s), 5.32 (1HA, bs), 5.50 (1HB, bs), 
6.68-6.75 (2HA+2HB, m), 6.89 (1HA+1HB, d, J = 8.2 Hz), 7.30-7.46 (10HA+10HB, m), 7.89 (1HB, d, 
J = 12Hz), 8.03 (1HA, s); 13C NMR (101 MHz, CDCl3): δ 34.9, 39.2, 71.3, 71.4, 115.4, 115.8, 
121.6, 127.4 (2C), 127.4 (2C), 127.9, 127.9, 128.5 (4C), 132.0, 137.2, 137.3, 147.7, 148.8, 161.3; 
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(129g): yellow oil, 888 mg, 46% yield; 1H NMR (400 MHz, CDCl3) (two 
rotamers A:B, ratio 4.9:1): δ 2.70-2.77 (2HA+2HB, m), 3.38-3.45 (2HB, m), 
3.47-3.54 (2HA, m), 5.92-5.94 (2HA+2HB, m), 6.60-6.76 (3HA+3HB, m), 7.90 (1HB, t, J = 11.7 Hz), 
8.11 (1HA, d, J = 7.3 Hz); 13C NMR (101 MHz, CDCl3): δ 35.0 (1CA), 37.1 (1CB), 39.4 (1CA), 43.3 
(1CB), 100.7 (1CA), 100.8 (1CB), 108.1 (1CA), 108.2 (1CB) 108.9 (1CA), 109.0 (1CB),  121.5 (1CA), 
121.7 (1CB), 131.5 (1CB), 132.4 (1CA), 146.0 (1CA), 146.2 (1CB), 147.6 (1CA), 147.7 (1CB), 161.6 
(1CA), 164.8 (1CB); 
 
(129h): yellow oil, 1.11 g 53% yield; 1H NMR (400 MHz, CDCl3) (two 
rotamers A:B, ratio 1.1:1) : δ 2.84 (2HB, t, J = 6.7 Hz), 2.87 (2HA, t, J = 6.7 
Hz), 3.48 (2HA, pq, J = 6.2 Hz), 3.54 (2HB, pq, J = 6.0 Hz), 3.85 (3HA, s), 
3.86 (3HB, s), 3.88 (3HA + 3HB, s), 6.77-6.80 (1HA+1HB, m), 6.82-6.85 (1HA+1HB, m), 7.00-7.05 
(1HA+1HB, m), 8.11 (1HA+1HB, s); 13C NMR (101 MHz, CDCl3): δ29.57 (1CA), 29.63 (1CB), 39.0 
(1CA), 40.5 (1CB), 55.6 (2CA), 60.5 (2CB), 110.8 (1CB), 110.9 (1CA), 122.16 (1CA), 122.17 (1CB), 
124.1 (1CB), 124.2 (1CA), 132.5 (1CA), 132.8 (1CB), 146.99 (1CB), 147.01 (1CA), 152.57 (1CA), 
152.58 (1CB), 161.6 (1CA), 170.5 (1CB); 
 
(129i): yellow oil, 1.22 g 68% yield; Spectroscopic data are according to those 
reported in literature.[5] 
 
Preparation of compound 129a. 
 
 
To a solution of 3,4-dimethoxyphenethylamine (3 mmol, 543 mg, 1 equiv.) in DCM (10 mL), Et3N 
(4.5 mmol, 0.624 mL, 1.5 equiv.) and DMAP (0.075 mmol, 9.15 mg, 0.025 equiv.) were added. To 
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the resulting solution at 0 °C, tosyl chloride (3.6 mmol, 688 mg, 1.2 equiv.) was slowly added in 
small portions. The mixture was allowed to reach room temperature and stirred for 24 h. 
Subsequently, water (10 mL) was added, the organic phase was separated and the aqueous layer 
was extracted with DCM (3 x 5 mL). The combined organic layers were washed with HCl 1M (10 
mL), NaHCO3 sat. sln. (10 mL) and brine (10 mL). The organic layers was dried with Na2SO4, 
filtered and concentrated under reduced pressure to give pure 129a, that was used as such, without 
further purification in the next steps. 
 
(129a): yellow solid, 894 mg, 89% yield; m.p. 133-135°C; 1H NMR 
(400 MHz, CDCl3): δ 2.43 (3H, s), 2.71 (2H, t, J = 6.7 Hz), 3.19 (2H, 
q, J = 6.4 Hz), 3.82 (3H, s), 3.86 (3H, s), 4.37 (1H, bs), 6.57 (1H, s), 
6.63 (1H, d, J = 8.5 Hz), 6.77 (1H, d, J = 8.5 Hz), 7.29 (2H, d, J = 7.6 Hz), 7.68 (2H, d, J = 7.8 Hz); 
13C NMR (101 MHz, CDCl3): δ 21.5, 35.3, 44.30, 55.7, 55.9, 111.3, 111.7, 120.7, 127.0 (2C), 129.6 
(2C), 130.1, 136.8, 144.3, 147.8, 149.0; EI-MS: m/z = 335 (60), 184 (14), 151 (100), 91 (84). 
 
Preparation of compound 129b. 
 
 
To a solution of 3,4-dimethoxyphenethylamine (3 mmol, 543 mg, 1 equiv.) and Na2CO3 (6 mmol, 
636 mg, 2 equiv.), in H2O/DCM (1/1, 20 mL), PhCOCl (4.5 mmol, 0.521 mL, 1.5 equiv.) was 
added dropwise. The mixture was stirred for 72 h, then water (10 mL) and DCM (10 mL) were 
added. The organic phase was separated and the aqueous layer was extracted with Et2O (3 x 10 
mL). The combined organic layers were washed with HCl 1M (15 mL), NaHCO3 sat. sln. (15 mL) 
and brine (15 mL). The organic layers was dried with Na2SO4, filtered and concentrated under 
reduced pressure. The crude product was washed with n-hexane and then it was used such as, 
without further purification in the next steps. 
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(129b): white solid, 710 mg, 83% yield; m.p. 63-65°C; 1H NMR (400 
MHz, CDCl3): δ 2.71-2.78 (2H, m), 3.38 (2H, m), 3.84 (3H, s), 3.85 (3H, 
s), 6.71-6.81 (3H, m), 7.34 (5H, s);13C NMR (101 MHz, CDCl3): δ 35.2 
(1CA+1CB), 41.3 (1CA+1CB), 55.8 (1CA+1CB), 55.9 (1CA+1CB), 111.4 (1CA+1CB), 111.9 
(1CA+1CB), 120.6 (1CA+1CB), 126.8 (2CA+2CB), 128.4 (1CB), 128.5 (2CA+2CB), 130.1 (1CA), 
131.3 (1CB), 131.4 (1CA), 133.5 (1CA), 134.5 (1CB), 147.7 (1CA+1CB), 149.0 (1CA+1CB), 167.6 
(1CA+1CB); EI-MS: m/z = 285 (8), 164 (100), 105 (53), 77 (48). 
 
 
 
Preparation of compound 129c. 
 
 
To a solution of 3,4-dimethoxyphenethylamine (3 mmol, 543 mg, 1 equiv.) and Na2CO3 (6 mmol, 
636 mg, 2 equiv.), in H2O/DCM (1/1, 20 mL), 3,5-(CF3)2-C6H3-COCl (3.6 mmol, 0.637 mL, 1.2 
equiv.) was added dropwise. The mixture was stirred for 72 h and then water (10 mL) and DCM (10 
mL) were added.The organic phase was separated and the aqueous layer was extracted with Et2O (3 
x 10 mL). The combined organic layers were washed with HCl 1M (15 mL), NaHCO3 sat. sln. (15 
mL) and brine (15 mL). The organic layers was dried with Na2SO4, filtered and concentrated under 
reduced pressure. The crude product was washed with n-hexane and then it was used such as, 
without further purification in the next steps. 
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(129c): white solid, 1.23 g, 97% yield; m.p. 99-101°C; 1H NMR 
(400 MHz, CDCl3): δ 2.93 (2H, t, J = 6.9 Hz), 3.75 (2H, q, J = 6.5 
Hz), 3.88 (3H, s), 3.89 (3H, s), 6.18 (1H, bs), 6.77-6.80 (2H, m), 
6.85 (1H, d, J = 7.8 Hz), 8.00 (1H, s), 8.14 (2H, s); 13C NMR (101 
MHz, CDCl3): δ 35.1, 41.6, 55.8, 55.9, 111.4, 111.8, 120.7, 122.7 (2C, q, JC-F = 273.3 Hz), 124.9 
(2C, t, JC-F = 4.1 Hz), 127.1 (2C, q, JC-F = 3.4 Hz), 130.8, 132.4, 136.7, 148.0, 149.3, 164.5; EI-MS: 
m/z = 421 (25), 241 (46), 213 (36), 164 (100). 
 
Preparation of compound 8d.[6] 
 
 
To a solution of 3,4-dimethoxyphenethylamine (3 mmol, 543 mg, 1 equiv.) in DCM (10 mL), Et3N 
(4.5 mmol, 0.624 mL, 1.5 equiv.), DMAP (0.075 mmol, 9.15 mg, 0.025 equiv.) were added. To the 
resulting solution at 0 °C, Boc2O (3.6 mmol, 785 mg, 1.2 equiv.) was slowly added in small 
portions. The mixture was allowed to reach room temperature and stirred for 24 h. Subsequently, 
water (10 mL) was added, the organic phase was separated and the aqueous layer was extracted 
with Et2O (3 x 5 mL). The combined organic layers were washed with HCl 1M (10 mL), NaHCO3 
sat. sln. (10 mL) and brine (10 mL). The organic layers was dried with Na2SO4, filtered and 
concentrated under reduced pressure. The crude product was washed with n-hexane and then it was 
used such as, without further purification in the next steps. 
 
(129d): sticky yellow solid,  767 mg, 91% yield; 1H NMR (400 MHz, 
CDCl3): δ 1.45 (9H, s), 2.75 (2H, t, J = 7.0 Hz), 3.33-3.38 (2H, m), 3.87 
(3H, s), 3.88 (3H, s), 4.54 (1H, bs), 6.72-6.75 (2H, m), 6.82 (1H, d, J = 
8.0 Hz); 13C NMR (101 MHz, CDCl3): δ 28.4 (3C), 35.7, 41.9, 55.8, 55.9, 79.2, 111.3, 111.9, 120.6, 
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131.5, 147.5, 148.9, 155.8; EI-MS: m/z =281 (129, 225 (14), 209 (13), 165 (58), 151 (100), 57 (63). 
Spectroscopic proprieties are according to those reported in literature.[6] 
 
 
 
General Procedure for the propargylation of amides. 
 
 
To a solution of 129a-i (5 mmol, 1 equiv.) in anhydrous THF (15 mL) and CH2Cl2 (5 mL) at 0 °C, 
NaH (6.5 mmol, 156 mg, 1.3 equiv.) was slowly added. After 20 minutes, propargyl bromide (6 
mmol, 0.539 mL, 1.2 equiv.) was added at 0°C. The reaction mixture was allow to reach room 
temperature and it was stirred for 24 h. Water (10 mL) was slowly added at 0 °C and organic 
volatiles were removed under reduced pressure. The residue was extracted with AcOEt (3 x 5mL). 
The combined organic layers were dried over Na2SO4, filtered and concentrated under reduced 
pressure. The crude mixture was purified by column chromatography on silica gel silica gel 
(cyclohexane/EtOAc 7/3) to give the desired products 130a-i. 
 
(130a): yellow solid, 1.66 g, 89% yield; m.p. 10-103°C; 1H NMR (400 
MHz, CDCl3): δ 2.06 (1H, t, J = 2.4 Hz), 2.42 (3H, s), 2.86 (2H, pt, J = 
7.6 Hz), 3.42 (2H, pt, J = 7.6 Hz), 3.87 (3H, s), 3.88 (3H, s), 4.08 (2H, 
d, J = 2.5 Hz), 6.74 (1H, s), 6.75 (1H, d, J = 6.9 Hz), 6.80 (1H, d, J = 8.7 Hz), 7.28 (2H, d, J = 6.6 
Hz), 7.71 (2H, d, J = 8.2 Hz); 13C NMR (101 MHz, CDCl3): δ 21.5, 34.3, 36.8, 48.0, 55.86, 55.87, 
73.7, 76.7, 111.3, 112.0, 120.7, 127.6 (2C), 129.4 (2C), 130.7, 135.9, 143.5, 147.7, 148.9; EI-MS: 
m/z = 373 (42), 222 (100), 155 (95), 151 (86), 91 (75). 
93 
 
(130b): yellow oil, 291 mg, 18% yield; Although numerous attempts by 
changing solvent and temperature, it has never been possible to obtain a 
well resolved spectrum of the product; 1H NMR (400 MHz, CDCl3, 25 
°C) : δ 2.30 (2H, t, J = 2.5 Hz), 2.76 (1H, bs), 2.98 (1H, bs), 3.62 (1H, bs), 3.73 (1H, bs), 3.84 (6H, 
bs), 4.42 (2H, bs), 6.41 (1H, bs), 6.75 (2H, bs), 7.20 (1H, bs), 7.39 (4H, bs); 13C NMR (101 MHz, 
CDCl3): δ 33.0 (1CB), 34.2 (1CA), 40.0 (1CA+1CB), 47.3 (1CA), 50.2 (1CB), 55.8 (2CA), 55.9 (2CA), 
72.4 (1CA), 73.0 (1CB), 78.8 (1CA+1CB), 113.3 (1CA+1CB), 111.8 (1CB), 112.0 (1CA), 120.7 
(2CA+2CB), 126.7 (2CA+2CB), 128.4 (1CA+1CB), 129.9 (1CB), 130.2 (1CA), 131.3 (1CA), 131.4 
(1CA), 135.7 (1CA+1CB), 147.7 (2CB), 148.9 (1CA), 171.1 (1CA+1CB); EI-MS: m/z = 323 (4), 164 
(100), 105 (89), 77 (64). 
 
(130c): yellow oil, 291 mg, 18% yield; Although numerous attempts 
by changing solvent and temperature, it has never been possible to 
obtain a well resolved spectrum of the product; 1H NMR (400 MHz, 
CDCl3, 25 °C) (two rotamers A:B, ratio 1:1):δ 2.73 (1HA+1HB, t, J = 
2.5 Hz), 2.80 (2HA, bs), 2.99 (2HB, bs),3.60 (2HA, bs),3.75 (2HA+2HB, bs),3.84 (6HA+6HB, bs), 
4.47 (2HB, bs), 6.44 (1HA, bs),6.50 (1HB, bs),6.74 (2HA, bs),6.80 (2HB, bs), 7.51 (1HA+1HB, bs), 
7.87 (2HA, bs), 7.96 (2HB, bs); 13C NMR (101 MHz, CDCl3): δ 33.0 (1CB), 33.6 (1CA), 34.2 (1CA), 
39.9 (1CB), 47.7 (2CB), 50.3 (2CA), 73.2 (1CA), 73.8 (1CB), 77.9 (1CA+1CB), 112.2 (1CA+1CB), 
111.9 (1CA+1CB), 120.7 (1CA+1CB), 122.9 (2CA+2CB, q, JC-F = 271.5 Hz), 123.3 (1CA), 123.7 
(1CB), 124.1 (1CA+1CB), 127.0 (1CA+1CB, bs), 129.3 (1CB), 130.8 (1CA), 131.2 (2CA+2CB), 137.7 
(1CA+1CB), 147.9 (1CA), 148.0 (1CB), 149.1 (1CA+1CB), 168.0 (1CB), 168.5 (1CA); EI-MS: m/z = 
459 (9), 241 (88), 213 (67), 164 (100). 
 
(130d): sticky white solid, 1.37 g, 86% yield; 1H NMR (400 MHz, 
CDCl3): δ 1.46 (9H, s), 2.22 (1H, s), 2.83 (2H, bs), 3.52 (2H, pt, J = 7.4 
Hz), 3.86 (3H, s), 3.88 (3H, s), 4.03 (2H, bs), 6.74-6.82 (3H, m); 13C 
NMR (101 MHz, CDCl3): δ 28.3, 29.7, 30.9, 48.5, 55.8, 55.9, 71.5, 79.9, 80.1, 111.3, 111.0, 120.7, 
131.7, 147.5, 148.9, 154.8; EI-MS: m/z = 319 (31), 246 (25), 151 (100), 57 (87). 
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(130e): yellow oil, 469 mg, 38% yield; 1H NMR (400 MHz, CDCl3) (two 
rotamers A:B, ratio 2:1): δ 2.28 (1HB, t, J = 2.3 Hz), 2.34 (1HA, t, J = 2.5 
Hz), 2.85 (2HA, pt, J = 6.8 Hz), 2.86 (2HB, pt, J = 6.4 Hz), 3.60 (2HA, pt, J = 
6.8 Hz), 3.63 (2HB, pt, J = 6.8 Hz), 3.86 (3HA, s), 3.87 (3HA+3HB, s), 3.88 
(3HB, s), 4.18 (2HA+2HB, d, J = 2.4 Hz), 6.67-6.83 (3HA+3HB, m), 7.80 (1HA, bs), 8.10 (1HB, bs); 
13C NMR (101 MHz, CDCl3): δ 31.4 (1CA), 32.8 (1CB), 34.4 (1CA), 37.5 (1CB), 43.9 (1CB), 48.7 
(1CA), 55.8 (2CA+ 2CB), 72.5 (1CA), 73.6 (1CB), 77.7 (1CB), 78.0 (1CA), 111.3 (1CB), 111.4 (1CA), 
111.8 (1CB), 111.9 (1CA), 120.6 (1CB), 120.8 (1CA), 130.1 (1CA), 130.9 (1CB), 147.6 (1CB), 147.8 
(1CA), 148.9 (1CB), 149.0 (1CA), 162.1 (1CA), 162.1 (1CB); ESI-MS: m/z = 248.2 [M+H]+, 270.0 
[M+Na]+, 495.2 [2M+H]+; ESI-MS: m/z = 248.0 [M+H]+, 270.0 [M+Na]+, 495.2 [2M+H]+. 
(130f): brown oil, 1.26 g, 63% yield;1H NMR (400 MHz, CDCl3) 
(two rotamers A:B, ratio 1.7:1): δ 2.23 (1HA, t, J = 2.2 Hz), 2.29 
(1HB, t, J = 2.0 Hz), 2.78 (2HA, t, J = 6.8 Hz), 2.80 (2HB, t, J = 7.02 
Hz),  3.49 (2HB, t, J = 6.9 Hz), 3.52 (2HA, t, J = 6.8 Hz), 3.68 (2HB, d, 
J = 1.6 Hz), 4.13 (2HA, d, J = 2.2 Hz), 5.14 (2HA+2HB, s), 5.16 (2HA, s), 5.18 (2HB, s), 6.67 (1HA, 
d, J =8.3 Hz), 6.73 (1HA, s), 6.74 (1HB, s), 6.80 (1HB, s), 6.88 (1HA+1HB, d, J = 8.0 Hz), 7.30-7.45 
(10HA+10HB, m), 7.71 (1HA, s), 8.00 (1HB, s); 13C NMR (101 MHz, CDCl3) (two rotamers A:B, 
ratio 6:1): δ 31.4 (1CA), 32.9 (1CB), 34.3 (1CA), 37.6 (1CB), 44.1 (1CB), 48.5 (1CA), 71.4 (1CB), 
71.4 (1CA), 71.5 (1CA), 73.5 (1CB), 77.8 (1CB),  78.0 (1CA), 115.4 (1CA), 115.5 (1CB), 115.8 (1CB), 
116.0 (1CA), 121.6 (1CB), 121.8 (1CA), 127.3 (4CA), 127.4 (4CB), 127.76 (2CB), 127.80 (1CA), 
127.82 (1CA), 128.44 (2CB), 128.46 (2CA), 128.48 (2CB), 128.5 (2CA), 131.0 (1CA), 132.0 (1CB), 
137.2 (1CA+1CB), 137.2 (1CA +1CB), 147.6 (1CB), 147.9 (1CA), 148.9 (1CB), 149.0 (1CA), 162.1 
(1CA), 162.1 (1CB); ESI-MS: m/z = 400.2 [M+H]+, 422.2 [M+Na]+, 799.4 [2M+H]+. 
 
(130g): yellow oil, 658 mg, 57% yield; 1H NMR (400 MHz, CDCl3) (two 
rotamers A:B, ratio 1.9:1): δ 2.28 (1HA, t, J = 2.6 Hz), 2.34 (1HB, t, J = 2.5 
Hz), 2.83 (2HA+2HB, t, J = 6.7 Hz), 3.58 (2HA, t, J =7.5 Hz), 3.62 (2HB, pt, J 
= 7.4 Hz), 3.90 (2HB, d, J = 2.1 Hz), 4.19 (2HA, d, J = 2.2 Hz), 5.94 (2HB, s), 5.95 (2HA, s), 6.60-
6.76 (3HA+3HB, m), 7.82 (1HA, s), 8.11 (1HB, s); 13C NMR (101 MHz, CDCl3): δ 31.2 (1CA), 32.9 
(1CB), 34.4 (1CA), 37.4 (1CB), 44.1 (1CB), 48.5 (1CA),72.6 (1CA), 73.7 (1CB), 77.9 (1CB), 78.0 
(1CA), 100.8 (1CB), 100.9 (1CA), 108.2 (1CB), 108.3 (1CA), 108.9 (1CA), 109.0 (1CB), 121.5 (1CB), 
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121.7 (1CA), 131.3 (1CA), 132.2 (1CB), 146.0 (1CB), 146.3 (1CA), 147.6 (1CB), 147.8 (1CA), 162.0 
(1CA), 162.1 (1CB); ESI-MS: m/z = 232.2 [M+H]+, 254.0 [M+Na]+, 463.2 [2M+H]+. 
 
(130h): yellow oil, 630 mg, 51% yield;1H NMR (400 MHz, CDCl3) (two 
rotamers A:B, ratio 2.2:1): δ 2.26 (1HA, t, J = 2.6 Hz), 2.31 (1HB, t, J = 2.5 
Hz), 2.91 (2HA, t, J = 6.9Hz), 2.92 (2HB, t, J = 7.0 Hz), 3.61 (2HA, t, J = 7.0 
Hz), 3.67 (2HB, t, J = 7.3 Hz), 3.85 (6HB, s), 3.87 (6HA, s), 3.92 (2HB, d, J = 2.5 Hz), 4.22 (2HA, d, 
J = 2.5 Hz), 6.72 (1HA, dd, J1 = 7.7 Hz, J2 = 1.4 Hz), 6.81-6.84 (1HA + 2HB, m), 6.99 (1HA + 1HB, 
pt, J = 8.0 Hz), 7.82 (1HA, s), 8.10 (1HB, s); 13C NMR (101 MHz, CDCl3): δ27.6 (1CB), 29.4 (1CA), 
31.1 (1CA), 37.3 (1CB), 43.0 (1CB), 47.3 (1CA), 55.50 (1CB), 55.51 (1CA), 60.4 (1CA), 60.6 (1CB), 
72.4 (1CA), 73.5 (1CB), 78.0 (1CB), 78.1 (1CA), 110.9 (1CB), 111.3 (1CA), 122.11 (1CA), 122.13 
(1CB), 123.9 (1CB), 124.0 (1CA), 131.2 (1CA), 132.1 (1CB), 147.15 (1CA), 147.23 (1CB), 152.55 
(1CB), 152.62 (1CA), 162.0 (1CA), 162.1 (1CB); ESI-MS: m/z = 248.2 [M+H]+, 270.0 [M+Na]+, 
494.2 [2M+H]+. 
 
(130i): yellow oil, 521 mg, 48% yield;1H NMR (400 MHz, CDCl3) (two 
rotamers A:B, ratio 1.8:1): δ 2.28 (1HA, t, J = 2.5 Hz), 2.34 (1HB, t, J = 2.5 Hz), 
2.87-2.91 (2HA+2HB, m), 3.63 (2HA, t, J = 7.1Hz), 3.68 (2HB, t, J =7.5 Hz), 3.80 
(3HA, s), 3.81 (3HB, s), 3.88 (2HB, d, J = 2.6 Hz), 4.20 (2HA, d, J = 2.6 Hz), 6.72-
6.85 (3HA+3HB, m), 7.21-7.26 (1HA+1HB), 7.84 (1HA, s), 8.11 (1HB, s); 13C NMR (101 MHz, 
CDCl3): δ 31.3 (1CA), 33.3 (1CB), 34.7 (1CA), 37.4 (1CB), 43.8 (1CB), 48.3 (1CA), 55.01 (1CB), 
55.02 (1CA), 72.6 (1CA), 73.8 (1CB), 77.9 (1CB), 78.1 (1CA), 111.88 (1CB), 111.91 (1CA), 114.3 
(1CB), 114.6 (1CA), 120.96 (1CA), 120.98 (1CB), 129.5 (1CB), 129.7 (1CA), 139.3 (1CA), 140.1 
(1CB), 159.7 (1CB), 159.8 (1CA), 162.0 (1CB), 162.3 (1CA); ESI-MS: m/z = 218.2 [M+H]+, 240.2 
[M+Na]+, 435.2 [2M+H]+. 
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General Procedure for the isomerization to allenamide compounds 131a-i. 
 
 
To a solution of propargylic amide 130a-i (1.5 mmol, 1 equiv.) in THF (8 mL) at 0°C, tBuOK (0.3 
mmol, 33.6 mg, 0.2 equiv.) and NaH (1.5 mmol, 36 mg, 1 equiv.) were added. The reaction was 
stirred for 24 h at room temperature, and then it was quenched with water (5 mL) at 0 °C. THF was 
removed under reduced pressure and the aqueous layer was extracted with ethyl acetate (3 x 5 mL). 
The combined organic layers were dried over Na2SO4, filtered and concentrated under reduced 
pressure. The crude mixture was purified by column chromatography on silica gel silica gel 
(cyclohexane/EtOAc 7/3) to give the desired products 131a-i. 
 
(131a): yellow oil, 509 mg, 91% yield;1H NMR (400 MHz, CDCl3): δ 
2.42 (3H, s), 2.82 (2H, pt, J = 8.0 Hz), 3.32 (2H, pt, J = 8.0 Hz), 3.85 
(3H, s), 3.87 (3H, s), 5.39 (2H, d, J = 6.4 Hz), 6.70 (2H, bs), 6.77-6.79 
(1H, m), 6.88 ( 1H, t, J = 6.2 Hz), 7.30 (2H, d, J = 7.8 Hz), 7.68 (2H, 
d, J =7.80 Hz);13C NMR (101 MHz, CDCl3): δ 21.4, 34.0, 48.1, 55.6, 55.7, 87.6, 100.0, 111.1, 
112.0, 120.6, 126.9 (2C), 129.6 (2C), 130.8, 135.3, 143.6, 147.5, 148.7, 201.4; ESI-MS: m/z = 
374.0 [M+H]+, 396.0 [M+Na]+, 769.0 [2M+H]+. 
 
(131b): brown oil, 49 mg, 64% yield; although numerous attempts by 
changing solvent and temperature, it has never been possible to obtain a 
well resolved spectrum of the product. 1H NMR (400 MHz, CDCl3, 25 
°C) (two rotamers A:B, ratio 2:1): δ2.78 (2HB, bs), 2.94 (2HA, bs), 3.64 (2HB, bs),3.77 (2HA, bs), 
3.89 (6HA+6HB, bs), 5.40 (2HA, bs), 5.53 (2HB, bs), 6.68 (3Hb, bs), 6.83 (3HA, bs), 7.18 (1HA+1HB, 
m), 7.46 (5HA+5HB, bs); 13C NMR (50 MHz, CDCl3): δ 35.4 (1CA+1CB), 41.3 (1CA+1CB), 55.9 
(1CA+1CB), 56.0 (1CA+1CB), 111.4 (1CB), 111.5 (1CB), 111.6 (1CA), 112.1 (1CA), 120.8 (1CA), 
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120.9 (1CA), 121.0 (2CB), 126.9 (2CA+2CB), 128.5 (1CA+1CB), 128.7 (2CA+2CB), 131.5 
(1CA+1CB), 134.7 (1CA+1CB), 147.9 (1CA), 149.0 (1CB), 149.1 (1CB), 149.2 (1CA), 151.1 (1CB), 
(1CA+1CB), 167.5 (1CA+1CB), 198.1 (1CA+1CB); ESI-MS: m/z = 324.2 [M+H]+. 
 
(131c): yellow oil, 185 mg, 27% yield; although numerous attempts 
by changing solvent and temperature, it has never been possible to 
obtain a well resolved spectrum of the product. 1H NMR (400 MHz, 
CDCl3, 25 °C) (two rotamers A:B, ratio 3:1):δ 2.77 (2HB, bs), 2.93 
(2HB, t, J = 7.2 Hz), 2.80 (2HA, bs),3.59 (2HB, bs),3.75 (2HA, bs), 3.84 (6HA+6HB, bs), 5.40 (2HA, 
d, J = 5.9 Hz),5.57 (2HB, bs), 6.36-6.45 (1HA+1HB, bs),6.71-6.80 (2HA+2HB, bs), 7.40 (2HA, 
bs),7.62 (2HB, bs), 7.86 (2HA, bs),7.94 (2HB, bs); 13C NMR (101 MHz, CDCl3): δ 33.1, 46.4, 55.9 
(2C), 87.5, 101.4, 112.3, 113.2, 121.0 (2C), 122.3 (2C, q, JC-F = 272.4 Hz), 123.9 (1C, m), 128.3 
(2C, bs), 131.9 (2C), 137.4, 149.1, 151.1, 168.3, 198.1; ESI-MS: m/z = 460.2 [M+H]+, 492.0 
[M+Na]+. 
 
(131d): yellow oil, 325 mg, 80% yield; Although numerous attempts by 
changing solvent and temperature, it has never been possible to obtain a 
well resolved spectrum of the product; 1H NMR (200 MHz, CDCl3, 25 
°C) (two rotamers A:B, ratio 1:1): δ1.38 (9HA, bs), 1.47(9HB, bs), 2.73 (2HA+2HB, bs),3.52 
(2HA+2HB, bs),3.83 (3HA+3HB, bs),3.84 (3HA+3HB, bs), 5.37 (2HA+2HB, bs), 6.65-6.78 (3HA+3HB, 
m), 6.98 (1HA, m),7.16 (1HA, m); ESI-MS: m/z = 319.1 [M+H]+, 342.0 [M+Na]+, 639.2 [2M+H]+. 
 
(131e): brown oil, 133 mg, 36% yield;1H NMR (400 MHz, CDCl3) (two 
rotamers A:B, ratio 1.2:1): δ 2.77-2.83 (2HA + 2HB, m), 3.56 (2HA, t, J = 6.6 
Hz), 3.63-3.67 (2HB, m), 3.86 (6HB,s), 3.87 (3HA, s), 3.88 (3HA, s), 5.48 
(2HB, d, J = 6.3 Hz), 5.51 (2HA, d, J = 6.6 Hz), 6.58 (1HA, t, J = 6.3 Hz), 6.64-6.82 (3HA + 3HB, m), 
7.30 (1HB, t, J = 6.4 Hz), 7.76 (1HB, s), 8.20 (1HA, s);13C NMR (101 MHz, CDCl3): δ 32.8 (1CB), 
34.0 (1CA), 43.5 (1CB), 48.2 (1CA), 55.8 (2CB), 55.9 (2CA), 87.3 (1CA), 87.9 (1CB), 97.4 (1CA), 
100.4 (1CB), 111.2 (1CB), 111.4 (1CA), 112.0 (1CB), 112.0 (1CA), 120.7 (1CB), 120.9 (1CA), 130.4 
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(1CA), 131.0 (1CB), 147.6 (1CA), 147.9 (1CB), 148.8 (1CB), 149.0 (1CA), 160.3 (1CB), 160.5 (1CA), 
200.4 (1CA), 202.2 (1CB); ESI-MS: m/z = 248.0 [M+H]+, 270.0 [M+Na]+, 495.2 [2M+H]+. 
 
(131f): yellow oil, 479 mg, 80% yield; 1H NMR (400 MHz, CDCl3) 
(two rotamers A:B, ratio 1.7:1): δ 2.71-2.75 (2HA+2HB, m), 3.46-3.52 
(2HA, m), 3.59 (2HB, t, J = 7.7 Hz), 5.14 (4HA, s), 5.15 (2HB, s), 5.17 
(2HB, s), 5.38 (2HB, d, J = 6.2 Hz), 5.45 (2HA, d, J = 6.4 Hz), 6.45 
(1HA, t, J = 6.3 Hz), 6.64 (1HA, d, J = 8.3 Hz), 6.69 (1HB, s), 6.72 (1HB, d, J = 8.3 Hz), 6.79 (1HA, 
s), 6.87 (1HA+1HB, d, J = 8.0 Hz), 7.25 (1HA, t, J = 6.6 Hz), 7.30-7.47 (10HA+10HB, m), 7.67 (1HA, 
s), 8.10 (1HB, s); 13C NMR (101 MHz, CDCl3): δ 32.7 (1CB), 33.4 (1CA), 43.4 (1CB), 48.1 (1CA), 
71.2 (1CA), 71.35 (1CB), 71.40 (1CB), 71.5 (1CA), 87.2 (1CA), 87.9 (1CB), 95.4 (1CA), 100.4 (1CB), 
115.27 (1CB), 115.31 (1CA), 115.9 (1CA), 116.1 (1CB), 121.7 (1CB), 121.9 (1CA), 127.27 (2CB), 
127.31 (2CB+2CA), 127.3 (2CA), 127.7 (1CA+1CB), 127.7 (1CA), 127.9 (1CB), 128.44 (2CB), 128.46 
(2CA+2CB), 128.49 (2CA), 131.2 (1CB), 131.9 (1CA), 137.3 (1CA+1CB), 137.4 (1CA+1CB), 147.6 
(1CB), 148.0 (1CA), 148.8 (1CA), 149.0 (1CB), 160.3 (1CA), 160.5 (1CB), 200.3 (1CA), 202.2 (1CB); 
ESI-MS: m/z = 400.0 [M+H]+, 422.0 [M+Na]+, 799.0 [2M+H]+. 
 
(131g): yellow oil, 208 mg, 60% yield; 1H NMR (400 MHz, CDCl3) (two 
rotamers A:B, ratio 1.1:1): δ 2.74-2.80 (2HA+2HB, m), 3.54 (2HA, t, J = 6.8 
Hz), 3.62 (2HB, pt, J = 7.8 Hz), 5.48 (2HB, d, J = 6.2 Hz), 5.50 (2HA, d, J = 
6.2 Hz), 5.93 (2HB, s), 5.95 (2HA, s), 6.56-6.76 (3HA+4HB, m), 7.30 (1HA, t, J = 6.3 Hz), 7.79 (1HA, 
s), 8.10 (1HB, s);13C NMR (101 MHz, CDCl3): δ 32.9 (1CB), 34.1 (1CA), 43.5 (1CB), 48.2 (1CA), 
87.3 (1CA), 88.0 (1CB), 95.4 (1CA), 100.4 (1CB), 100.8 (1CB), 100.9 (1CA), 108.2 (1CB), 108.4 
(1CA), 109.0 (1CA), 109.2 (1CB), 121.7 (1CB), 121.9 (1CA), 131.5 (1CA), 132.1 (1CB), 146.1 (1CA), 
146.4 (1CB), 147.5 (1CB), 147.8 (1CA), 160.3 (1CB), 160.5 (1CA), 200.24 (1CB), 202.18 (1CA); ESI-
MS: m/z = 270.0 [M+Na]+. 
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(131h): yellow oil, 256 mg, 69% yield; 1H NMR (400 MHz, CDCl3) (two 
rotamers A:B, ratio 1.3:1): δ 2.86-2.90 (2HA+2HB, m), 3.59 (2HA, t, J = 7.2 
Hz), 3.67 (2HB, t, J = 7.7 Hz, 3.84-3.87 (6HA+6HB, m), 5.43 (2HB, d, J = 6.2 
Hz), 5.50 (2HA, d, J = 6.5 Hz), 6.56 (1HB, t, J = 6.6 Hz), 6.68 (1HA, d, J = 7.5 Hz), 6.82 (1HA+2HB, 
pt, J = 7.9 Hz), 6.98 (1HA+1HB, pt, J = 7.5 Hz), 7.26-7.29 (1HA, m), 7.83 (1HA, s ), 8.20 (1HB, s); 
13C NMR (101 MHz, CDCl3): δ 27.8 (1CB), 29.6 (1CA), 42.5 (1CB), 46.9 (1CA), 55.6 (1CA + 1CB), 
60.6 (1CA), 60.7 (1CB), 87.2 (1CA), 87.9 (1CB), 95.5 (1CA), 100.4 (1CB), 110.9 (1CB), 111.3 (1CA), 
122.4 (1CB), 122.4 (1CA), 123.8 (1CB), 124.1 (1CA), 131.5 (1CA), 132.3 (1CB), 147.2 (1CA), 147.5 
(1CB), 152.7 (1CB), 152.8 (1CA), 160.4 (1CB), 160.6 (1CA), 200.1 (1CB), 200.2 (1CA); ESI-MS: m/z 
= 248.0 [M+H]+, 270.0 [M+Na]+, 495.2 [2M+H]+. 
 
(131i): brown oil, 208 mg, 64% yield; 1H NMR (400 MHz, CDCl3) (two 
rotamers A:B, ratio 1.1:1): δ 2.80-2.86 (2HA+2HB, m), 3.58 (2HA, t, J = 7.2 Hz), 
3.67 (2HB, pt, J = 7.8 Hz), 3.80 (3HA, s), 3.81 (3HB, s), 5.48 (2HB, d, J = 6.5 Hz), 
5.51 (2HA, d, J =6.6 Hz), 6.58 (1HB, t, J = 6.1 Hz) 6.68-6.83 (3HA+3HB, m), 
7.20-7.25 (1HA+1HB, m), 7.30 (1HA, t, J = 6.5 Hz), 7.80 (1HA, s), 8.20 (1HB, s); 13C NMR (101 
MHz, CDCl3): δ 33.3 (1CB), 34.5 (1CA), 43.2 (1CB), 47.9 (1CA), 55.1 (1CB), 55.1 (1CA), 87.3 (1CA), 
87.9 (1CB), 95.4 (1CA), 100.4 (1CB), 111.8 (1CB), 111.9 (1CA), 114.5 (1CA), 114.7 (1CB), 121.10 
(1CB), 121.13 (1CA), 129.4 (1CB), 129.7 (1CA), 139.5 (1CB), 140.0 (1CA), 159.6 (1CB), 159.8 (1CA), 
160.3 (1CB), 160.5 (1CA), 200.3 (1CB), 202.2 (1CA); ESI-MS: m/z = 218.0 [M+H]+, 240 [M+Na]+. 
 
 
 
General Procedure for the organocatalytic enantioselective cyclization of compounds 131a-i. 
 
To a solution of allenammide (0.1 mmol, 1 equiv.) in trifluorotoluene (1 mL), Brønsted acid (0.01 
mmol, 0.1 equiv.) and MS 4Å (0.05 g) were added and the reaction was stirred for 24h. The solvent 
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was removed under reduced pressure and the crude was purified by flash chromatography on silica 
gel (cyclohexane/ethyl acetate 3/7) to obtain the desired products. 
 
(132a): sticky white solid, 23.5 mg, 63% yield, 21% ee; the ee was 
determined by HPLC analysis, Daicel Chiralpak® ia column: hexane/i-
PrOH from 70:30, flow rate 1.0 mL/min, 40°C, λ = 280 nm: τmajor = 8.18 
min., τminor = 6.98 min; 1H NMR (400 MHz, CDCl3): δ 2.38 (3H, s), 2.48-2.54 (1H, m), 2.65-2.74 
(1H, m), 3.27-3.34 (1H, m), 3.82 (3H, s), 3.84 (3H, s), 3.85-3.89 (1H, m), 5.05 (1H, d, J = 17.14 
Hz), 5.18 (1H, d, J = 10.20 Hz), 5.46 (1H, d, J = 5.98 Hz), 5.91 (1H, ddd, J = 5.72 Hz, J = 10.12 
Hz, J = 16.98 Hz), 6.47 (1H, s), 6.53 (1H, s), 7.20 (2H, d, J = 8.08 Hz), 7.67 (2H, d, J = 8.33 Hz); 
13C NMR (101 MHz, CDCl3): δ 21.5, 27.2, 39.1, 55.8, 55.9, 57.7, 110.4, 111.3, 117.7, 125.4, 125.6, 
127.1 (2C), 129.4 (2C), 137.3, 137.9, 143.9, 147.4, 148.0; EI-MS: m/z = 373 (12), 346 (84), 308 
(75), 217 (82), 198 (87), 91 (100); ESI-MS: m/z = 374.0 [M+H]+, 396.0 [M+Na]+, 769.0 [2M+Na]+; 
HMRS calcd for C18H19N: 373.13478; found 373.13486. 
 
(132b): sticky white solid, 21.0 mg, 65% yield, 14% ee; the ee was 
determined by HPLC analysis, Daicel Chiralpak® IA column: hexane/i-
PrOH from 60:40 , flow rate 0.50 mL/min, 40°C, λ = 280 nm: τmajor = 
11.62 min., τminor = 16.86 min; Although numerous attempts by changing solvent and temperature, 
it has never been possible to obtain a well resolved spectrum of the product; 1H NMR (400 MHz, 
CDCl3, 25 °C) (two rotamers A:B, ratio 2:1): δ 2.61 (1HA, bs), 2.89 (1HA, bs), 3.22 (1HB, bs), 3.40 
(1HB, bs), 3.75 (2HA+2HB, bs), 3.85 (6HA+6HB, bs), 4.72-5.11 (2HA+2HB, m), 5.26 (1HA+1HB, bs), 
6.07 (1HA+1HB, bs), 6.17 (1HA, bs), 6.36 (1HB, bs), 6.61 (2HA, bs), 6.67 (2HB, bs),7.38 (5HA+5HB, 
bs); 13C NMR (101 MHz, CDCl3): δ 28.9 (1CB), 29.7 (1CA), 41.2 (1CA+1CB), 54.2 (1CA+1CB), 55.8 
(1CA+1CB), 56.0 (1CA+1CB), 111.4 (1CA+1CB), 117.4 (1CA+1CB), 120.6 (1CA+1CB), 126.0 
(1CA+1CB), 126.7 (2CA+2CB), 128.5 (2CA+2CB), 129.2 (2CA+2CB), 131.4 (1CA+1CB), 136.3 (1CA), 
137.1 (1CB), 147.6 (1CA+1CB), 148.1 (1CA+1CB), 170.4 (1CA+1CB); ESI-MS: m/z = 323 (25), 308 
(20), 280 (6), 264 (11), 218 (34), 105 (100), 77 (85); ESI-MS: m/z = 324.2 [M+H]+, 346.0 
[M+Na]+, 669.2 [2M+Na]+; 
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(132c): sticky yellow solid, 28.9 mg, 63% yield, 0% ee; the ee was 
determined by HPLC analysis, Daicel Chiralpak® IA colum hexane/i-
PrOH from 90:10, flow rate 0.5 mL/min, 40°C, λ = 285 nm: τmajor = 
14.66 min., τminor = 16.76 min; Although numerous attempts by changing solvent and temperature, 
it has never been possible to obtain a well resolved spectrum of the product; 1H NMR (400 MHz, 
CDCl3, 25 °C) (two rotamers A:B, ratio 2:1): δ2.60 (1HA+1HB, bs), 2.89 (1HA+1HB, bs), 3.00 (2HA, 
bs), 3.28 (1HB, bs),3.53 (1HA, bs),3.85 (6HA+6HB, bs), 4.72-5.16 (2HA+2HB, m),5.34 (1HA+1HB, d, 
J = 9.4 Hz),6.09 (1HA, bs),6.37 (1HB, bs),6.67 (2HA+2HB, bs),7.45 (1HA+1HB, bs),7.89 (2HA+2HB, 
bs); The presence of rotamers avoids the detection of some signals, that result too broad to be 
identified from the noise; 13C NMR (101 MHz, CDCl3): δ 34.2 (1CA), 35.1 (1CB), 41.6 (1CA), 41.7 
(1CB), 55.9 (2CA), 56.0 (1CB), 77.2 (1CA+1CB), 110.9 (1CA+1CB), 111.4 (1CA+1CB), 117.2 (1CA), 
118.3 (1CB), 119.8 (2CB, q, JC-F = 274.2 Hz), 122.8 (2CA, q, JC-F = 272.4 Hz), 123.6 (2CA+2CB), 
124.9 (1CB), 125.1 (1CA), 125.4 (1CB), 125.6 (1CA), 127.2 (1CA+1CB, bs), 136.5 (1CA), 136.8 
(1CB), 138.1 (1CA+1CB), 147.9 (1CA+1CB), 148.4 (1CA+1CB); EI-MS: m/z = 459 (22), 430 (76), 
241 (100), 213 (84); ESI-MS: m/z = 460.0 [M+H]+, 482.0 [M+Na]+, 941.0 [2M+Na]+; 
 
(132d): yellowish oil, 10.0 mg, 30% yield, 32% ee; the ee was determined 
by HPLC analysis, Daicel Chiralpak® ia column: hexane/i-PrOH from 
90:10, flow rate 0.70 mL/min, 40°C, λ = 280 nm: τmajor = 11.80 
min., τminor = 18.4 min; 1H NMR (400 MHz, CDCl3, 25 °C): δ 1.47 (9H, s), 2.60 (1H, dt,J = 3.4 Hz, 
J = 15.5 Hz), 2.71-2.77 (1H, m), 2.80-2.88 (1H, m), 3.13 (1H, bs), 3.83 (3H, s), 3.84 (3H, s), 3.85 
(1H, dJ = 4.0 Hz), 5.05 (1H, d,J = 17.0 Hz), 5.14 (1H, dt,J = 1.4 Hz, J = 10.2 Hz),  5.89-5.97 (1H, 
m), 6.58 (s, 1H), 6.59 (s, 1H); Due to the presence of rotamers, it was not possible to obtain suitable 
spectra performing a 13C NMR experiment; the signals have been determined from gHSQC and 
gHMBC experiments; 13C NMR (101 MHz, CDCl3): δ 28.9 (1CA+1CB), 29.6 (3CA), 32.5 (3CB), 
42.3 (1CA+1CB), 56.0 (1CA+1CB), 56.5 (1CA+1CB), 57.3 (1CA+1CB), 80.4 (1CA), 85.6 (1CB), 111.4 
(1CA), 111.3 (1CA), 111.6 (1CB), 112.4 (1CB),  116.8 (1CA+1CB),  127.3 (1CA), 128.7 (1CB), 129.2 
(1CA+1CB), 148.3 (1CA+1CB), 148.8 (1CA+1CB), 149.5 (1CA+1CB), 181.6 (1CA+1CB); ESI-MS: 
m/z = 342.2 [M+Na]+, 661.2 [2M+Na]+; 
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(132e): sticky white solid, 9.9 mg, 40% yield, 81% ee; to perform the HPLC 
analysis of product 132e, it was necessary to reduce the amide moiety to 
methyl group LiAlH4 (1.5 equiv.) was added to 132e. After 2h, a few drops of 
water were added, followed by MgSO4. The mixture was filtered and directly subjected to HPLC 
analysis; Daicel Chiralpak® OD-H column: hexane/i-PrOH from 90:10, flow rate 0.70 mL/min, 
40°C, λ = 285 nm: τmajor = 7.87 min., τminor = 14.93 min; 1H NMR (400 MHz, CDCl3) (two rotamers 
A:B, ratio 1:1): δ 2.62-2.72 (2HB, m), 2.78-2.91 (2HA, m), 3.13 (1HB, ddd, J = 4.7 Hz, J = 11.0 Hz, 
J = 15.6 Hz), 3.45 (1HA, ddd, J = 4.2 Hz, J = 13.0 Hz, J = 13.0 Hz), 3.65 (1HA, dd, J = 5.8 Hz, J = 
13.2 Hz), 3.80 (3HA, s), 3.81 (3HA + 3HB, bs), 3.82 (3HB, s),  4.29 (1HB, m),  5.02 (1HB, d, J = 5.7 
Hz), 5.09 (1HA, d, J = 17 Hz), 5.11 (1HB, d, J = 17.0 Hz), 5.19 (1HA, d, J = 10.1 Hz), 5.20 (1HB, d, 
J = 10.1 Hz), 5.78 (1HA, d, J = 5.6 Hz), 5.86-5.99 (1HA +1HB, m), 6.55 (1HA, s), 6.56 (1HA +1HB, 
bs), 6.59 (1HB, s), 8.15 (1HA, s), 8.25 (1HB, s);13C NMR (101 MHz, CDCl3): δ 27.6 (1CB), 29.2 
(1CA), 35.1 (1CB), 40.2 (1CA), 52.7 (1CA), 55.8 (1CA), 55.8 (1CA), 55.9 (1CA), 56.0 (1CB), 58.7 
(1CB), 110.1 (1CB), 110.6 (1CA),111.3 (1CA), 111.5 (1CB), 117.0 (1CB), 117.3 (1CA), 125.2 (1CA + 
1CB), 125.4 (1CA), 126.5 (1CB), 136.4 (1CA), 138.0 (1CB), 147.6 (1CB), 147.7 (1CA), 148.0 (1CA), 
148.3 (1CB), 161.1 (1CA), 161.6 (1CB); ESI-MS: m/z = 248.2 [M+H]+, 270.0 [M+Na]+, 495.2 
[2M+H]+; HMRS calcd for C18H19N: 247.12084; found 247.12075. 
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4. INTRODUCTION: ALLENOATES 
Another type of heteroatom-substituted allenes is represented by allenoates where the amide group 
of the allenamides is replaced with an ester group. One easy way to obtain allenoates consists of the 
gold-catalysed [3,3]-sigmatropic rearrangement of propargylic carboxylates. Indeed, it is already 
known that in gold catalysis these propargylic esters can undergo 1,2-acyloxy migration leading to a 
gold vinyl carbenoid species or 1,3-acyloxy migration resulting in a gold allenic intermediate 
(Scheme 1). 
 
Scheme 1: Au-catalysed 1,2- or 1,3-acyloxy migration of propargylic carboxylates. 
The intermediates obtained through the 1,2- or 1,3-migration are in equilibrium.[1] Recently, it was 
reported a computation study to rationalize the rearrangement selectivity.[2] In particular, two 
resonance structures models were associated to the selectivity of the cyclization (Figure 1). 
 
Figure 1: Resonance structure models. 
Substrates are more likely to be stabilized to the resonance structure K and the C3 atom in more 
likely to accept the electron from the ester group except for the substrates featuring hydrogen or 
EWG for R3, which undergo the gold-catalysed 1,2-acyloxy migration. 
The gold vinyl carbenoid species are principally employed in cyclopropanation reaction of alkenes 
and dienes, as well as insertion into C‒H bonds.[3–5] On the contrary, the allenic intermediate can 
follow two different routes:  
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 the allenoates intermediate can undergo a gold-catalysed electrophilic activation and 
subsequent nucleophilic trapping; 
 the allene moiety can act as nucleophilic reagent. 
4.1 Electrophilic Activation 
The first type of reactivity was used by Zhang in 2005[6] to develop an new efficient procedure to 
prepare highly functionalized 2,3-indoline-fused cyclobutanes. In particular, in the presence of 
gold(I) catalyst, the propargylic indole-3-acetates resulted after 2 hours in the corresponding 
products in good yields (Scheme 2). 
 
 
Scheme 2: Scope of the Au-catalysed synthesis of 2,3-indoline-fused cyclobutanes. 
In the proposed reaction mechanism reported in Scheme 3, the [3,3]-sigmatropic rearrangement 
promoted by the catalyst, led to an allenoate intermediate that can be efficiently activated by the 
gold(I) specie toward the subsequent nucleophilic attack by the C(3)-indole. 
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Scheme 3: Proposed reaction mechanism. 
The electrophilic activation followed by nucleophilic trapping can be also used to prepare 
polysubstituted 2,5-dihydrofurans as reported by Gagosz.[7] The methodology proved to be flexible 
and several substituted butynediol monobenzoates resulted in the corresponding products in the 
presence of 2 mol% of (Ph3P)AuNTf2 (Scheme 4).  
 
 
Scheme 4: Application in the synthesis of 2,5-dihydrofurans. 
Also enantioenriched butyenediol monobenzoates were submitted under the same experimental 
conditions and in most of these cases the desired products were isolated without loss of optical 
purity. Also propargylic ester featuring three stereogenic centers was used as starting material by 
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providing the corresponding trans-2,5-disubstituted dihydrofuran in 99% yield and complete 
transfer of the stereochemical information (Scheme 5).  
 
 
 
Scheme 5: Complete transfer of optical purity using enantioenriched substrates. 
Recently, Hashmi and co-workers employed the electrophilic activation of the in situ formed 
allenoates in order to prepare 3,4-disubstituted pyrrolidin-2-ones through tandem 1,3- and 1,5-
acyloxy migration.[8] In particular, the substituted propargylic ester undergoes the [3,3]-sigmatropic 
rearrangement resulting in the allenoate intermediate which is attacked by the olefin forming the 
intermediate N. The final 1,5-acyloxy migration leads to the desired product (Scheme 6). 
 
Scheme 6: Tandem 1,3-1,5-acyloxy migration. 
The large flexibility exhibited by the methodology makes this new route a useful and easy way to 
prepare diastereomerically pure butyrolactams, which are important building blocks for the total 
synthesis of various natural products and for the development of new compounds with 
pharmaceutical activities[9] (Scheme 7).  
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Scheme 7: Scope of the formal 1,6-acyloxy migration promoted by Au(I)-catalyst. 
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4.2 Nucleophilic Activation 
The presence of the oxygen directly bonded to the allene moiety in the allenoates, allows at the 
allenoates undergoing nucleophilic activation. Toste and co-workers in 2006[10] used this type of 
reactivity of the allenoates to develop a very efficient synthesis of aromatic ketones promoted by 
transition metal, in particular silver- and gold-catalysts (Scheme 8).  
 
Scheme 8: Synthesis of aromatic ketones promoted by transition metal-catalysts. 
The AgSbF6 in the presence of PPh3 was able to promote the reaction in good yield when acetyl 
group was employed as ester and the terminal substituent of the propargylic acetate was a methyl 
group, but no traces of the corresponding product were observed when pivalic ester 146 were used 
instead of 144. To obtain the desired naphthylphenyl ketone 147 was developed a new catalyst-
system using gold(I) catalyst in a mixture of dichloromethane and acetonitrile as solvent. An ample 
scope with ten differently substituted ketones isolated with good to excellent yields proved the 
flexibility of the catalytic process promoted by silver catalyst. The gold(I)-catalytic system 
demonstrated to be complementary to the silver-protocol because in all of the cases where the 
silver-conditions failed, the gold(I)-catalytic system produced the desired products (Scheme 9). 
 
Scheme 9: Complementarity of the Au(I)-catalytic system with the Ag(I) ones. 
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Mechanistically, as it is shown in Scheme 10, the formation of the allenoates promoted by the 
metal-catalyst is followed by activation of the remaining alkyne which undergoes the nucleophilic 
trapping from the allene moiety. 
 
Scheme 10: Proposed reaction mechanism. 
An efficient method to prepare δ-diketones through nucleophilic trapping by allenoate intermediates 
was reported by Fensterbank and co-workers.[11] In particular, the nucleophilic attack by the allene 
moiety on the alkyne, resulted in an intermediate which undergoes 1,5-acyl migration and leads to 
the desired product (Scheme 11). 
 
Scheme 11: Synthesis of δ-diketones through 1,5-acyloxy migration. 
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Not only gold(I) catalyst could promote this reaction, but also complexes of AuIII, PtII and PtIV gave 
the desired product in good to excellent yield. All the products isolated exhibited only the E 
configuration for the exocyclic double bond. The DTF computational studies demonstrated that the 
E configuration was the favourite and the formation of the Z stereoisomer was kinetically very 
difficult to achieve. A scope with more than twenty diketones was obtained and the methodology 
resulted to be very tolerant toward several functional groups; only one limitation related to the triple 
bond was found: when substituted propargyl ester was employed, the second triple bond must 
remain monosubstituted. 
Above it was reported that the allenoate intermediates underwent nucleophilic trapping by 
inactivated alkene in order to prepare disubstituted pyrrolidinone.[8] Subsequently, Chan and co-
workers demonstrated that the allene moiety can also react as nucleophile in a reaction with alkenes. 
In particular, they developed a gold-catalysed tandem 1,3-migratory/[2,2] cycloaddition of 
propargylic esters in order to prepare azabicyclo[4.2.0]oct-5-enes.[12]  
 
 
 
Scheme 12: Au-catalysed tandem 1,3-migratory/[2,2] cycloaddition of propargylic esters. 
Several 1,7-enyne benzoates, prepared from the opportune L-α-aminoacids, were submitted under 
optimized reaction conditions resulting in a variety of highly substituted bicycles in good to 
excellent yields. The reaction demonstrated efficient transfer of chirality from the enantiopure 
substrates leading to the products. Moreover, when mixtures of diastereoisomers were employed as 
starting materials the reactions exhibited highly stereoconvergence since the corresponding products 
were isolated as single diastereoisomers. 
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5. GOLD(I)-CATALYSED [3,3]-SIGMATROPIC REARRANGEMENT OF 
PROPARGYLIC CARBOXYLATES 
5.1 Catalytic α-Allylation of Enones with Alcohols 
The few examples reported above for the electrophilic trapping of the allenoates were limited to 
studies of intramolecular process. Hashmi and co-workers in 2013 developed the first 
intermolecular reaction involving nucleophilic gold allenic intermediates.[1] In particular, they 
developed an efficient catalytic protocol able to prepare various isochromane derivatives which are 
powerful building blocks for the synthesis of natural products (Scheme 1). 
 
Scheme 1: Synthesis of isochromanes promoted by Au-catalysts. 
Several gold(I) catalysts were tested in different solvents demonstrating that the 
SPhosAuCl/AgNTf2 in DCE was the best catalytic system for the process leading to the 
corresponding product in 68% yield and with complete stereocontrol toward the formation of the Z 
isomer. Moreover, it was also observed that the replacement of the acetate group with the pivalate 
group increased the yield of the product up to 85%. Subsequently, the scope of the reaction was 
investigated submitting under optimized reaction conditions differently substituted isochromane 
acetal derivatives in combination with several propargylic pivalates (Scheme 2). 
The large scope reported below shows the versatility of the protocol and its tolerance toward 
different functional groups. Propargylic pivalates featuring aliphatic as well as aromatic groups 
resulted in the corresponding products in good to excellent yields. In most of the cases the Z 
isomers were isolated as single products or as major stereoisomer in a mixture with the E products.  
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Scheme 2: Scope of the reaction. 
Mechanistically, the oxocarbenium ion, resulted from the gold activation of the isochromane 
acetate, underwent the nucleophilic attack by the allenoate intermediate, the latter generated by 
gold-catalyzed 1,3-pivalate migration (Scheme 3). In order to support this pathway, the allenoate 
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intermediate was isolated and submitted with the isochromane acetate under optimized reaction 
conditions. The corresponding product was isolated in 85% yield. 
 
Scheme 3: Proposed reaction mechanism. 
Inspired by this type of reactivity and considering our interest in the manipulation of allene-
derivatives[2–5], we envisioned the possibility to use this nucleophilic reactivity of the allenoates in 
order to develop the direct α-allylation of enones using activated alcohols as alkylating agents.[6] 
We started our investigation considering the condensation between the easily accessible propargylic 
acetate 155a and the activated alcohol 157a in the presence of different gold-catalysts (Table 1).  
Interestingly, the carbene-gold catalyst[7] promoted moderately the reaction providing the desired 
product in 40% yield (entry 1, Table 1). The phosphine-based complexes furnished not homogenous 
results; in particular only the JohnPhosAuCl/AgNTf2 provided the allylated product in satisfactory 
yield and good cis-diastereoselectivity (entry 3, Table 1).[8] The optimization continued evaluating 
the effect of the counterion: weakly coordinating anions performed better the catalytic reaction than 
that the more nucleophilic ones.[9,10] The obtained results elected the commercially available silver-
free [JohnPhosAu(CH3CN)SbF6][11,12] as the best catalyst for the titled transformation furnishing the 
corresponding α-allylated product in 74% yield and excellent diastereoselectivity (entry 10, Table 
1). It was also demonstrated that the AgSbF6 was not able to promote the catalytic reaction (entry 6, 
Table 1). Moreover, the well-known attitude of pivalates as better 1,3-migrating group respect to 
the acetate group, suggested us to replace the acetyl group with bulkier pivalate. Gratifyingly, under 
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the latter conditions, the desired product was isolated in higher yield (86%) without loss of 
diastereoselectivity (entry 11, Table 1).  
Table 1: Optimization table.[a] 
 
Entry [Au] (2 mol%) 155a/156a Yield 158aa (%)[b] Z : E[c] 
1[d] [Au(IPr)NTf2] 155a 40 95:5 
2[e] PPh3AuNTf2 155a 23 95:5 
3 JohnPhosAuCl/AgNTf2 155a 65 97:3 
4[d] JackiePhosAuNTf2 155a 12 --:-- 
5[d,e] Me-Dalphos-AuNTf2 155a 38 95:5 
6 AgNTf2 155a n. r. --:-- 
7[e] JohnPhosAuOTs 155a 48 95:5 
8[e] JohnPhosAuTFA 155a 45 95:5 
9[e] JohnPhosAuBArF 155a 61 95:5 
10 JohnPhosAu(ACN)SbF6 155a 74 97:3 
11 JohnPhosAu(ACN)SbF6 156a 86 97:3 
12[f] JohnPhosAu(ACN)SbF6 156a 76 98:2 
[a] All the reaction were carried out under nitrogen. Ratio 155a/156a:157a:[Au] = 1:1.5:0.02 unless otherwise 
specified. All the reagents used and the products obtained should be considered as racemic mixtures. [b] Isolated 
yield after flash chromatography. [c] Yield determined via GC-MS on the reaction crude. [d] Large amount of 
unreacted acetate 155a was recovered. Reaction time 48 h. [e] the catalyst was prepared in situ by treating 
equimolar amounts of LAuCl and AgX. [f] A 156a:157a:[Au] = 1:1:0.02 ratio was utilized. n.r. = no reaction. 
 
Subsequently, in order to further increase the yield and the diastereoselectivity, the reaction was 
performed in different solvents. In particular, dichloromethane, benzene and trifluorotoluene proved 
to be efficient in the reaction, but no significant improvement in term of yield or diastereoselectivity 
was recorder. 
With the optimized reaction conditions in our hand, we tested the scope and limitations of the 
protocol submitted differently substituted activate alcohols with propargylic pivalate 156a in the 
presence of JohnPhosAu(ACN)SbF6 in Toluene at reflux (Scheme 4). All the corresponding 
products were isolated in good to excellent yields demonstrating that the synthetic procedure was 
tolerant toward different functional groups. Indeed, activated alcohols featuring electron-
withdrawing groups as well as moderate electron-donating groups resulted in the corresponding 
allylated products in satisfactory yields. Only the strong electron-withdrawing group, such as OMe, 
was not tolerated and no traces of the product were found after the reaction. In that case a 
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disproportion of the alcohol to the corresponding chalcone and 1,3-diphenylpropene was 
observed.[13] Furthermore, the replacement of one or both the aromatic substituents of the alcohols 
with hydrogen atom or alkylic substituents caused the failure of the reactions. 
 
 
Scheme 4: Scope of the reaction with different activated alcohols. 
When asymmetric alcohol 157f was employed in the reaction, a 1:1 mixture of regioisomers was 
isolated; this evidence supports a SN1-type mechanism reaction. 
Furthermore, in several cases the formation of traces of trisubstituted dihydroindenyl compounds 
was observed. It is noteworthy that the bicycle 159ah was isolated as major product in 1.2:1 
mixture of diastereoisomers A:B. The formation of these compounds can be rationalized in term of 
a cascade Friedel-Crafts-type alkylation by the aromatic ring to the β-position of the enone 
intermediate (Scheme 5). 
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Scheme 5: Cascade Friedel-Crafts-type alkylation. 
Only two diastereoisomers were obtained and it was demonstrated by NMR studies that the 
distereoselective protonation occurred always at the opposite face respect the styrene group. (Figure 
1) 
 
Figure 1: Peak assignment of the products in 1HNMR spectrum. 
After that, the NOE experiments have been carried out by irradiation of the Hb proton of both 
diastereoisomers.  
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As it can see in Figure 2, only the Ha of the diastereoisomer A (major diastereoisomer) is visible in 
the spectrum as well as the Hc of both isomers. With these results it is easy to determinate that the 
carbonyl group and the styrene group are always in cis position while the methyl group is in cis in 
the major diastereoisomer (A) and anti in the minor one (B). 
 
Figure 2: 159ah and 159ah’ NOE experiments. 
The same Michael-type-Friedel-Crafts alkylation was observed when tertiary allylic alcohol 160 
was employed in the transformation with propargylic pivalates 156a in the presence of 
JohnPhosAu(ACN)SbF6 (Scheme 6).  
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Scheme 6: Michael-type-Friedel-Crafts alkylation observed with tertiary allylic alcohol 160. 
The bicycle 161 was isolated in moderate yield and high trans-diastereoselectivity; the 
configuration of the dihydrobenzo[7]annulene was unambiguously determined through NMR 
experiments. 
Additionally, in order to further prove the flexibility of the synthetic protocol, differently 
substituted propargylic pivalates were prepared and submitted under optimized reaction conditions 
(Scheme 7).  
 
 
Scheme 7: Scope of the reaction with different propargylic pivalates. 
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Propargylic pivalates featuring aliphatic as well as aromatic groups as R1 substituent resulted in the 
desired products in good to excellent yields (up to 99%). Not only secondary, but also primary and 
tertiary esters were employed in the reaction and the corresponding products were isolated in good 
yields. Only modest yield was achieved when propargylic pivalate featuring aliphatic group as R2 
substituent was used as starting material.  
The structure of enone 158ag was determined by single crystal X-ray diffraction. In particular, the 
data collected demonstrated that the enone unit adopts the Z configuration. The geometry of the 
molecule in the crystal is influenced by high steric hindrance. Indeed, the enone moiety exhibits a 
significant deviation from planarity forming a torsion angle of 52.3 (3)° between the C=C double 
bond and the carbonyl group. This particular arrangement allows weak intermolecular π-π stackings 
among the phenyl groups linked to the carbonyl (Figure 3). 
 
 
Figure 3: X-ray structure of 158ag. 
The unexpected Z configuration of the enones was rationalized as shown in Scheme 8: in the 
unfavoured approaching trajectory is present an interaction between the allyl moiety and the methyl 
group in Ȗ position on the allenyl framework which is not present in the transition state that will 
result in a Z configuration. 
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Scheme 8: Favoured and unfavoured approaches in the transition state. 
Finally, the role of the in situ formed pivalic acid was investigated. Some reactions were performed 
in the presence of different organic and inorganic bases and no traces of product were observed. No 
traces of product were observed even when a stoichiometric amount of pivalic acid was utilized in 
the absence of the gold catalyst. These results demonstrated that the concomitant presence of the 
gold catalyst and the Brønsted acid is necessary for the success of the reaction. Moreover, it was 
rationalized that the role of the gold-catalyst is the formation of the nucleophilic species through 
[3,3]-sigmatropic rearrangement of the propargylic ester, while the pivalic acid actives the alcohol 
toward the nucleophilic trapping (Scheme 9). 
 
Scheme 9: Proposed reaction mechanism. 
In conclusion, an unprecedent gold(I)/H+ co-catalysed α-allylation of enones using activated 
alcohols as electrophilic partner was developed. The catalytic protocol demonstrated to be tolerant 
toward different functional groups furnishing all the desired products in good to excellent yields and 
very high Z-stereocontrol. In some cases it was also possible to obtain fused bicycles in moderate 
yields and good diastereoselectivity.  
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5.1.1 Experimental Section 
1H-NMR spectra were recorded on Varian 200 (200 MHz) or Varian 400 (400 MHz) spectrometers. 
Chemical shifts are reported in ppm from TMS with the solvent resonance as the internal standard 
(deuterochloroform: 7.27 ppm). Data are reported as follows: chemical shift, multiplicity (s = 
singlet, d = doublet, t = triplet, q = quartet, sext = sextet, sept = septet, p = pseudo, b = broad, m = 
multiplet), coupling constants (Hz). 13C-NMR spectra were recorded on a Varian 200 (50 MHz), 
Varian 400 (100 MHz) spectrometers with complete proton decoupling. Chemical shifts are 
reported in ppm from TMS with the solvent as the internal standard (deuterochloroform: 77.0 ppm). 
GC-MS spectra were taken by EI ionization at 70 eV on a Hewlett-Packard 5971 with GC injection. 
They are reported as: m/z. LC-electrospray ionization mass spectra were obtained with Agilent 
Technologies MSD1100 single-quadrupole mass spectrometer. Chromatographic purification was 
done with 240-400 mesh silica gel. Anhydrous solvents were supplied by Fluka or Sigma Aldrich in 
Sureseal® bottles and used without any further purification. Commercially available chemicals 
were purchased from Sigma Aldrich, Stream and TCI and used without any further purification.  
 
Synthesis of 4-phenylbut-3-yn-2-yl acetate (1) 
 
To a solution of alkyne phenylacetylene (5 mmol)) in THF (15 mL) under nitrogen atmosphere, n-
BuLi was added dropwise at -78 °C. The mixture was stirred at -78 °C for 2h and then acetaldehyde 
(1 eq, 5 mmol) was added at the same temperature and then the mixture was allow to reach at room 
temperature and stirred for 4h. Subsequently, brine (15 mL) was added and the aqueous layer was 
extracted with AcOEt (3 x 10 mL). The combined layers were washed with brine (15 mL) and then 
dried with Na2SO4, filtered and concentrated under reduced pressure. The crude product was used 
such as, without further purification in the next step. 
To a solution of 4-phenylbut-3yn-2ol, Et3N (10eq, 50mmol, 7mL), and DMAP (5%, 0,25mmol, 31 
mg) in DCM (10 mL) was added acetylchloride (1,2 eq, 6 mmol, 429 μL) and the mixture was 
stirred at rt overnight. Then the mixture was quenched with water (10 mL) and the aqueous layer 
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was extracted with DCM (3 x 10 mL). The combined organic layers were washed with brine (15 
mL) and dried with Na2SO4, filtered and concentrated under educed pressure. The crude product 
was purificated by column chromatography on silica gel (ciclohexane:AcOEt 98:2) to give 4-
phenylbut-3-yn-2-yl acetate (155a). 
 
 
155a Yellow oil; Y = 78%; Spectroscopic data are according to those reported 
in literature; [1] GC-MS (m/z): 188 (M). 
 
 
 
 
 
General procedure for the synthesis of pivaloyl derivates (156a-h): 
 
To a solution of alkyne (5 mmol)) in THF (15 mL) under nitrogen atmosphere, n-BuLi was added 
dropwise at -78 °C. The mixture was stirred at -78 °C for 2h and then the opportune aldehyde (1 eq, 
5 mmol) was added and then the mixture was allow to reach at room temperature and stirred for 4h. 
Subsequently, brine (15 mL) was added and the aqueous layer was extracted with AcOEt (3 x 10 
mL). The combined layers were washed with brine (15 mL) and then dried with Na2SO4, filtered 
and concentrated under reduced pressure. The crude product was used such as, without further 
purification in the next step. 
To a solution of propargyl acohol, Et3N (10eq, 50mmol, 7mL), and DMAP (5%, 0,25mmol, 31 mg) 
in DCM (10 mL) was added trimethlyacetylchloride (1,2 eq, 6 mmol, 742 μL) and the mixture was 
stirred at rt overnight. Then the mixture was quenched with water (10 mL) and the aqueous layer 
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was extracted with DCM (3 x 10 mL). The combined organic layers were washed with brine (15 
mL) and dried with Na2SO4, filtered and concentrated under educed pressure. The crude product 
was purificated by column chromatography on silica gel (ciclohexane:AcOEt 98:2) to give the 
desiderated product. 
 
 
 
156a Yellow oil; Y = 76% (un-optimized yield); Spectroscopic data are 
according to those reported in literature.[2] GC-MS (m/z): 230 (M). 
 
 
 
 
 
156b Yellow oil; Y = 73% (un-optimized yield); 1H-NMR (400 MHz, 
CDCl3), δ 1.16 (s, 9H), 1.48 (d, 3H, J = 6.7 Hz), 2.25 (s, 3H), 5.59 (q, 1H, J 
= 6.6 Hz), 7.05 (d, 1H, J = 7.5 Hz), 7.11 (t, 1H, J = 7.5 Hz), 7.20-7.15 (m, 
2H); 13C-NMR (100 MHz, CDCl3), δ 21.1, 21.3, 27.0 (3C), 38.6, 60.6, 
84.4, 87.3, 122.2, 128.1, 128.8, 129.3, 132.4, 137.8, 177.3; GC-MS (m/z): 
244 (M). 
 
 
156c Yellow oil; Y = 77% (un-optimized yield); 1H-NMR (400 MHz, 
CDCl3), δ 1.10-1.32 (m, 13H), 1.66-1.91 (m, 6H), 5,39 (d, 1H, J = 6.1 Hz), 
7.24-7.29 (m, 3H), 7.40-7.43 (m, 2H); 13C-NMR (100 MHz, CDCl3), δ 
25.8(2C), 26.3, 27.1 (3C), 28.4, 28.5, 38.9, 42.1, 68.4, 85.4, 86.0, 122.6, 
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128.2 (2C), 128.3, 131.8 (2C), 177.4. GC-MS (m/z): 298 (M) 
 
 
156d White solid; Y = 68% (un-optimized yield); mp = 38 °C; 1H-NMR 
(400 MHz, CDCl3), δ 0.98 (d, 3H, J = 4.5 Hz), 1.00 (d, 3H, J = 4.4 Hz), 1.25 
(s, 9H), 1.93- 1.70 (m, 3H), 5.64 (t, 1H, J = 7.0 Hz), 7.31-7.29 (m, 3H), 
7.45-7.43 (m, 2H); 13CNMR (100 MHz, CDCl3), δ 22.4, 22.5, 24.9, 27.0 
(3C), 38.7, 43.6, 63.0, 84.8, 87.0, 122.5, 128.2 (2C), 128.4, 131.8 (2C), 
177.4; GC-MS (m/z): 272 (M). 
 
 
156e White solid; Y = 78% (un-optimized yield); mp = 44 °C; spectroscopic 
data are in accordance to those reported in literature. [2] GC-MS (m/z): 292 
(M). 
 
156f Yellow oil; Y = 48% (un-optimized yield); 1H-NMR (400 MHz, CDCl3), δ 
1.19 (s, 9H), 1.72 (s, 6H), 7.28-7.24 (m, 3H), 7.42-7.39 (m, 2H); 13C-NMR (100 
MHz, CDCl3), δ 27.0 (3C), 28.9 (2C), 39.1, 72.0, 83.6, 90.4, 122.8, 128.1 (2C), 
128.1, 131.8 (2C), 176.6. GC-MS (m/z): 244 (M) 
 
 
 
156g Yellow oil; Y = 65% (un-optimized yield); Spectroscopic data are according 
to those reported in literature. [2] GC-MS (m/z): 216 (M). 
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156h White solid; Y = 71% (un-optimized yield); mp = 79 °C. 1H-
NMR (400 MHz, CDCl3), δ 1.26 (s, 9H), 6.85 (s, 1H), 7.35-7.32 (m, 
3H), 7.54-7.49 (m, 4H), 7.68 (dd, 1H, J = 8.6 Hz, J = 1.5 Hz), 7.87-
7.86 (m, 1H), 7.90 (d, 2H, J = 8.8 Hz), 8.06 (s, 1H); 13C-NMR (100 
MHz, CDCl3), δ 27.0 (3C), 38.8, 66.0, 85.0, 87.0, 122.3, 124.9, 126.3, 
126.5, 127.8, 127.7, 128.2, 128.3, 128.5, 128.7, 131.9 (2C), 133.0, 133.3, 134.8, 177.2; GC-MS 
(m/z): 342 (M). 
 
 
156i Yellow oil; Y = 60% (un-optimized yield); Spectroscopic data are in 
accordance to those reported in literature.[2] 
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Gold-catalysed α-allylation of enons (158aa-fh)  
 
A dried two-necked round bottom flask was charged with anhydrous toluene (1 mL), the desired 
carboxylate (155a, 156a-h) (0.1 mmol), the allylic alcohol (0.15 mmol) and the 
[JohnPhosAu(ACN)]SbF6 (2 mol%). The mixture was poured in a pre-heated oil bath (110 °C) and 
the reaction left stirring at the same temperature for the indicated time. After cooling to room 
temperature, the reaction crude was directly charged into a column for purification by flash 
chromatography (cHex:AcOEt 98:2). 
 
 
(Z,E)-158aa Yellow oil, Y = 77%. 1H-NMR (400 MHz, CDCl3), δ 
1.58 (dd, 3H, J = 7.1 Hz, J =1.3 Hz), 4.66 (dd, 1H, J = 7.9 Hz, J =1.0 
Hz), 5.86 (dq, 1H, J = 7.1 Hz, J = 1.4 Hz), 6.39 (d, 1H, J = 15.9 Hz), 
6.54 (dd, 1H, J = 15.8 Hz, J = 7.9 Hz), 7.23-7.18 (m, 2H), 7.35-7.27 
(m, 8H), 7.44-7.37 (m, 2H), 7.55-7.51 (m, 1H), 7.83-7.81 (m, 2H); 13C-NMR (100 MHz, CDCl3), 
δ 16.0, 53.0, 126.4 (2C), 126.9, 127.5, 128.5, 128.60 (2C), 128.64 (2C), 128.7 (2C), 128.8 (2C), 
129.3 (2C), 130.7, 132.0, 133.1, 137.3, 137.7, 141.0, 143.3, 199.6; GC-MS (m/z): 338 (M); anal. 
calcd for (C25H22O: 338.17): C, 88.72; H, 6.55; found: C, 88.56, H, 6.64. 
 
 
(Z,E)-158ab Yellow oil, Y = 68%. 1H-NMR (400 MHz, CDCl3), δ 
1.55 (dd, 3H, J = 7.2 Hz, J = 1.1 Hz), 2.29 (s, 3H), 2.30 (s, 3H), 4.59 
(d, 1H, J =7.8 Hz), 5.82 (dq, 1H, J = 7.0 Hz, J = 1.2 Hz), 6.32 (d, 
1H, J = 15.9 Hz), 6.43 (dd, 1H, J = 15.8 Hz, J = 7.8 Hz), 7.08 (t, 3H, 
J = 7.6 Hz), 7.24-7.15 (m, 5H), 7.40 (t, 2H, J = 7.6 Hz), 7.50 (t, 1H, 
J = 7.4 Hz), 7.82 (d, 2H, J = 7.3 Hz); 13C-NMR (100 MHz, CDCl3), δ 15.8, 21.0, 52.4, 126.2 (2C), 
128.1, 128.51 (2C), 128.54 (2C), 129.07, 129.09 (2C), 129.15 (2C), 129.17 (2C), 129.7, 131.4, 
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132.9, 134.4, 136.2, 137.0, 137.5, 137.9, 143.4, 199.6; GC-MS (m/z): 366 (M); anal. calcd for 
(C27H26O: 366.20): C, 88.48; H, 7.15; found: C, 88.39, H, 7.11.   
 
 
(Z,E)-158ac Yellow oil, Y = 80%. 1H-NMR (400 MHz, CDCl3), δ 
1.59 (dd, 3H, J = 7.2 H, J = 1.4 Hz), 2.20 (s, 3H), 2.34 (s, 3H), 4.97 (d, 
1H, J =7.8 Hz), 5.79 (dq, 1H, J = 7.1 Hz, J = 1.4 Hz), 6.34 (dd, 1H, J = 
15.7 Hz), 7.25-7.08 (m, 6H), 7.47-7.36 (m, 4H), 7.55-7.51 (m, 1H), 
7.86 (dd, 2H, J = 8.4 Hz, J = 1.3 Hz); 13C-NMR (100 MHz, CDCl3), δ 16.0, 19.5, 19.7, 48.8, 
125.7, 125.9 (2C), 126.6, 127.2, 128.4, 128.5 (2C), 128.7, 129.1 (2C), 128.8, 130.1, 130.6, 131.6, 
132.9, 135.3, 136.4, 136.5, 137.8, 139.0 142.6, 199.5; LC-ESI-MS: 367 [M+H+ ], 389 [M+Na]; 
anal. calcd for (C27H26O: 366.20): C, 88.48; H, 7.15; found: C, 88.55, H, 7.26. 
 
 
 
(Z,E)-158ad Yellow oil, Y = 80%. 1H-NMR (400 MHz, CDCl3), δ 
1.58 (d, 3H J = 7.1 Hz), 4.63 (d, 1H, J = 7.5 Hz), 5.86 (q, 1H, J = 
7.1 Hz), 6.31 (d, 1H, J = 15.9 Hz), 6.41 (dd, 1H, J = 7.6 Hz, J = 15.8 
Hz), 6.98 (dt, 4H, J = 8.6 Hz, J = 3.6 Hz), 7.30-7.23 (m, 4H), 7.43 
(t, 2H, J = 7.6 Hz), 7.56-7.52 (m, 1H), 7.81 (d, 2H, J = 7.9 Hz); 
13C-NMR (100 MHz, CDCl3), δ 15.8, 52.0, 115.3 (d, 2C, J = 21.0 Hz), 115.4 (d, 2C, J = 21.0 Hz), 
127.8 (d, 2C, J = 7.0 Hz), 128.5, 128.6 (2C), 129.1 (2C), 130.1 (d, 2C, J = 8.0 Hz), 130.1, 130.8, 
133.1, 133.1 (d, 1C, J = 3.0 Hz), 136.4 (d, 1C, J = 4.0 Hz), 137.36, 142.9, 161.6 (d, 1C, J = 244.0 
Hz), 162.2 (d, 1C, J = 244.0 Hz), 199.3; ESI-MS: 375 [M+H+ ], 395 [M+Na]; anal. calcd for 
(C25H20F2O: 374.15): C, 80.20; H, 5.38; found: C, 80.06, H, 5.15. 
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(Z,E)-4ag White solid, Y = 92%. 1H-NMR (400 MHz, CDCl3), δ 
1.58 (dd, 3H, J = 7.1 Hz, J = 1.0 Hz), 4.63 (d, 1H, J = 7.7 Hz), 5.86 
(dq, 1H, J = 7.1 Hz, J = 1.2 Hz), 6.30 (d, 1H, J = 15.7 Hz), 6.46 
(dd, 1H, J = 7.8 Hz, J = 15.8 Hz), 7.21-7.30 (m, 9H), 7.43 (t, 2H, J 
= 7.7 Hz), 7.49-7.60 (m, 2H), 7.81 (d, 2H, J = 7.1 Hz); 13C-NMR 
(100 MHz, CDCl3), δ 15.9, 52.2, 127.5 (2C), 128.63 (2C), 128.65 (2C), 128.68 (2C), 128.9, 129.1 
(2C), 130.0 (2C), 130.7, 130.9, 132.6, 133.1, 133.2, 135.4, 137.3, 139.1, 142.4, 199.1; ESI-MS: 407 
[M+H+ ], 429 [M+Na]; anal. calcd for (C25H20Cl2O: 406.09): C, 73.72; H, 4.95; found: C, 73.60, 
H, 4.81. 
 
 
(Z,E)-4ae White solid, Y = 95%. 1H-NMR (400 MHz, CDCl3), δ 
1.58 (d, 3H, J = 7.2 Hz), 4.61 (d, 1H, J = 7.7 Hz), 5.86 (q, 1H, J = 
7.1 Hz), 6.28 (d, 1H, J = 15.8 Hz), 6.47 (dd, 1H, J = 7.8 Hz, J = 
15.8 Hz), 7.17 (dd, 3H, J = 8.2 Hz, J = 5,1 Hz), 7.28-7.23 (m, 1H), 
7.45-7.40 (m, 5H), 7.56- 7.50 (m, 2H), 7.81 (d, 2H, J = 7.5 Hz); 
13C-NMR (100 MHz, CDCl3), δ 15.9, 52.2, 120.8, 121.3, 127.8 (2C), 128.7 (2C), 129.1, 129.1 
(2C), 130.4 (2C), 130.8, 131.0, 132.6 (2C), 131.7 (2C), 133.2, 135.8, 137.3, 139.6, 142.3, 199.0; 
ESI-MS: 497 [M+H+ ], 519 [M+ Na]; anal. calcd for (C25H20Br2O: 493.99): C, 60.51; H, 4.06; 
found: C, 60.35, H, 3.85. 
 
 
4af Yellow oil, Y = 83%. 1H-NMR (400 MHz, CDCl3), (two 
regioisomers A:B, ratio 1.25:1), δ 1.54-1.57 (m, 3HA + 3HB), 4.62 (d, 
1HA +1HB, J = 7.9 Hz), 5.78-5.89 (m, 1HA + 1HB), 6.29-6.35 (m, 
1HA + 1HB), 6.52-6.43 (m, 1HA + 1HB), 7.32-7.20 (m, 9HA + 9HB), 
7.35-7.43 (m, 2HA + 2HB), 7.48-7.54 (m, 1HA + 1HB), 7.78-7.80 (m, 
2HA + 2HB); 13C-NMR (100 MHz, CDCl3), (two regioisomers A:B, ratio 1.25:1), δ 15.8 (1CA), 
15.9 (1CB), 52.2 (1CB), 52.8 (1CA), 126.3 (2CB), 126.8 (1CA), 127.5 (2CA), 128.43 (1CA), 
128.49 (2CB), 128.54 (2CA), 128.56 (4CA), 128.63 (4CB), 128.66 (2CA), 129.11 (2CA), 129.12 
(4CB), 129.99 (2CB), 130.01 (2CB), 130.6 (2CA), 131.2 (1CA), 132.2 (1CB), 133.0 (1CA), 133.1 
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(1CB), 135.6 (1CA), 136.9 (1CB), 137.4 (1CB), 137.5 (1CB), 139.4 (1CA), 140.6 (1CA), 142.6 
(1CB), 142.9 (1CA), 199.2 (1CB), 199.4 (1CA); GC-MS (m/z): 372 (M) 
 
 
159ah Yellow solid, Y = 38%. 1H-NMR (400 MHz, CDCl3), (as a mixture 
of diastereoisomers A:B, ratio 1.2:1), diagnostic signals δ 1.12 (d, 3HA, J = 
7.0 Hz), 1.40 (d, 3HB, J = 7.1 Hz), 2.89-2.92 (m, 1HA + 1HB), 3.23 (dt, 
1HA, J = 11.0 J= 7.0 Hz), 3.45 (dt, 1HB, J = 11.0 J = 7.0 Hz), 4.35 (t, 1HB, 
J = 7.5 Hz), 4.84 (ddd, 1HA, J = 6.9 Hz J = 5.6 Hz J = 1.2 Hz), 6.33 (dd, 
1HA, J = 15.9 Hz J = 7.2 Hz), 6.53 (dd, 1HB, J = 15.7 Hz J = 8.5 Hz), 6.68 
(d, 1HA, J = 16.0 Hz), 6.73 (d, 1HB, J = 15.7 Hz); 13C-NMR (100 MHz, 
CDCl3), (two diastereoisomers A:B, ratio 1.2:1) ), diagnostic signals δ 20.4 
(1CA), 20.7 (1CB), 36.1 (1CB), 39.2 (1CA), 47.4 (1CB), 49.0 (1CA), 59.0 
(1CB), 59.4 (1CA), 140.6 (1CB), 141.3 (1CA), 157.8 (1CA), 158.0 (1CB), 
205.4 (1CA), 205.8 (1CB); ESI-MS: 497 [M+H+ ], 519 [M+Na]. 
 
 
(Z,E)-158ba Yellow oil, Y = 75%. 1H-NMR (400 MHz, CDCl3), δ 
1.55 (dd, 3H, J = 7.1 Hz, J = 1.3 Hz), 2.35 (s, 3H), 4.63 (d, 1H, J = 
7.8 Hz), 5.82 (q, 1H, J = 7.1 Hz), 6.36 (d, 1H, J = 15.8 Hz), 6.52 (dd, 
1H, J = 7.9 H, J = 15.8 Hz), 7.20-7.16 (m, 2H), 7.32-7.24 (m, 10H), 
7.57-7.60 (m, 2H); 13C-NMR (100 MHz, CDCl3), δ 15.8, 21.3, 52.8, 126.3 (2C), 126.6, 126.7, 
127.3, 128.1, 128.4, 128.4 (2C), 128.5 (2C), 128.7 (2C), 129.5, 130.6, 131.8, 133.8, 137.2, 137.5, 
138.3, 140.9, 143.4, 199.7; GC-MS (m/z): 352 (M); anal. calcd for (C26H34O: 352.18): C, 88.60; 
H, 6.86; found: C, 88.45, H, 6.71. 
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(Z,E)-158bg Yellow oil, Y = 74%. 1H-NMR (400 MHz, 
CDCl3), δ 1.58 (d, 3H, J = 7.1 Hz), 2.38 (s, 3H), 4.62 (d, 1H, J = 
7.7 Hz), 5.84 (q, 1H, J = 7.1 Hz), 6.30 (d, 1H, J = 15.4 Hz), 6.46 
(dd, 1H, J = 15.8 Hz, J = 7.7 Hz), 7.21-7.36 (m, 10H), 7.59 (d, 
2H, J = 11.0 Hz); 13C-NMR (100 MHz, CDCl3), δ 15.8, 21.3, 
52.2, 126.5, 127.5 (2C), 127.9, 128.2, 128.5, 128.6 (2C), 128.7 
(2C), 128.7, 128.8, 129.4, 130.0, (2C), 130.8, 130.9, 134.0, 135.4, 138.5, 139.2, 142.6, 199.3; ESI-
MS: 421 [M+H+ ], 443 [M+Na]; anal. calcd for (C36H22Cl2O: 420.10): C, 74.11; H, 5.26; found: 
C, 73.91, H, 5.03. 
 
(Z,E)-158ca Yellow oil, Y = 80%. 1H-NMR (400 MHz, CDCl3), δ 
1.08- 0.96 (m, 4H), 1.28-1.21 (m, 2H), 1.63-1.50 (m, 4H), 1.97-1.88 
(m, 1H), 4.55 (d, 1H, J =7.8 Hz), 5.55 (d, 1H, J = 10.4 Hz), 6.33 (d, 
1H, J = 15.8 Hz), 6.48 (dd, 1H, J = 7.8 Hz, J = 15.8 Hz), 7.21-7.15 (m, 
2H), 7.32- 7.24 (m, 8H), 7.39 (t, 2H, J = 7.6 Hz), 7.50 (t, 1H, J = 7.4 
Hz), 7.79 (d, 2H, J =7.7 Hz); 13C-NMR (100 MHz, CDCl3), δ 25.3, 25.4, 25.7, 32.7, 32.8, 38.6, 
52.6, 126.3 (2C), 126.7, 127.3, 128.3 (2C), 128.4 (4C), 128.7 (2C), 129.1 (2C), 130.7, 131.7, 132.9, 
137.2, 137.6, 139.1, 140.2, 140.8, 199.5; GC-MS (m/z): 406 (M); anal. calcd for (C30H30O: 
406.23): C, 88.63; H, 7.44; found: C, 88.51, H, 7.28. 
 
 
(Z,E)-158da Yellow oil, Y = 67%. 1H-NMR (400 MHz, CDCl3), δ 
0.78 (d, 3H, J = 6.6 Hz), 0.79 (d, 3H, J = 6.6 Hz), 1.59 (ept, 1H, J = 6.7 
Hz), 1.80 (t, 1H, J = 7.4 Hz), 4.62 (d, 1H, J = 7.8 Hz), 5.75 (dt, 1H, J = 
7.6 Hz, J = 1.2 Hz), 6.37 (d, 1H, J = 15.8 Hz), 6.51 (dd, 1H, J = 7.8 Hz, 
J = 15.8 Hz), 7.21-7.15 (m, 2H), 7.32-7.24 (m, 8H), 7.40-7.36 (m, 2H), 
7.50 (t, 1H, J = 7.4 Hz), 7.80-7.78 (m, 2H); 13C-NMR (100 MHz, 
CDCl3), δ 22.3, 22.3, 28.7, 38.7, 52.9, 126.3 (2C), 126.7, 128.4 (4C), 128.5 (2C), 128.7 (2C), 129.2 
(2C), 130.6, 131.8, 132.9, 132.95, 137.2, 137.5, 140.9, 142.8, 199.5; GC-MS: 380 (M); anal. calcd 
for (C28H28O: 380.21): C, 88.38; H, 7.42; found: C, 88.19, H, 7.39. 
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158ea Yellow oil, Y = 99%. 1H-NMR (400 MHz, CDCl3), δ 4.81 (d, 
1H, J = 7.8 Hz), 6.44 (d, 1H, J = 15.8 Hz), 6.63 (dd, 1H, J = 7.8 Hz, J = 
15.8 Hz), 6.81 (s, 1H), 7.05-7.11 (m, 3H), 7.14 (d, 2H, J = 6.6 Hz), 
7.24-7.20 (m, 4H), 7.41-7.28 (m, 9H), 7.75 (d, 2H, J = 7.3 H); 13C-
NMR (100 MHz, CDCl3), δ 53.8, 126.4 (2C), 126.9, 127.4, 127.7, 
128.06 (2C), 128.14 (2C), 128.5 (2C), 128.6 (2C), 128.7 (2C), 128.8 
(2C), 129.4 (2C), 130.1, 132.0, 132.4, 132.9, 135.6, 136.2, 137.1, 140.3, 143.3, 199.8; GCMS 
(m/z): 400 (M); anal. calcd for (C28H28O: 400.18): C, 89.97; H, 6.04; found: C, 89.81, H, 5.91. 
 
 
158fa Yellow oil, Y = 73%. 1H-NMR (400 MHz, CDCl3), δ 4.86 (d, 
1H, J = 7.8 Hz), 6.47 (d, 1H, J = 15.8 Hz), 6.67 (dd, 1H, J = 7.8 Hz, J = 
15.8 Hz), 6.96 (s, 1H), 7.13 (t, 3H, J = 7.7 Hz), 7.36-7.19 (m, 10H), 
7.42-7-40 (m, 2H), 7.51 (d, 2H, J = 8.5 Hz), 7.64-7.59 (m, 3H), 7.77-
7.75 (m, 2H); 13C-NMR (100 MHz, CDCl3), δ 54.0, 126.1, 126.2, 
126.2, 126.4 (2C), 127.0, 127.4, 127.5, 127.7, 128.0, 128.2 (2C), 128.5 
(2C), 128.6, 128.6 (2C), 128.9 (2C), 129.3 (2C), 130.1, 131.9, 132.5, 132.5, 132.9, 132.9, 133.1, 
136.3, 137.1, 140.4, 143.6, 200.0; ESI-MS: 451 [M+H+ ], 473 [M+Na]; anal. calcd for (C34H26O: 
450.20): C, 90.63; H, 5.82; found: C, 90.51, H, 5.61. 
 
 
158ga Yellow oil, Y = 84%. 1H-NMR (400 MHz, CDCl3), δ 1.60 (s, 
3H), 1.90 (s, 3H), 4.81 (t, 1H, J = 3.6 Hz), 4.49 (s, 1H), 6.50 (d, 1H, J = 
1.0 Hz), 7.20-7.26 (m, 6H), 7.33-7.36 (m, 5H), 7.43-7.48 (m, 2H), 
7.79-7.82 (m, 2H); 13C-NMR (100 MHz, CDCl3), δ 20.5, 23.3, 50.4, 
126.3, 126.3 (2C), 127.1, 128.20 (2C), 128.3 (2C), 128.3 (2C), 128.4 
(2C), 129.3 (2C), 130.5, 131.3, 132.7, 134.0, 135.6, 137.3, 138.1, 141.9, 200.6; ESIMS: 352 (M); 
anal. calcd for (C26H24O: 352.18): C, 88.60; H, 6.86; found: C, 88.45, H, 6.71. 
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158ha Yellow oil, Y = 57%. 1H-NMR (400 MHz, CDCl3), δ 5.08 (d, 
1H, J = 7.4 Hz), 5.81 (s, 1H), 5.87 (s, 1H), 6.40 (d, 1H, J = 15.9 Hz), 
6.54 (dd, 1H, J = 7.4 Hz, J = 15.9 Hz), 7.22-7.18 (2H, m), 7.36-7.24 
(8H, m), 7.41 (t, 2H, J =7.5 Hz), 7.51 (t, 1H, J = 7.4 Hz), 7.74 (d, 2H, J 
= 7.3 Hz); 13CNMR (100 MHz, CDCl3), δ 49.6, 126.3 (2C), 126.4, 
126.7, 127.4, 128.2 (2C), 128.5 (2C), 128.6 (2C), 128.7 (2C), 129.6 (2C), 130.5, 132.0, 132.3, 
137.1, 137.5, 140.9, 150.2, 197.0; ESI-MS: 324 (M); anal. calcd for (C24H20O: 324.15): C, 88.85; 
H, 6.21; found: C, 88.51, H, 6.02. 
 
 
158ia Yellow oil, Y = 40%. 1H-NMR (400 MHz, CDCl3), δ 0.59 (t, 
3H, J = 7.3 Hz), 0.92 (dd, 2H, J = 15.0 Hz, J = 7.4 Hz), 1.83-1.91 (m, 
2H), 2.04- 2.12 (m, 2H), 4.73 (d, 1H, J = 7.5 Hz), 6.35 (d, 1H, J = 
15.9 Hz), 6.56 (dd, 1H, J = 15.9 Hz, J = 7.5 Hz), 6.67 (s, 1H), 7-16-
7.38 (m, 15H); 13CNMR (100 MHz, CDCl3), δ 13.6, 21.7, 25.6, 
43.5, 52.9, 126.3 (2C), 127.0, 127.4, 128.0, 128.4 (2C), 128.5 (2C), 
128.5 (2C), 128.6 (2C), 128.8 (2C), 130.2, 130.7, 132.3, 136.3, 137.0, 140.2, 147.1, 200.0; HPLC-
MS: 381 [M+H+ ], 403 [M+Na]; anal. calcd for (C28H28O: 380.21): C, 88.38; H, 7.42; Found: C, 
88.49, H, 7.61. 
 
 
 (+/-)-trans-161 Yellow solid, Y = 35%; 1H-NMR (400 MHz, CDCl3), δ 
1.44 (d, 3H, J = 7.0 Hz), 2.36 (dt, 1H, J = 8.7 Hz, J = 4.5 Hz), 2.49 (dt, 1H, 
J = 14.7 Hz, J = 8.1 =Hz), 2.78 (ddd, 1H, J = 14.7 Hz, J = 6.9 Hz, J = 4.8 
Hz), 3.04 (m, 1H), 6.15 (t, 1H, J = 7.4 Hz), 7.17-7.21 (m, 4H), 7.22-7.23 
(m, 2H), 7.25-7.26 (m, 1H), 7.30-7.31 (m, 1H), 7.35-7.39 (m, 3H), 7.46 (d, 
1H, J = 7.7 Hz), 7.60 (dt, 1H, J = 7.7 Hz, J = 1.0 Hz), 7.72 (d, 1H, J = 7.6 Hz); 13C-NMR (100 
MHz, CDCl3), δ 20.1, 30.2, 39.0, 56.5, 123.5, 124.9, 126.5, 127.0, 127.1, 127.2 (2C), 127.4, 128.1 
(2C), 128.3 (2C), 129.8 (2C), 134.9, 135.9, 139.8, 142.3, 143.4, 158.1, 207.1; ESI-MS: 339 [M+H+ 
], 355 [M+NH4], 361 [M+Na], 377 [M+K]; anal. calcd for (C25H22O: 338.17): C, 88.72; H, 6.55; 
found: C, 88.52, H, 6.31. 
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Crystallographic Data Collection and Structure Determination for (Z,E)-158ag.  
The X-ray intensity data were measured on a Bruker SMART Apex II CCD area detector 
diffractometer. Cell dimensions and the orientation matrix were initially determined from a least-
squares refinement on reflections measured in three sets of 20 exposures, collected in three different 
 regions, and eventually refined against all data. A full sphere of reciprocal space was scanned by 
0.3  steps. The software SMART[3] was used for collecting frames of data, indexing reflections, 
and determination of lattice parameters. The collected frames were then processed for integration by 
the SAINT program[4] and an empirical absorption correction was applied using SADABS.[4] The 
structures were solved by direct methods (SIR 2004)[5] and subsequent Fourier syntheses and 
refined by full-matrix least-squares on F2 (SHELXTL)[6], using anisotropic thermal parameters for 
all non-hydrogen atoms. All hydrogen atoms were added in calculated positions, included in the 
final stage of refinement with isotropic thermal parameters, U(H) = 1.2 Ueq(C) [U(H) = 1.5 Ueq(C-
Me)], and allowed to ride on their carrier carbons. Crystal data and details of the data collection for 
(Z,E)-158ag are reported in Table S1.  
X-ray crystal structure of (Z,E)-158ag. 
 
 
 
 
Figure S1. a) Molecular structure of (Z,E)-158ag. 
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Table S1. Crystal data and structure refinement for (Z,E)-158ag. 
 (Z,E)-158ag 
Empirical formula C25H20Cl2O 
Formula weight 407.31 
Temperature/K 296 (2) 
Crystal system monoclinic 
Space group P 21/n 
a, Å 6.1008(8) 
b, Å 13.366(2) 
c, Å 26.012(3) 
, ° 90 
, ° 90.785(2) 
, ° 90 
Cell volume, Å3 2121(5) 
Z 4 
ρc, mg m-3 1.276 
(Mo-K), mm-1 0.318 
F(000) 848 
Crystal size mm 0.25 × 0.10 × 0.07 
 limits, ° 1.566 to 24.978  
Refl. collected, unique (Rint) 13542 / 3697 [R(int) = 0.0447] 
Goodness-of-fit-on F2 1.019 
R1(F)a, wR2(F2) [I > 2(I)]b R1 = 0.0502, wR2 = 0.1186 
Largest diff. peak and hole, e. Å-3 0.462 and -0.384  
a R1
 
= Fo-Fc/Fo.b wR2 = [w(Fo2-Fc2)2/w(Fo2)2]1/2
 
where w = 1/[2(Fo2)
 
+
 
(aP)2+ bP]  where 
P = (Fo2 + Fc2)/3. 
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6. INTRODUCTION: C‒H ACTIVATION 
In the past 10 years, C–H activation has emerged as a powerful alternative method to traditional 
cross-coupling reactions, for the formation of new C–C or C–X bonds. The most attractive 
advantage in this type of approach relies in the possibility to avoid the pre-activation of the 
substrates, improving the atom- and step-economy, and the reduction of toxic wastes. In the past, 
this type of reactions was promoted principally by 4d and 5d transition metals. Only recently, the 
interest in the development of C–H activation catalysed by first-row transition-metals, increased 
due to their high abundance in the Earth’s crust and their low costs. In particular, cobalt, nickel and 
iron have received considerable interest while the interest in manganese has been increased only in 
the last 3-5 years.  
Manganese is the twelfth most abundant element in the Earth and the third transition metal only 
after iron and titanium. 
 
6.1 Stoichiometric Reaction 
The first C–H activation promoted by manganese complex was developed by Stone and Bruce in 
1970[1] using stoichiometric amount of MnMe(CO)5.  
 
 
Scheme 1: First C–H activation promoted by manganese complex. 
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Under the optimized reaction conditions it was possible to isolate different five-membered 
manganacycles in excellent yields (Scheme 1). 
Subsequently, Nicholson and Main studied in depth the reactivity of these compounds. In particular 
in 1987[2] they treated the manganacycle 164 with activated alkene in the presence of palladium 
catalysts. Different products were isolated from the same substrates when different palladium 
catalysts were employed in the reaction. Moreover, when manganacycle derived from 2-
acetylthiophene was submitted under the same conditions in the presence of methyl vinyl ketone or 
allyl alcohol, the alkylated thiophene or allylic thiophene were achieved in good yields (Scheme 2). 
 
 
Scheme 2: Reactivity of the manganacycles. 
Not only aromatic but also olefinic manganacycles can react with methyl acrylate resulting in the 
corresponding products in good yields as reported by the same authors in 1995.[3] Several 
applications in the use of manganacycles with activated olefins were reported; for example, 
Woodgate and co-workers[4,5] developed a procedure using a manganacycle derived from 
podocarpic acid, while Nicholson[6] employed a cyclomanganated triphenylphosphine chalgogenide 
obtaining in both cases the corresponding products in satisfactory yields.  
Moreover, the coupling of manganacycles with alkynes was investigated in order to extend the 
applications of these compounds. In particular, Liebeskind and co-workers reported in 1989 the 
annulation reaction of ketone-based mangacycles with differently substituted alkynes.[7] The desired 
products were achieved when anhydrous trimethylamine N-oxide (TMANO)[8] was added in the 
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reaction. Several substituted alkynes were submitted in the reaction with manganacycle 164b in 
acetonitrile and in the presence of TMANO resulting in the corresponding products in good yields 
(Scheme 3). The procedure demonstrated to be tolerant toward different functional groups and the 
reactions proceeded smoothly with terminal, internal, electron-rich as well as electron-deficient 
alkynes. 
 
 
Scheme 3: Coupling with alkynes. 
On the basis of the observed regiochemistry of the products, the authors rationalized that the 
insertion of the alkyne into the Mn–C bond of the manganacycle has been controlled by steric 
effects; indeed, the large alkyne substituent occupied the 2-position of the indenol, predominantly. 
It was assumed that the desired products were achieved through the formation of seven-member 
metallacycle intermediate generated by insertion of alkyne into the Mn–C bond and subsequently 
the nucleophilic attack of the Mn–C bond to the carbonyl group led to the corresponding indenol. 
The formation of the seven-member mangancycle was demonstrated by Nicholson and Main[9,10] 
one year later when they examined again the photochemical reaction of ortho-manganated 
triphenylphosphite with diphenylacetylene reported the first time by Onaka and co-workers.[11] In 
that situation, they were able to isolate the seven-member manganacycle which was unambiguously 
characterized by X-ray diffraction analysis (Scheme 4a). Subsequently, Suárez and co-workers 
reported the synthesis of the first N-containing seven-membered manganacycle achieved by 
reaction of phenylimidazole-based manganacycle with diphenylacetylene (Scheme 4b) 
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Scheme 4: Isolation of the seven-membered manganacycle (a) and preparation of the first N-containing seven-
membered manganacycle (b). 
 
6.2 Catalytic Reaction 
Pioneering results in manganese-catalysed C–H activation were reported by Kuninobu and Takai in 
2007[12] when they started to investigate the stoichiometric C–H bond activation of 1-methyl-2-
phenyl-1H-inidazole and consequent insertion of aldehydes promoted by MnBr(CO)5. In particular, 
using benzaldehyde the authors were able to isolate the corresponding product in 52% yield 
(Scheme 5). 
 
Scheme 5: Stoichiometric C‒H bond activation. 
Unfortunately, when the manganese complex was used in catalytic amount, only traces of the 
product have been produced. However, they detected a possible method to recycle the catalyst in 
order to use only catalytic amount of manganese complex. In particular, they demonstrated that 
adding 2.0 equivalent of triethylsilane in the reaction mixture from the beginning it was possible to 
obtain the corresponding product in 93% yield. Subsequently, they proved the scope of the 
methodology by submitting several aldehydes under optimized catalytic conditions. The protocol 
revealed to be tolerant toward differently substituted aromatic as well as aliphatic aldehydes 
resulting in the corresponding products in satisfactory yields (Scheme 6). 
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Scheme 6: Scope of the Mn-catalysed C‒H activation. 
The authors investigated the mechanism through several experiments finding that the hydrosilane 
promoted the reductive elimination of manganese by silylation of the alkoxy moiety; the proposed 
mechanism is illustrated in Scheme 7. 
 
Scheme 7: Proposed reaction mechanism. 
Subsequently in 2013, Chen and Wang reported a manganese-catalysed aromatic C–H 
alkenylation.[13] In particular, arylpiridines reacted with terminal alkynes in the presence of 
MnBr(CO)5 and dicyclohexylamine (Cy2NH) resulting in the corresponding E-alkenylated products. 
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The protocol demonstrated high chemo-, regio- and stereoselectivity and the ample scope shows its 
flexibility (Scheme 8). 
 
Scheme 8: Mn-catalysed aromatic C–H alkenylation 
It is noteworthy that in stoichiometric reaction of MnBr(CO)5 and 2-phenylpyridine only traces of 
the product were observed in the absence of Cy2NH, while the rate reaction increased when the base 
was used as an additive. This result has been rationalized considering the cooperation of the 
manganese catalyst with the base in the C–H activation step (Scheme 9). In particular, using Cy2NH 
the C–H bond cleavage resulted to be easier to achieve. This preliminary hypothesis has been 
subsequently confirmed by deuterium-labeling experiments and DFT calculations. 
 
Scheme 9: Base-assisted C‒H activation. 
Subsequently, Wang and co-worker increased the applications in manganese-catalysed C–H 
activation reporting two different procedures for the dehydrogenative [4+2] annulation of N–H 
imines with alkynes[14] and the C–H conjugate addition to α,β-unsatured carbonyl compounds[15] 
respectively.  
The dehydrogenative [4+2] annulation of imines with alkynes is a useful protocol to prepare 
differently substituted isoquinolines. The methodology demonstrated to be tolerant toward different 
functional groups due to the mild reaction conditions which do not require any oxidants, external 
ligands or additives.  
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Scheme 10: Dehydrogenative [4+2] annulation of imines with alkynes and proposed reaction mechanism. 
As it is shown in the catalytic cycle in Scheme 10, the production of H2 and CO as by-products was 
detected by analytical methods, confirming consequently the proposed reaction mechanism. 
Continuing with their interest in manganese-catalysed C–H activation, the same authors reported an 
alternative one-step catalysed-reaction[15] for the stoichiometric methodology reported by Nicholson 
and Main and above illustrated (Scheme 11).[2] 
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Scheme 11: One-step catalysed-reaction for the stoichiometric methodology reported by Nicholson and Main. 
Several 2-arylpyridines featuring electron-donating as well as electron-withdrawing groups were 
submitted under optimized reaction conditions, furnishing the corresponding products in good 
yields. The reaction showed high levels of regio-control when arylpyridines featuring two adjacent 
C–H bonds were available for the activation favouring the addition of less sterically congested one. 
Subsequently, it was further tested the scope of the reaction employing primary, secondary and also 
tertiary alkylacrylates. The methodology revealed to be tolerant toward different functional groups 
furnishing the corresponding products in good yields. Only styrene cannot be used as reagent 
highlighting the importance of the carbonyl group. On the base of the experimental results obtained 
it was proposed a hypothetical reaction mechanism which was then confirmed by DFT calculations. 
Moreover, it was also demonstrated that the use of dicyclohexylamine increased the C–H bond 
cleavage through its cooperation with manganese catalyst. 
In 2015 Ackermann and co-workers developed a new powerful route to synthetize β-amino acid 
derivatives from manganese-catalysed C‒H activation of easily available imines.[16] The authors 
started their investigation choosing the transformation of ketimine 175 with ethyl acrylate as model 
reaction. The desired product was isolated in 94% yield when the reaction was promoted by 
[Mn2(CO)10] in DCE at 120 °C (Scheme 12). 
 
Scheme 12: Synthetize β-amino acid derivatives from Mn-catalysed C‒H activation. 
The unusual cis-configuration exhibited by the obtained product was determined in unambiguous 
way by bidimensional NMR studies. 
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Subsequently, the scope of the reaction was investigated, by submitting differently substituted 
ketimines and alkenes under optimized reaction conditions. All the corresponding products were 
achieved in good to excellent yields (Scheme 13). 
 
Scheme 13: Scope of the Mn-catalysed C‒H activation of imines. 
The methodology demonstrated to be tolerant toward different functional groups such as 
cyclopropyl, ester and halogen substituents and moreover the reaction was not limited to terminal 
alkenes but also internal alkenes resulted in the corresponding products in good yields. Finally, 
several experiments were carried out in order to shed light on the reaction mechanism which is 
illustrated in Scheme 14. 
 
Scheme 14: Reaction mechanism. 
Subsequently, it was also reported the first manganese(I)-catalysed intermolecular C–H allylation of 
ketimines.[17] In particular, it was demonstrated that using [Mn2(CO)10] and NaOAc as catalytic 
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system it was possible using allyl-carbonate derivatives for the C–H allylation of ketimines 
(Scheme 15).  
 
Scheme 15: Mn-catalysed intermolecular C‒H of ketimines. 
The methodology resulted to be tolerant toward several functional groups and all the corresponding 
products were isolated in good to excellent yields. Subsequently, it was discovered that the 
methodology was not limited to the use of arenes. Indeed, indole as well as pyrrole and thiophene 
heterocycles can be employed in the transformation resulting in the desired products in good yields 
(Scheme 16). 
 
 
Scheme 16: Scope of the Mn-catalysed C‒H allylation. 
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The authors investigated the reaction mechanism through several mechanistic experiments in order 
to determinate the catalytic cycle which allows the formation of desired allylated products (Scheme 
17). 
 
Scheme 17: Reaction mechanism. 
In the same line, Ackermann and co-workers reported a highly efficient manganese-catalysed C–H 
aminocarbonylation of heteroarenes.[18] The authors were able to develop a method where 
challenging sterically bulky alkyl isocyanates could be used and moreover the success of the 
reaction was not dependent to the presence of additional ligands or additives.  
 
Scheme 18: Mn-catalysed aminocarbonylation of heteroarenes. 
The ample scope reveals the large flexibility of the protocol and the tolerance toward several 
functional groups. Furthermore, intermolecular competition experiments demonstrated that 
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electron-deficient isocyanates and electron-rich indoles were more reactive in the transformation. 
These evidences can be rationalized considering the nucleophilic attack of the metallated indole on 
the coordinated isocyanate the rate-determining step. Finally, through several experimental 
mechanistic studies the authors proposed a mechanism reaction which is shown in Scheme 19. 
 
Scheme 19: Proposed reaction mechanism. 
The large benefit in manganese-catalysed C–H activation has been demonstrated by Ackermann in 
2016 when with his co-workers developed a highly efficient hydroarylation of ketones with 
heteroarenes.[19] They started their investigation considering the reaction of indole 179 with ketone 
180 in the presence of different transition-metal-catalysts (Scheme 20). 
 
Scheme 20: Hydroarylation of ketones. 
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When the reaction was carried out in the presence of catalysts derived from palladium, ruthenium, 
rhodium, iridium, rhenium, cobalt, nickel and iron, only the C3-functionalized indole 181 was 
isolate in quantitative yields. Only manganese-catalysts were able to lead to the selective formation 
of the C2-derivate 182 in excellent yield. In particular, Mn2(CO)10 promoted the reaction furnishing 
the desired product in 90%  yield, while MnBr(CO)5 provided the C2-adduct in 88%  yield only 
when NaOAc was used as additive. Subsequently the authors demonstrated that not only ketones 
but also aldehydes and imines could be used in the reaction resulting in the corresponding products 
in excellent yields. Moreover, the protocol demonstrated to be not limited to the indole scaffold and, 
also pyrroles and thiophene derivatives were employed in the reaction resulting in the desired 
products in satisfactory yields. 
Continuing with the interest toward manganese-catalysed C‒H activation, very recently Ackermann 
and co-workers reported the first C–H cyanation of heteroarenes promoted by manganese(I)-
catalysts.[20] They started the investigation studying the reaction between indole 183 and Beller’s 
NCTS (N-cyano-N-phenyl-p-toluenesulfonamide) 184 in the presence of MnBr(CO)5. 
Unfortunately, under these reaction conditions, only unsatisfactory yields of the desired products 
were achieved. In contrast, when ZnCl2 and HNCy2 were added in the mixture as additive and base 
respectively, the desired product was isolated in good yield. They also demonstrated that catalytic 
amount of Zn(II) were enough to guarantee the success of the reaction (Scheme 21a).  
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Scheme 21: First C–H cyanation of heteroarenes promoted by Mn(I)-catalysts (a) and its application with tryptophan 
derivatives (b).  
The ample scope showed the large tolerance of the methodology toward different functional groups 
and moreover, the authors were able to obtain the first manganese-catalysed C–H cyanation of 
tryptophan derivatives in good yields and without racemization of the stereogenic centers (Scheme 
21b).  
This new heterobimetallic catalytic system for the C‒H cyanation was deeply studied through DFT 
calculations. In particular, it was demonstrated that the coordinative interaction of the Zn(II) 
additive allowed a stabilizing effect on the cyclomanganated transition state of 30 kcal mol-1 (Figure 
1). 
 
Figure 1: Stabilizing effect of the Zn(II) additive on the cyclomanganated transition state. 
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7. MANGANESE-CATALYSED C‒H ACTIVATION 
7.1 Mn-Catalysed C–H Alkynylation 
During the third year of my PhD I spent five months in Gӧttingen (Germany) where I joined in the 
Ackermann’s group. In particular, in collaboration with Z. Ruan and N. Sauermann, the goal was 
the development of a very efficient strategy for a manganese-catalysed C–H alkynylation of indoles. 
Below, all the results obtained in this project to give a complete overview about the powerful 
methodology will be described, highlighting the collaborative nature of the investigation. 
 
We started to prepare differently substituted indole derivatives featuring the pyridine or pyrimidine 
as directing group. To prepare the 1-(pyrimidin-2-yl)-1H-indoles and 1-(pyrimidin-2-yl)-1H-
pyrrole, the synthetic procedure already reported in literature was followed.[1] In particular, the 
indoles reacted smoothly with 2-chloropyrimidine in the presence of NaH in DMF at 130 °C after 
24 h (Scheme 1). 
 
Scheme 1: Synthetic procedure for 1-(pyrimidin-2-yl)-1H-indoles. 
The synthetic procedure for the preparation of the 1-(pyridine-2-yl)-1H-indole consists of a 
coupling reaction between indole and 2-bromopyridine promoted by CuI in the presence of N,N’-
dimethyl-ethylenediamine and K3PO4 (Scheme 2).[1] 
 
Scheme 2: Synthetic procedure for 1-(pyridine-2-yl)-1H-indoles. 
Subsequently the bromoacetylenes were prepared using the already known procedure reported by 
Bolm (Scheme 3).[2]   
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Scheme 3: Synthetic procedure for the bromoacetylenes from corresponding aldehydes (a) or from alkynes (b). 
We started the investigation studying the condensation between indole 189a with silyl bromoalkyne 
190a in the presence of MnBr(CO)5 as catalyst and HNCy2 as base. We evaluated the loading the 
Mn(I) catalyst and the solvent of the reaction. It was demonstrated that using 1,4-dioxane as 
solvent, the product 191aa has been isolated in excellent yield when 10 mol% of catalyst has been 
used and 78% yield when the catalyst has been used in 5 mol% (Table 1).  
Table 1: Optimization table for the catalyst loading.[a] 
 
Entry MnBr(CO)5 (x mol%) T (°C) Solvent Yield 191aa (%)[b] 
1 10.0 120 1,4-dioxane 93 
2 5.0 100 1,4-dioxane 78 
3 5.0 80 DCE 85 
[a] Reaction condition: 189a (0.5 mmol), 190a (0.75 mmol), MnBr(CO)5 (x mol%), 
HNCy2 (1.0 mmol), T (°C), 16 h. [b] Yield of isolated product. TIPS = triisopropylsilyl. 
 
Subsequently, pyrimidine instead of pyridine was used as directing group and different bases were 
tested in the transformation. The HNCy2 led to the formation of the desired products in highest 
yield. Finally, different solvents and temperatures were investigated and the product was isolated in 
excellent yield using DCE as solvent at 80 °C (entry 9, Table 2). 
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Table 2: Screening of bases, solvents, and temperatures.[a] 
 
Entry MnBr(CO)5 (x mol%) Base Solvent T (°C) Yield 193aaa (%)[b] 
1 10.0 HNCy2 1,4-dioxane 120 94 
2 5.0 HNCy2 1,4-dioxane 120 71 
3 5.0 NaOAc 1,4-dioxane 120 41[c] 
4 5.0 Na2CO3 1,4-dioxane 120 33[c] 
5 5.0 HNCy2 TFE 120 15[c] 
6 5.0 HNCy2 DCE 120 96 
7 2.5 HNCy2 DCE 120 71 
8 5.0 HNCy2 DCE 100 92 
9 5.0 HNCy2 DCE 80 95 (99) [d] 
10 5.0 HNCy2 DCE 60 71[e] 
11 5.0 HNCy2 DCE 40 23[e] 
12 - HNCy2 DCE 80 0   0 
13 5.0 - DCE 80 <5 
[a] Reaction conditions: 192a (0.5 mmol), 190a (0.75 mmol), MnBr(CO)5 (x mol%), HNCy2 (1.0 mmol), 
T (°C), 16 h. [b] Yield of isolated product. [c] Determined by GC conversion using n-dodecane as the 
internal standard. [d] 190a (0.6 mmol). [e] Personal contribution. DCE = 1,2-dichloroethane, TFE = 2,2,2-
trifluoroethanol, TIPS = triisopropylsilyl. 
With the optimal catalytic conditions in our hands, we proved the scope of the reaction by 
submitting differently substituted indoles in the reaction with 190a in the presence of MnBr(CO)5 
(Scheme 4). 
The ample scope showed in Scheme 4 highlights the versatility of the methodology. Indoles 
featuring electron-withdrawing groups as well as electron-donating groups resulted in the 
corresponding products with comparable levels of yields. Sensitive groups such as bromo, ester and 
cyano were fully tolerated in the transformations. Moreover, the methodology resulted to be not 
limited to the use of indoles; indeed, pyrrole derivatives demonstrated to be suitable substrates for 
the manganese-catalysed C–H alkynylation as well. 
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Scheme 4: Scope of the reaction with different indoles. [a] Personal contribution. 
Subsequently, the scope of the reaction was further investigated by submitting different silyl 
haloacetylenes under optimized catalytic conditions with indole 192a. Bromoacetylene as well as 
chloroacetilene reacted smoothly with the 1-(pyrimidin-2-yl)-1H-indole allowing the formation of 
the products in excellent yields. On the contrary, the iodoacetylene resulted in the desired product 
only in moderate yield. Satisfyingly, all the bromoacetylenes featuring different silyl groups reacted 
smoothly with the indole and all the corresponding products were isolated in quantitative yields 
(Scheme 5). 
 
 
 
 
159 
 
 
 
Scheme 5: Manganese-catalysed C–H alkynylation with different silyl haloalkynes. TMS = trimethylsilyl, TBS = tri-n- 
butylsilyl, TBDMS = tert-butyldimethylsilyl, DPMS = diphenylmethylsilyl. 
So far, all methodologies for the metal-catalysed C–H alkynylation were limited to the use of 
activated alkynes featuring silyl groups. To overcome this limitation, we developed a new protocol 
which allows the use of aryl, alkenyl and alkyl bromoacetylenes. We started the investigation by 
analysing the results obtained carrying out the manganese-catalysed C–H alkynylation of indole 
192a with phenylacetilene bromide in the presence of different additive (Table 3). Only the BPh3 
gave promising results in the formation of the product 195aa. In particular, with a 5 mol% of 
loading the desired product was isolated in 61% yield. In order to check that the concomitant 
presence of the additive and the manganese catalyst was necessary for the success of the reaction, 
two reaction were carried out with the only presence of manganese catalyst (entry 1, Table 3) and 
with the only presence of BPh3 (entry 3, Table 3) and both of them failed in the formation of the 
product. 
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Table 3: Screening of the additives.[a] 
 
Entry Additive x mol% additive Yield 195aa (%)[b] 
1 - -   0[c] 
2 BPh3 5.0 61[c] (99) [c, e] 
3 BPh3 5.0   0[c, d] 
4 CuBr2 5.0   0[c] 
5 AlCl3 5.0 32 
6 BBr3 5.0 56 
7 ZnCl2 5.0 Trace 
8 ZnBr2 5.0 Trace 
9 ZnI2 5.0   0 
10 FeCl 2.5   0 
11 MgCl2 5.0   0 
12 BPh3 0.05 92[c] (95) [c, e] 
13 BPh3  0.05 86[c, f] 
[a] reaction conditions: 192a (0.5 mmol), 194a (0.6 mmol), MnBr(CO)5 (5 mol%), HNCy2 
(1.0 mmol), DCE (1 mL), 80 °C, 16 h. [b] Yield of isolated product. [c] Personal 
contribution. [d] Without [Mn]. [e] 1 h. [f] [Mn] (2.5 mol%) 
Surprisingly, when the loading of the additive was decreased up to 0.05 mol%, the yield of the 
product increased up to 92% (entry 12, Table 3) and moreover, after 1 h we were able to isolate the 
desired product in 95% yield. Since the great catalytic efficacy of the protocol we evaluated the 
possibility to lower the manganese-catalyst loading and with 2.5 mol% of MnBr(CO)5 and 0.05 
mol% of BPh3, the product was obtained in 86% yield (entry13, Table 3). 
With the optimized reaction conditions in our hands, we proved the flexibility of the new 
methodology by testing bromoalkynes featuring different aryl, alkyl and alkenyl substituents 
(Scheme 6). The methodology demonstrated to be tolerant toward different functional groups. The 
corresponding products were isolated in good to excellent yields. Moreover, the protocol was 
extended to more complex substrates. Indeed, the bromoalkynes featuring complex steroid motif 
resulted in the corresponding product 195at in quantitative yield and aminoacid derivative from the 
(S)-valine was converted in the product 195au without loss of enantiomeric excess. 
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Scheme 6: Manganese-catalysed C‒H alkynylation with bromo alkynes featuring aryl, alkenyl and alkyl substituents. 
[a] Personal contribution. [b] 1 h. [c] [Mn] (2.5 mol%). 
Since the great result obtained with the aminoacid derivative in this transformation, we wanted to 
test if the methodology could be used with more complex peptides as well, in order to develop an 
efficient route for their diversification. We started to prepare different peptides through peptidic 
coupling reaction of several enantiopure aminoacids including the tryptophan, where the nitrogen of 
the indole moiety was protected with a pyrimidyl group. Satisfactory results were achieved when 
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these peptides were submitted under optimized reaction conditions with the silyl bromoacetilene 
190a (Scheme 7). 
 
 
Scheme 7: Mn-catalysed C‒H alkynylation with peptide derivatives. 
All the corresponding peptides were isolate in good to excellent yields. The presence of powerful 
functional group such as the iodo- and the azido- groups could be exploited for further modification 
of the alkynylated peptides. It was possible to be synthesized cyclic peptides through Sonogashira-
coupling and click chemistry respectively, after silyl deprotection of the opportune alkynes.  
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Furthermore, we investigated the possibility to use the manganese-catalysed C–H alkynylation to 
directly prepare cyclic peptide through intramolecular reaction. In particular, we prepared the 
acyclic peptide 198 featuring a bromoalkynyl moiety which was submitted under optimized 
catalytic conditions (Scheme 8). Gratefully, the corresponding 21-membered-macrocycle was 
isolated in 53% yield. 
 
Scheme 8: Synthesis of cyclic peptide through intramolecular Mn-catalysed C‒H alkynylation of indole. 
In order to shed light on the mode of action of the manganese-catalysed C–H alkynylation, 
mechanistic experiments were performed (Scheme 9). In particular, through experiments with a 
mixture of DCE and D2O in ratio 9:1 as solvent, it was revealed an major H/D scrambling at C2-
position with respect the C3-position which is even observed also in the absence of the metal-
catalyst due to its nucleophilic nature (Scheme 9a). Moreover, we were also able to demonstrate 
that the organometallic complex is a key intermediate in the catalytic cycle. To do this, we prepared 
the intermediate 200a (Scheme 9b) and subsequently it has been used as substrate in a 
stoichiometric reaction with TIPS-bromoalkyne 190a and with bromophenylacetilene 194a 
(Scheme 9c). Moreover, intermediate 200a was used as catalyst (5.0 mol%) in a catalytic reaction 
with indole 192a and TIPS-bromoalkyne 190a (Scheme 9d). In both of the cases it was possible to 
isolate the desired producst in good yields.  
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Scheme 9: Mechanistic experiments. 
Studies with isotopically labeled substrate 192a revealed a minor kinetic isotope effect (KIE) which 
is indicative of a fast C–H manganesation process (Scheme 10a) and intermolecular competition 
experiments between indole featuring electron-donating group and electron-withdrawing group 
demonstrated a slight preference toward the latter one (Scheme 10b). 
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Scheme 10: KIE experiments and intermolecular competition experiments. 
In stark contrast with the previously reported manganese-catalysed C–H activation[3–7], the catalytic 
efficacy dropped down when the reaction was performed under air or in the presence of the radical 
scavenger TEMPO (Scheme 11). 
 
Scheme 11: Experiments performed under air or in the presence of TEMPO. 
On the bases of the experimental collected data, a plausible catalytic cycle is shown in Scheme 12 
starting with a fast and facile C–H metallation and formation of metallated intermediate 200a. 
Subsequently, the seven-membered manganacycle was formed by migratory insertion of the 
bromoalkyne derivatives in the compound 200a. Finally, β-Br elimination delivered the desired 
alkynylated indole (Scheme 12). We proposed that in the presence of haloalkynes featuring aryl, 
alkenyl and alkyl substituents, the rate of the β-Br elimination step, is increased by the BPh3 
additive. However, an oxidative addition followed by reductive elimination mechanism cannot be 
ruled out.  
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Scheme 12: Proposed reaction mechanism. 
Last, but not least, it was also demonstrated the easiness in the removal of the protecting groups. In 
particular, the chemoselective removal of the silyl-group (Scheme 13a) or the concomitant removal 
of both silyl-group and directing group (Scheme 13b) were achieved in good yields.  
 
Scheme 13: Removal of silyl group or concomitant removal of silyl group and directing group. 
In conclusion the first manganese-catalysed C–H activation of indole derivatives to develop a new 
C–H alkynylation protocol was reported. The methodology resulted to be tolerant toward differently 
substituted indoles and silyl haloalkynes. Moreover the transformation revealed to be not limited to 
the use of haloalkynes featuring silyl groups but can be extended to the less employed aryl, alkenyl 
and alkyl moiety adding to the mixture sub-catalytic amount of BPh3. The protocol demonstrated to 
be also suitable for functionalization of more complex substrates such as alkyne featuring steroids 
or acyclic peptides. The corresponding alkynylated peptides were isolated without loss of chiral 
purity. Finally, it was also illustrated the possibility to perform an intramolecular manganese-
catalysed C–H alkynylation to synthesize macrocycle. 
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7.1.1 Experimental Section 
Catalytic reactions were performed under N2 atmosphere using pre-dried glassware and standard 
Schlenk techniques. 1,4-Dioxane and toluene were dried with sodium and freshly distilled under N2, 
DCE and TFE were dried with CaH2 and freshly distilled under N2. The substrates 189a-c 192a-
1n,[1,2] [D]1-192a, [2] 190, [3, 4] 194, [3, 5] 196 [2, 6] and 198 [2, 6] were synthesized according to 
previously described methods. Other chemicals were obtained from commercial sources and were 
used without further purification. Yields refer to isolated compounds, estimated to be >95% pure as 
determined by 1H-NMR and GC. TLC: Macherey-Nagel, TLC plates Alugram®Sil G/UV254. 
Detection under UV light at 254 nm. Chromatography: Separations were carried out on Merck 
Silica 60 (0.040–0.063 mm, 70–230 mesh ASTM). All IR spectra were recorded on a BRUKER 
ALPHA-P spectrometer. MS: EI-MS: Finnigan MAT 95, 70eV; ESI-MS: Finnigan LCQ. High 
resolution mass spectrometry (HRMS): APEX IV 7T FTICR, Bruker Daltonic. M. p. Stuart® 
Melting Point Apparatus SMP3 melting point apparatus, values are uncorrected. 1H, 13C, 19F 
NMR-spectra were recorded at 300 (1H), 400 (1H), 500 (1H), 600 (1H), 75, 100, 125 {13C, APT 
(Attached Proton Test)} and 283 MHz (19F), respectively, on Varian Unity-300 (600) and AMX 300 
instruments in CDCl3 solutions. If not otherwise specified, chemical shifts (δ) are given in ppm. 
 
General Procedure for the manganese-catalysed C-H alkynylation 
General Procedure A: To a solution of substrates 192 (0.5 mmol), MnBr(CO)5 (6.9 mg, 5.0 mol 
%) and Cy2NH (181 mg, 1.0 mmol) in DCE (1.0 mL), silyl bromoalkynes 190 (0.6 mmol) was 
added. The mixture was stirred at 80 °C for 16 h. After completion of the reaction, CH2Cl2 (3.0 mL) 
was added at ambient temperature and the volatiles were removed in vacuo. Purification by 
chromatography on silica gel afforded the desired product 193. 
 
General Procedure B: To a solution of substrates 192 (0.5 mmol), MnBr(CO)5 (6.9 mg, 5.0 mol 
%), Cy2NH (181 mg, 1.0 mmol) and BPh3 (25 μL, 0.05 mol %, 0.01 M stock solution in DCE) in 
DCE (1 mL), aryl or alkyl bromoalkynes 194 (0.6 mmol) was added. The mixture was stirred at 80 
°C for 16 h. After completion of the reaction, CH2Cl2 (3 mL) was added at ambient temperature and 
the volatiles were removed in vacuo. Purification by chromatography on silica gel afforded the 
desired product 195. 
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(193aa): The general procedure A was followed using substrate 192a (98 
mg, 0.5 mmol) and 190a (157 mg, 0.6 mmol). Isolation by column 
chromatography (n-hexane/EtOAc: 9/1) yielded 193aa (186 mg, 99%) as 
a colorless liquid. 1H NMR (400 MHz, CDCl3) δ = 8.75 (d, J = 4.8 Hz, 
2H), 8.30 (dd, J = 8.5, 0.9 Hz, 1H), 7.58 (dd, J = 8.0, 1.0 Hz, 1H), 7.34 (ddd, J = 8.5, 7.1, 1.3 Hz, 
1H), 7.23 (ddd, J = 8.0, 7.1, 1.0 Hz, 1H), 7.12 (t, J = 4.8 Hz, 1H), 7.10 (s, 1H), 1.15‒1.14 (m, 21H). 
13C NMR (100 MHz, CDCl3) δ = 157.9 (CH), 157.2 (Cq), 136.1 (Cq), 128.4 (Cq), 124.7 (CH), 122.3 
(CH), 120.8 (Cq), 120.6 (CH), 117.5 (CH), 115.6 (CH), 114.0 (CH), 98.7 (Cq), 97.7 (Cq), 18.6 
(CH3), 11.3 (CH). IR (neat): 2957, 2151, 1561, 1421, 1248, 839, 746 cm-1. MS (EI) m/z (relative 
intensity) 375 (30) [M+], 332 (100). HR-MS (ESI) m/z calcd for C23H30N3Si [M+H+] 375.2131, 
found 375.2125. The analytical data are in accordance with those previously published in the 
literature.[1] 
 
 
(193fa): The general procedure A was followed using substrate 1f 
(105 mg, 0.5 mmol) and 190a (157 mg, 0.6 mmol). Isolation by 
column chromatography (n-pentane/EtOAc: 9/1) yielded 193fa (160 
mg, 82%) as a yellow liquid. 1H NMR (500 MHz, CDCl3) δ = 8.74 
(d, J = 4.8 Hz, 2H), 8.32 (d, J = 8.4 Hz, 1H), 7.53 (d, J = 7.8 Hz, 1H), 7.31 (ddd, J = 8.4, 7.1, 1.0 
Hz, 1H), 7.21 (ddd, J = 8.0, 7.1, 1.0 Hz, 1H), 7.11 (t, J = 4.8 Hz, 1H), 2.45 (s, 3H), 1.13 (m, 21H). 
13C NMR (125 MHz, CDCl3) δ = 157.9 (CH), 157.4 (Cq), 135.8 (Cq), 129.4 (Cq), 125.1 (Cq), 125.0 
(CH), 121.9 (CH), 119.0 (CH), 118.7 (Cq), 117.0 (CH), 114.2 (CH), 100.7 (Cq), 98.3 (Cq), 18.7 
(CH3), 11.4 (CH), 9.9 (CH3). IR (neat): 2940, 2862, 2142, 1561, 1426, 728 cm-1. MS (EI) m/z 
(relative intensity) 389 (56) [M+], 346 (100), 330 (49). HR-MS (ESI) m/z calcd for C24H32N3Si 
[M+H+] 390.2365, found 390.2360.  
The analytical data are in accordance with those previously published in the literature.[1] 
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(193ha): The general procedure A was followed using substrate 192h (119 
mg, 0.5 mmol) and 190a (157 mg, 0.6 mmol). Isolation by column 
chromatography (n-Pentane/EtOAc : 9/1) yielded 193ha (70 mg, 34%) as 
yellow oil. 1H NMR (300MHz, CDCl3) δ = 8.88 (d, J = 4.8 Hz, 2H), 8.47 
(dt, J = 6.3, 2.5 Hz, 1H), 7.83‒7.78 (m, 1H), 7.37‒7.29 (m, 3H), 2.86 (s, 
3H), 1.06 (s, 18H), 1.04 (s, 3H). 13C NMR (126 MHz, CDCl3) δ = 194.8 (Cq), 158.5 (CH), 156.7 
(Cq), 136.0 (Cq), 126.2 Cq), 125.7 (CH), 124.7 (Cq), 124.1 (CH), 124.0 (Cq), 123.2 (CH), 119.2 
(CH), 112.0 (CH), 107.3 (Cq), 97.6 (Cq), 30.8 (CH3), 18.6 (CH3), 11.3 (CH).  IR (neat): 2942, 
2864, 2149, 1651, 1563, 1419, 1384, 1193, 721 cm-1; MS (EI) m/z (relative intensity) 417 (29) 
[M+], 402 (9), 375 (100), 332 (77), 290 (76). HR-MS (EI) m/z calcd for C25H31N3OSi [M+] 
417.2236, found 417.2231. 
 
 
(193ia): The general procedure A was followed using substrate 192i (134 
mg, 0.5 mmol) and 190a (157 mg, 0.6 mmol). Isolation by column 
chromatography (n-pentane/EtOAc: 9/1) yielded 193ia (195 mg, 87%) as 
a yellow solid. M.p. = 68‒70 °C. 1H NMR (500 MHz, CDCl3) δ = 8.75 (d, 
J = 4.8 Hz, 2H), 8.34 (d, J = 8.5 Hz, 1H), 7.58 (d, J = 7.7 Hz, 1H), 7.33 
(ddd, J = 8.4, 7.2, 1.1 Hz, 1H), 7.25‒7.22 (m, 1H), 7.14 (t, J = 4.8 Hz, 1H), 3.96 (s, 2H), 3.65 (s, 
3H), 1.13‒1.12 (m, 21H). 13C NMR (125 MHz, CDCl3) δ = 171.1 (Cq), 158.0 (CH), 157.3 (Cq), 
135.7 (Cq), 128.4 (Cq), 125.2 (CH), 122.4 (CH), 121.0 (Cq), 120.2 (Cq), 119.3 (CH), 117.4 (CH), 
114.4 (CH), 101.7 (Cq), 97.4 (Cq), 52.0 (CH3), 31.3 (CH2), 18.6 (CH3), 11.3 (CH). IR (neat): 2942, 
2863, 2142, 1737, 1566, 1426, 655 cm-1. MS (ESI) m/z (relative intensity) 470 [M+Na+] (100), 448 
[M+H+] (60). HR-MS (ESI) m/z calcd for C26H34N3O2Si [M+H+] 448.2420, found 448.2415. 
 
 
(193ja): The general procedure A was followed using substrate 192j (112 
mg, 0.5 mmol) and 190a (157 mg, 0.6 mmol). Isolation by column 
chromatography (n-pentane/EtOAc: 9/1) yielded 193ja (160 mg, 79%) as 
a yellow solid. M.p. = 74‒76 °C. 1H NMR (500 MHz, CDCl3) δ = 8.85 (d, 
J = 4.7 Hz, 2H), 7.44 (d, J = 7.6 Hz, 1H), 7.34 (t, J = 4.8 Hz, 1H), 7.13‒ 7.06 (m, 2H), 6.97 (s, 1H), 
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2.29 (q, J = 7.4 Hz, 2H), 0.99‒0.98 (m, 21H), 0.93 (t, J = 7.4 Hz, 3H). 13C NMR (125 MHz, CDCl3) 
δ = 158.9 (Cq), 158.3 (CH), 135.4 (Cq), 128.7 (Cq), 128.1 (Cq), 124.6 (CH), 122.8 (Cq), 121.9 (CH), 
119.7 (CH), 119.0 (CH), 112.4 (CH), 97.8 (Cq), 97.4 (Cq), 25.4 (CH2), 18.5 (CH3), 13.9 (CH3), 11.2 
(CH). IR (neat): 2940, 2864, 2146, 1560, 1420, 734, 669 cm-1. MS (EI) m/z (relative intensity) 403 
(51) [M+], 360 (100), 332 (18), 318 (29). HR-MS (ESI) m/z calcd for C25H34N3Si [M+H+] 
404.2522, found 404.2517.  
The analytical data are in accordance with those previously published in the literature.[1] 
 
 
(193na): The general procedure A was followed using substrate 1n 
(73 mg, 0.5 mmol) and 190a (261 mg, 1.0 mmol). Isolation by 
column chromatography (n-pentane/EtOAc: 9/1) yielded 193na 
(225 mg, 89%) as a yellow solid. M.p. = 72‒74 °C. 1H NMR (400 
MHz, CDCl3) δ = 8.76 (d, J = 4.8 Hz, 2H), 7.26 (t, J = 4.8 Hz, 1H), 6.51 (s, 2H), 0.99 (m, 42H). 13C 
NMR (100 MHz, CDCl3) δ = 158.3 (CH), 156.5 (Cq), 119.4 (CH), 117.6 (CH), 117.3 (Cq), 97.7 
(Cq), 95.2 (Cq), 18.5 (CH3), 11.2 (CH). IR (neat): 2941, 2863, 2146, 1563, 1422, 1014, 767, 653 cm-
1
. MS (ESI) m/z (relative intensity) 528 [M+Na+] (100), 506 [M+H+] (92). HR-MS (ESI) m/z calcd 
for C30H48N3Si2 [M+H+] 506.3387, found 506.3381. 
 The analytical data are in accordance with those previously published in the literature.[1] 
 
 
(193ka): The general procedure A was followed using substrate 192k (127 
mg, 0.5 mmol) and 190a (157 mg, 0.6 mmol). Isolation by column 
chromatography (n-pentane/EtOAc: 9/1) yielded 193ka (185 mg, 85%) as 
a white solid. M.p. = 140‒142 °C. 1H NMR (500 MHz, CDCl3) δ = 8.79 
(d, J = 4.8 Hz, 2H), 8.45 (d, J = 8.4 Hz, 1H), 7.96 (dd, J = 7.5, 1.0 Hz, 
1H), 7.70 (s, 1H), 7.34 (dd, J = 8.1, 8.1 Hz, 1H), 7.21 (t, J = 4.8 Hz, 1H), 3.99 (s, 3H), 1.11 (m, 
21H). 13C NMR (125 MHz, CDCl3) δ = 167.4 (Cq), 158.2 (CH), 157.1 (Cq), 136.7 (Cq), 128.3 (Cq), 
125.5 (CH), 123.9 (CH), 122.9 (Cq), 121.5 (Cq), 118.6 (CH), 118.0 (CH), 116.1 (CH), 99.3 (Cq), 
98.3 (Cq), 51.9 (CH3), 18.6 (CH3), 11.3 (CH). IR (neat): 2943, 2865, 2143, 1705, 1567, 1414, 732 
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cm-1. MS (ESI) m/z (relative intensity) 456 [M+K+] (100), 434 [M+H+] (73). HR-MS (ESI) m/z 
calcd for C25H32N3O2Si [M+H+] 434.2264, found 434.2258. 
 
 
(195aa): The general procedure B was followed using substrate 192a 
(98 mg, 0.5 mmol) and 194a (108 mg, 0.6 mmol) for 1 h. Isolation by 
column chromatography (n-pentane/EtOAc: 5/1) yielded 195aa (141 
mg, 95%) as a colorless oil. 1H NMR (500 MHz, CDCl3) δ = 8.85 (d, J 
= 4.9 Hz, 2H), 8.31 (d, J = 8.4 Hz, 1H), 7.60 (d, J = 7.6 Hz, 1H), 7.52–7.48 (m, 2H), 7.35–7.31 (m, 
4H), 7.25‒7.21 (m, 1H), 7.21 (t, J = 4.9 Hz, 1H), 7.08 (s, 1H). 13C NMR (125 MHz, CDCl3) δ = 
158.1 (CH), 157.4 (Cq), 136.4 (Cq), 131.3 (CH), 128.8 (Cq), 128.4 (CH), 128.3 (CH), 124.8 (CH), 
123.3 (Cq), 122.4 (CH), 120.9 (Cq), 120.8 (CH), 117.7 (CH), 114.6 (CH), 114.1 (CH), 95.0 (Cq), 
82.5 (Cq). IR (neat): 3048, 2963, 2851, 1560, 1418, 1081, 741, 686, 521 cm-1. MS (ESI) m/z 
(relative intensity) 296 (5) [M+], 214 (11), 196 (100), 173 (20), 149 (15). HR-MS (ESI) m/z calcd 
for C20H14N3 [M+H+] 296.1182, found 296.1188. 
 
(195ab): The general procedure B was followed using substrate 
192a (98 mg, 0.5 mmol) and 194b (117 mg, 0.6 mmol) for 1 h. 
Isolation by column chromatography (n-pentane/EtOAc: 9/1) 
yielded 195ab (153 mg, 99%) as a colorless solid. M.p. = 100‒102 
°C. 1H NMR (500 MHz, CDCl3) δ = 8.84 (d, J = 4.8 Hz, 2H), 8.30 (d, J = 8.4 Hz, 1H), 7.59 (d, J = 
7.8 Hz, 1H), 7.39 (d, J = 8.0 Hz, 2H), 7.32 (ddd, J = 8.3, 6.9, 1.0 Hz, 1H), 7.24‒7.21 (m, 1H), 7.19 
(t, J = 4.8 Hz, 1H), 7.14 (d, J = 7.9 Hz, 2H), 7.06 (s, 1H), 2.35 (s, 3H). 13C NMR (125 MHz, 
CDCl3) δ = 158.1 (CH), 157.4 (Cq), 138.5 (Cq), 136.3 (Cq), 131.2 (CH), 129.1 (CH), 128.8 (Cq), 
124.6 (CH), 122.4 (CH), 121.0 (Cq), 120.7 (CH), 120.2 (Cq), 117.7 (CH), 114.3 (CH), 114.0 (CH), 
95.1 (Cq), 81.8 (Cq), 21.5 (CH3). IR (neat): 3046, 2920, 2851, 1557, 1422, 800, 739, 526 cm-1. MS 
(EI) m/z (relative intensity) 309 (100) [M+], 294 (15). HR-MS (ESI) m/z calcd for C21H16N3 [M+H+] 
310.1344, found 310.1339. 
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(195ae): The general procedure B was followed using substrate 192a 
(98 mg, 0.5 mmol), 194e (117 mg, 0.6 mmol) and MnBr(CO)5 (3.4 
mg, 2.5 mol %). Isolation by column chromatography (n-
pentane/EtOAc: 8/2) yielded 195ae (100 mg, 65%) as a colorless 
solid. M.p. = 111‒ 113 °C. 1H NMR (300 MHz, CDCl3) δ = 8.84 (d, J = 4.8 Hz, 2H), 8.31 (dd, J = 
8.4, 0.9 Hz, 1H), 7.60 (d, J = 7.7 Hz, 1H), 7.36‒7.28 (m, 3H), 7.25‒7.18 (m, 3H), 7.13 (d, J = 7.7 
Hz, 1H), 7.07 (s, 1H), 2.34 (s, 3H). 13C NMR (125 MHz, CDCl3) δ = 158.0 (CH), 157.3 (Cq), 137.9 
(Cq), 136.3 (Cq), 131.8 (CH), 129.2 (CH), 128.7 (Cq), 128.3 (CH), 128.1 (CH), 124.6 (CH), 123.0 
(Cq), 122.3 (CH), 120.9 (Cq), 120.7 (CH), 117.6 (CH), 114.5 (CH), 114.0 (CH), 95.1 (Cq), 82.1 
(Cq), 21.3 (CH3). IR (neat): 3038, 2916, 2204, 1558, 1451, 1416, 810, 791, 746 cm-1. MS (EI) m/z 
(relative intensity) 309 (85), 308 (100), 294 (14). HR-MS (EI) m/z calcd for C21H15N3 [M+] 
309.1266, found 309.1264. 
 
 
 (195af): The general procedure B was followed using substrate 192a 
(98 mg, 0.5 mmol) and 194f (164 mg, 0.6 mmol). Isolation by 
column chromatography (n-pentane/EtOAc: 8/2) yielded 195af (146 
mg, 75%) as a colorless oil. 1H NMR (400 MHz, CDCl3) δ = 8.75 (d, 
J = 5.7 Hz, 2H), 8.31 (d, J = 8.4 Hz, 1H), 7.59 (d, J = 7.9 Hz, 1H), 7.38‒7.27 (m, 4H), 7.23‒7.21 
(m, 2H), 7.16‒7.13 (m, 2H), 7.09‒7.03 (m, 4H), 6.99 (ddd, J = 8.2, 2.5, 1.1 Hz, 1H). 13C NMR (100 
MHz, CDCl3) δ = 158.1 (CH), 157.3 (Cq), 157.2 (Cq), 156.6 (Cq), 136.4 (Cq), 129.9 (CH), 129.7 
(CH), 128.7 (Cq), 126.0 (CH), 124.9 (CH), 124.7 (Cq), 123.7 (CH), 122.5 (CH), 120.9 (CH), 120.8 
(CH), 120.5 (Cq), 119.4 (CH), 119.0 (CH), 117.7 (CH), 114.8 (CH), 114.2 (CH), 94.4 (Cq), 83.1 
(Cq). IR (neat): 3039, 2205, 1734, 1562, 1421, 1238, 1212, 748 cm-1. MS (ESI) m/z (relative 
intensity) 410 [M+Na+] (78), 388 [M+H+] (100). HR-MS (ESI) m/z calcd for C26H18N3O [M+H+] 
388.1450, found 388.1444. 
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 (195ai): The general procedure B was followed using substrate 192a 
(98 mg, 0.5 mmol) and 194i (149 mg, 0.6 mmol). Isolation by column 
chromatography (n-pentane/EtOAc: 9/1) yielded 195ai (155 mg, 85%) 
as a colorless oil. 1H NMR (300 MHz, CDCl3) δ = 8.83 (d, J = 4.8 Hz, 
2H), 8.36 (dd, J = 8.4, 0.6 Hz, 1Hz), 7.68‒7.60 (m, 3H), 7.50 (dd, J = 7.4, 7.4 Hz, 1H), 7.40‒7.33 
(m, 2H), 7.26‒7.17 (m, 3H). 13C NMR (75 MHz, CDCl3) δ = 158.2 (CH), 157.2 (Cq), 136.5 (Cq), 
133.8 (CH), 131.3 (CH), 130.7 (q, 2JCF = 30.5 Hz, Cq), 128.7 (Cq), 127.8 (CH), 125.8 (q, 3JCF = 5.1 
Hz, CH), 125.1 (CH), 123.5 (q, 1JCF = 273.4 Hz, Cq), 122.5 (CH), 121.6 (q, 3JCF = 2.1 Hz, Cq), 
120.9 (CH), 120.2 (Cq), 117.6 (CH), 116.1 (CH), 114.3 (CH), 91.0 (Cq), 88.1 (Cq). 19F NMR (282 
MHz, CDCl3) δ = –62.16. IR (neat): 3050, 2205, 1562, 1422, 1314, 1125, 744 cm-1. MS (EI) m/z 
(relative intensity) 363 (100) [M+], 294 (28). HR-MS (ESI) m/z calcd for C21H14F3N3 [M+H+] 
364.1062, found 364.1056. 
 
 
 (195aj): The general procedure B was followed using substrate 192a 
(98 mg, 0.5 mmol), 194j (135 mg, 0.6 mmol) and MnBr(CO)5 (3.4 mg, 
2.5 mol %). Isolation by column chromatography (n-pentane/EtOAc: 
8/2) yielded 195aj (168 mg, 99%) as a colorless oil. 1H NMR (400 
MHz, CDCl3) δ = 8.84 (d, J = 4.8 Hz, 2H), 8.29 (dd, J = 8.4, 0.9 Hz, 1H), 7.59 (d, J = 7.8 Hz, 1H), 
7.45 (dd, J = 7.6, 1.7 Hz, 1H), 7.31 (ddd, J = 8.4, 7.1, 1.3 Hz, 1H), 7.27‒ 7.20 (m, 2H), 7.18 (dd, J = 
4.8, 4.8 Hz, 1H), 7.10 (s, 1H), 6.90 (ddd, J = 7.5, 7.5, 1.1 Hz, 1H), 6.86 (d, J = 8.3 Hz, 1H), 4.11 (q, 
J = 7.0 Hz, 2H), 1.42 (t, J = 7.0 Hz, 3H). 13C NMR (100 MHz, CDCl3) δ = 159.4 (Cq), 158.1 (CH), 
157.4 (Cq), 136.3 (Cq), 133.3 (CH), 129.7 (CH), 128.9 (Cq), 124.6 (CH), 122.3 (CH), 121.3 (Cq), 
120.7 (CH), 120.4 (CH), 117.5 (CH), 114.5 (CH), 114.0 (CH), 113.1 (Cq), 112.3 (CH), 91.9 (Cq), 
86.2 (Cq), 64.3 (CH2), 14.8 (CH3). IR (neat): 2979, 2928, 1733, 1421, 804, 746 cm-1. MS (ESI) m/z 
(relative intensity) 362 [M+Na+] (100), 340 [M+H+ ] (38). HR-MS (ESI) m/z calcd for C22H18N3O 
[M+H+] 340.1450, found 340.1444. 
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 (5195ak): The general procedure B was followed using substrate 192a 
(98 mg, 0.5 mmol) and 194k (156 mg, 0.6 mmol). Isolation by column 
chromatography (n-pentane/EtOAc:8/2) yielded 195ak (185 mg, 99%) 
as a colorless oil. 1H NMR (400 MHz, CDCl3) δ = 8.84 (d, J = 4.8 Hz, 
2H), 8.34 (dd, J = 8.5, 0.9 Hz, 1H), 7.61 (dd, J = 7.9, 1.0 Hz, 1H), 7.57 (dd, J = 8.1, 1.2 Hz, 1H), 
7.54 (dd, J = 7.7, 1.7 Hz, 1H), 7.35 (ddd, J = 8.4, 7.1, 1.3 Hz, 1H), 7.30–7.21 (m, 2H), 7.18 (t, J = 
4.8 Hz, 1H), 7.17–7.12 (m, 2H). 13C NMR (125 MHz, CDCl3) δ = 158.1 (CH), 157.2 (Cq), 136.4 
(Cq), 133.2 (CH), 132.4 (CH), 129.2 (CH), 128.7 (Cq), 126.9 (CH), 125.5 (Cq), 124.9 (CH), 124.8 
(Cq), 122.4 (CH), 120.8 (CH), 120.4 (Cq), 117.6 (CH), 115.5 (CH), 114.2 (CH), 93.5 (Cq), 86.9 
(Cq). IR (neat): 3049, 2925, 2202, 1990, 1911, 1562, 1422, 1024, 745, 459 cm-1. MS (EI) m/z 
(relative intensity) 375 (79) [M+] (81Br), 374, (100) [M–H+] (81Br), 373 (79) [M+] (79Br), 372 (88) 
[M–H+] (79Br), 293 (50), 214 (22), 147 (28). HR-MS (EI) m/z calcd for C20H12BrN3 [M+] 373.0215 
(79Br), found 373.0199 (79Br). 
 
 
 (195al): The general procedure B was followed using substrate 192a 
(98 mg, 0.5 mmol) and 194l (111 mg, 0.6 mmol). Isolation by column 
chromatography (n-pentane/EtOAc: 9/1) yielded 195al (118 mg, 79%) 
as a colorless oil. 1H NMR (300 MHz, CDCl3) δ = 8.81 (d, J = 4.8 Hz, 
2H), 8.24 (dd, J = 8.4, 0.9 Hz, 1H), 7.55 (ddd, J = 7.8, 1.0, 1.0 Hz, 1H), 7.28 (ddd, J = 8.4, 7.2, 1.2 
Hz, 1H), 7.21‒7.16 (m, 2H), 6.94 (s, 1H), 6.18 (tt, J = 4.0, 1.8 Hz, 1H), 2.22‒2.18 (m, 2H), 2.15‒
2.11 (m, 2H), 1.68‒1.57 (m, 4H). 13C NMR (125 MHz, CDCl3) δ = 158.0 (CH), 157.3 (Cq), 136.2 
(Cq), 135.3 (CH), 128.7 (Cq), 124.3 (CH), 122.2 (CH), 121.3 (Cq), 120.7 (Cq), 120.5 (CH), 117.5 
(CH), 113.9 (CH), 113.7 (CH), 96.8 (Cq), 79.8 (Cq), 28.8 (CH2), 25.9 (CH2), 22.3 (CH2), 21.6 
(CH2). IR (neat): 2962, 2927, 1561, 1449, 1259, 1014, 796, 742 cm-1. MS (ESI) m/z (relative 
intensity) 338 [M+K+] (41), 322 [M+Na+] (100), 300 [M+H ] (95). HR-MS (ESI) m/z calcd for 
C20H18N3 [M+H+] 300.1501, found 300.1495.  
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 (195aq): The general procedure B was followed using substrate 192a 
(98 mg, 0.5 mmol), 194q (139 mg, 0.6 mmol) and MnBr(CO)5 (3.4 mg, 
2.5 mol %). Isolation by column chromatography (n-Pentane/EtOAc : 
9/1) yielded 195aq (66 mg, 38%) as brown oil. 1H NMR (400MHz, 
CDCl3) δ = 8.87 (d, J = 4.8 Hz, 2H), 8.55 (d, J = 8.1 Hz, 1H), 8.40 (d, J = 8.4 Hz, 1H), 7.84 (dd, J = 
14.6, 7.9 Hz, 2H), 7.75 (d, J = 7.1 Hz, 1H), 7.63 (d, J = 7.8 Hz, 1H), 7.57‒7.50 (m, 2H), 7.47‒7.43 
(m, 1H), 7.36 (ddd, J = 8.3, 6.9, 1.0 Hz, 1H), 7.27‒7.20 (m, 3 H). 13C NMR (101 MHz, CDCl3) δ = 
158.2 (CH), 157.5 (Cq), 136.5 (Cq), 133.4 (Cq), 133.2 (Cq), 130.2 (CH), 128.9 (Cq), 128.7 (CH), 
128.2 (CH), 126.6 (CH), 126.5 (CH), 126.4 (CH), 125.3 (CH), 124.9 (CH), 122.5 (CH), 121.1 (Cq), 
121.0 (Cq), 120.8 (CH), 117.6 (CH), 115.1 (CH), 114.4 (CH), 93.5 (Cq), 87.4 (Cq). IR (neat): 3044, 
2924, 2851, 1733, 1561, 1419, 798, 771, 744 cm-1. HR-MS (ESI) m/z calcd for C24H15N3 [M+H+] 
346.1344, found 346.1332. 
 
 
 (195as): The general procedure B was followed using substrate 192a 
(133 mg, 0.5 mmol) and 194s (109 mg, 0.6 mmol). Isolation by column 
chromatography (n-pentane/EtOAc:8/2) yielded 195as (157 mg, 85%) 
as a brown solid. M.p. = 135‒137 °C. 1H NMR (300 MHz, CDCl3) δ = 
8.83 (d, J = 4.8 Hz, 1H), 8.82 (d, J = 4.8 Hz, 1H), 8.37 (d, J = 8.4 Hz, 
1H), 7.61 (d, J = 7.8 Hz, 1H), 7.55‒7.50 (m, 2H), 7.38‒7.30 (m, 4H), 7.29‒7.22 (m, 1H), 7.18 (dd, J 
= 4.8, 4.8 Hz, 1H), 4.02 (s, 2H), 3.69 (s, 3H). 13C NMR (125 MHz, CDCl3) δ = 171.0 (Cq), 157.9 
(CH), 157.2 (Cq), 136.0 (Cq), 131.2 (CH), 128.5 (Cq), 128.3 (CH), 128.2 (CH), 125.1 (CH), 123.2 
(Cq), 122.4 (CH), 119.9 (Cq), 119.8 (Cq), 119.1 (CH), 117.5 (CH), 114.4 (CH), 98.6 (Cq), 81.2 (Cq), 
52.1 (CH3), 31.4 (CH2). IR (neat): 3048, 2953, 2848, 2197, 1730, 1561, 745, 691 cm-1. MS (EI) m/z 
(relative intensity) 367 (47), 352, (5), 308 (100). HR-MS (EI) m/z calcd for C23H17N3O2 [M+] 
367.1321, found 367.1305. 
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8. CONCLUSIONS 
In conclusion, in this work it was reported different employments of allene-derivatives in organic 
chemistry. In particular, it was reported the first metal-free enantioselective dearomatization of 
indoles using allenamides.  
 
Figure 1: First metal-free enantioselective dearomatization of indoles. 
The methodology resulted to be tolerant toward several functional groups. The indolenines were 
isolated in good to excellent yields and very high enantiomeric excesses. Moreover, it was also 
developed a one-pot three-component reaction for the dearomatization/hydrogenation cascade 
reaction that involving indoles, allenamides and a Hantzsch ester. The corresponding indolines were 
obtained in moderate yields and excellent diastereoisomeric ratios as well as enantiomeric excesses. 
Inspired by these satisfactory results obtained in electrophilic activation of allenamides promoted by 
BINOL-based phosphoric acids, we developed an enantioselective Friedel-Crafts reaction of 
allenamides in order to prepare 1-vinyl tetrahydroisoquinolines.  
 
Figure 2: Enantioselective synthesis of 1-vinyl tetrahydroisoquinolines from electrophilic activation of allenamides 
promoted by chiral BINOL-based phosphoric acids. 
The tetrahydroisoquinolines obtained with this methodology present a vinyl group in 1 position 
which is a powerful building block for further functionalizations. 
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Not only allenamides but also allenoates were considered in this work. Indeed, it was also reported 
an efficient α-allylation of enones promoted by gold(I)/H+ co-catalyst. In particular the allenoate 
intermediates generated by [3,3]-sigmatropic rearrangements of propargylic pivalates underwent 
electrophilic trapping by activated allylic alcohols. 
 
Figure 3: Gold(I)/H+ co-catalysed α-allylation of enones with activated alcohols. 
The transformation demonstrated large flexibility in the employment of different functional groups, 
and the corresponding α-allylated enones were obtained in good to excellent yields. In some of the 
cases it was possible to isolate bicycles compound delivered by an allylic alkylation/Michael-type 
Friedel-Crafts alkylation. 
Finally, the Mn-catalysed C‒H alkynylation of indoles was reported. The methodology resulted to 
be tolerant toward several functional groups. Several silyl haloalkynes as well as aryl, alkenyl and 
alkyl bromoacetylenes resulted in the corresponding products in good to excellent yields. Moreover, 
the protocol is suitable for the functionalization of more complex substrates such as peptides 
without loss of chiral purity. It is also reported the possibility to perform an intramolecular Mn-
catalysed C‒H alkynylation to synthetize macrocycles. 
 
 
Figure 4: Mn-catalysed C‒H alkynylation of indoles. 
